Document:

10.25 - EmergeHebAgree-redacted

Sales, Marketing, Distribution, and Supply     Agreement 
WHEREAS HEMISPHERX is a biopharmaceutical company with headquarters at One Penn Center, 1617 JFK Boulevard, Suite 500, Philadelphia, PA 19103, U.S. ("HEMISPHERX") and Emerge Health Pty Ltd. is a pharmaceutical company with its primary offices located at Suite 3, Level 1, 2 Theatre Place, Canterbury VIC 3126, Australia (" EMERGE”), each a “Party” together, “Parties” and
WHEREAS HEMISPHERX owns intellectual proprietary rights relating to poly I: poly C12U (Rintatolimod and Rintamod), with the trade name Ampligen® (“Ampligen”) and
WHEREAS HEMISPHERX desires to have Ampligen provided to physicians treating CFS patients in Australia and New Zealand prior to regulatory approval and to have Ampligen approved by the Australian regulatory authority, Therapeutic Goods Administration (“TGA”) and New Zealand’s Medicines and Medical Devices Safety Authority (“Medsafe”)
WHEREAS HEMISPHERX presently has no registered company or subsidiary in Australia or New Zealand and
WHEREAS EMERGE has sales, marketing, distribution capabilities in Australia and New Zealand and
WHEREAS EMERGE has the ability to supply Ampligen in Australia and New Zealand prior to approval by TGA and Medsafe in accordance with Australia’s Special Access Scheme (“SAS”) and New Zealand’s Section 29 of the Medicines Act (“Section 29”) and to seek to gain TGA and Medsafe approval of Ampligen and subsequently to sell market and distribute Ampligen in Australia and New Zealand and
WHEREAS, EMERGE desires to supply Ampligen under Australia’s SAS and New Zealand’s Section 29 and to seek approval of Ampligen from TGA and Medsafe to subsequently sell market and distribute Ampligen in Australia and New Zealand and
WHEREAS, HEMISPHERX desires to supply and sell Ampligen to EMERGE, and EMERGE is willing to purchase Ampligen from HEMISPHERX
NOW THEREFORE, in consideration of the mutual covenants and agreements made herein, and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Parties agree as follows:
I.    DEFINITIONS
"Affiliate"  means  any  corporation  or  other  business  entity,  which  controls,  is controlled by, or is under the common control of a Party.
"Ampligen®" means a synthetic double-stranded (dsRNA) TLR3 agonist manufactured by HEMISPHERX, the trademark for which is owned by HEMISPHERX and which is part of HEMISPHERX Intellectual Property.
"Ampligen® Data" means all data possessed by HEMISPHERX relating to the use of Ampligen® to treat CFS and which is needed to obtain regulatory approval in the Territory.
"Ampligen Unit" means 1 x100ml vial containing 200mg of Ampligen.

         
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

"Chronic Fatigue Syndrome" means a disease or condition in which a person suffers from continual fatigue and malaise often accompanies by pain and depression ("CFS").
"End User" means a physician, medical facility or institution, or government agency that purchases Ampligen with the intent of administering it to a patient.
"Field" means CFS.
"HEMISPHERX   Intellectual   Property"   means   all   HEMISPHERX   patents, patent applications, know-how, and trademarks owned or controlled by HEMISPHERX up to the termination or expiration of this Agreement.
"Sales Price" means the price EMERGE and/or its Affiliates charge an End User for an Ampligen Unit.
"Territory" means Australia and New Zealand.
“Transfer Price” means the price charged by HEMISPHERX to EMERGE for an Ampligen Unit.
II.    LICENSE 
A.    HEMISPHERX hereby grants EMERGE the exclusive license to sell, market, and distribute Ampligen for use in the Field in the Territory.
B.    EMERGE shall not use HEMISPHERX Intellectual Property nor sell nor permit the sale of any products that use the HEMISPHERX Intellectual Property outside the Territory or knowingly sell or have sold any products that use the HEMISPHERX Intellectual Property to any party in or outside the Territory for export or sale outside the Territory, without HEMISPHERX's prior written consent.
C.     EMERGE will have 24 months to gain TGA and Medsafe approval of Ampligen from the date of submission and assuming that HEMISPHERX has provided all the appropriate documentation and technical/medical support in a timely fashion to assist with the Registration otherwise the license can be terminated by HEMISPHERX (without penalty or payment) or HEMISPHERX can extend the period for approval.
Ill.    COMMERCIAL DEVELOPMENT
A.     HEMISPHERX will provide EMERGE:
1.    A CTD dossier for Ampligen which will assist EMERGE in attaining regulatory approval in the Territory. EMERGE will keep a record of each person in EMERGE to see any part of the dossier and will provide this record to HEMISPHERX. EMERGE will not allow anyone outside EMERGE to view the dossier or any part thereof without HEMISPHERX written permission.
2.    All the appropriate information about Ampligen that will assist with the promotion of Ampligen in the Territory.
3.    Market place information from overseas on successful strategies and tactics that can be utilized in the Territory.
4.    Ongoing scientific and medical support.
5.    Ampligen Units in quantities sufficient for EMERGE's commercial needs in the Territory.

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

B.    EMERGE will:
1.    Prepare and provide a Business Plan, under Australia’s SAS and New Zealand’s Section 29, to be provided and attached to this Agreement as Exhibit 1, to make aware and educate physicians and patients about Ampligen. 
2.    Assist in determining reimbursable End User pricing of Ampligen and gain reimbursement for Ampligen for CFS under SAS and Section 29 and post approval of Ampligen for CFS in the Territory.
3.    Assist physicians who desire to administer Ampligen to their CFS patients with the required paperwork under Australia’s SAS and New Zealand’s Section 29.
4.    Manage the cold chain logistics within the Territory from arrival to End user supply.
5.    Register Ampligen as an orphan drug in the Territory. 
6.    Be the sponsor, hold the product registration, and maintain all regulatory requirements as the sponsor in the Territory until HEMISPHERX establishes an Australian entity whereupon EMERGE will fully cooperative in transferring sponsorship and product registration to the HEMISPHERX Australian entity.
7.    Prepare and provide a 3-year post regulatory approval Sales, Marketing, and Distribution Plan including a 3-year minimum sale forecast and a committed dollar field sales force, product manager and marketing budget to be agreed by both Parties and a non-binding 12 month Product forecast no later than six (6) months prior to the anticipated registration and subsequent launch date, also to be agreed by both parties,
8.    Pay for all the above activities and related expenses.
9.    Hold 3 months inventory of the forecasted sales at all times. 
10.    Assist in recruiting clinical trial sites and principal investigators.
11.    Provide HEMISPHERX a monthly written report of EMERGE's efforts and status thereof under this Agreement.
IV.    SUPPLY
		
	A.
	Subject to the terms and conditions of this Agreement, HEMISPHERX agrees to exclusively supply Ampligen to EMERGE with a minimum expiry for stock of 24 months at the date of shipment arrival.

		
	B.
	EMERGE shall pay manufacturer for each order of Ampligen within 45 days after receipt of the goods except for the for first purchase order, which will be paid in advance of the order being delivered. All purchase orders are final.

		
	C.
	HEMISPHERX will supply Ampligen to EMERGE at a Transfer Price of US${***}  with a targeted sale price of US${***}/Unit making the targeted cost of a full {***} week treatment regimen ({***} Ampligen units) US${***}.

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

		
	D.
	EMERGE will ensure all necessary QA testing / approval for use occurs in the Territory and that Ampligen is stored under the conditions stipulated in a Quality Agreement (QA) to be executed and appended to this Agreement as Exhibit 2.

E.    Forecasts, Orders, Payment, and Delivery.
Unapproved Setting
Following the signing of this Agreement, EMERGE will start a full and comprehensive market analysis of the potential of Ampligen in an unapproved setting. This will be from a market potential and willingness to pay point of view and will be completed within 3months of the signature of this Agreement. Forecasts will then be provided for Ampligen as an unapproved medicine and this data will be added as a supplement to the Business Plan (Exhibit 1). 
Approved Setting 
Six (6) months prior to the approval of Ampligen in the Territory:
1.     EMERGE will provide HEMISPHERX a rolling 12-month forecast of the estimated sales of Ampligen Units, the first 3 months of which will be firm and the second three (3) months of which cannot vary by more than 25% when these become the first three (3) months. This forecast will be updated at 3-month intervals thereafter.
2.     In accordance with this forecast, EMERGE agrees to order Ampligen from HEMISPHERX under this Agreement by submitting to HEMISPHERX written purchase orders specifying the quantity, packaging, delivery dates, and delivery location.
3.     HEMISPHERX shall manufacture Ampligen as described in the purchase order from EMERGE and HEMISPHERX shall make all shipments to the location specified on EMERGE's purchase order as follows:
      (a) Delivery of Products is INCOTERMS 2010, CIP. The risk of loss or damage               in transit shall be upon HEMISPHERX.
                    (b) Hemispherx shall pack, mark and ship Ampligen in accordance with               temperature thermometer specifications as clearly set out in the QA Agreement.           Hemispherx shall package Ampligen so as to prevent damage or deterioration      
                    and shall comply with all applicable temperature and packaging laws. 

4.     Unless otherwise stipulated, Ampligen shall be packaged, marked, crated and otherwise prepared in accordance with HEMISPHERX's current packaging and crating practices, and good commercial practices.

5.     EMERGE will prominently display on all Ampligen it sells the Ampligen trademark, which shall remain the sole property of HEMISPHERX and be so noted and on a visible surface thereof and/or on tags, labels, manuals, and other materials with which Ampligen is sold, the fact that the Ampligen is manufactured and supplied to EMERGE by HEMISPHERX for sale in the Territory shall be clearly displayed.

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

		
	F.
	If, for any reason, at any time, HEMISPHERX shall be unable, or should reasonably anticipate being unable to deliver any part or all of the ordered Ampligen in accordance with the terms hereof or the accompanying purchase order, HEMISPHERX shall notify EMERGE of such inability at the earliest possible time (but no later than five (5) workings after HEMISPHERX becomes aware of this their inability to supply Ampligen), whereupon HEMISPHERX and EMERGE will devise a plan to manage the situation.

		
	G. 
	HEMISPHERX warrants that the Ampligen (i) shall conform to the specifications set out in the EMERGE purchase order for Ampligen and (ii) shall meet all, if any, reasonably applicable regulatory requirements in the Territory once Ampligen is Registered. In the unapproved setting, the Ampligen that HEMISPHERX supplies must confirm with all manufacturing and regulatory requirements (including labelling) for the country in which Ampligen is approved in and was intended to be sold.  EMERGE's acceptance of the Ampligen shall relieve HEMISPHERX from the obligations arising from this warranty

		
	H. 
	EMERGE shall have the right to return and demand replacement of any Ampligen which violates this warranty.

		
	I. 
	HEMISPHERX and/or EMERGE shall have the right to cancel, without further obligation to the other party, one or more orders for Ampligen if HEMISPHERX's or EMERGE's business is interrupted because of an event of force majeure beyond the control of HEMISPHERX or EMERGE. 

		
	J. 
	HEMISPHERX shall permit EMERGE or its agent, at EMERGEs' expense, to conduct periodic audits of HEMISPHERX's Quality System and Manufacturing records relating to HEMISPHERX's performance under this Agreement. The audits shall be conducted upon reasonable advance notice during regular business hours at HEMISPHERX's principal office and in such a manner as not to unduly interfere with HEMISPHERX's operations.

		
	K. 
	EMERGE will provide HEMISPHERX with copies of product specification sheets, product inserts, user manuals, user bulletins, and user product updates and any other customer materials such as brochures, educational materials, web pages or other electronic information relating to EMERGE's efforts to sell, market and distribute Ampligen under this Agreement at least 10 (ten) days prior to the public release or use of such information. 

V.    REPORTS AND PAYMENTS
		
	A. 
	Within 30 days following the end of each calendar quarter after execution of the Agreement, EMERGE will provide HEMISPHERX with quarterly reports on the number of Ampligen Units sold and the Sales Price during the preceding three months, key market place issues and successes, regulatory and reimbursement subjects and revisions to the sales and marketing plans. 

		
	B. 
	Ampligen will be considered sold by EMERGE on the date it is shipped or invoiced to an End User, whichever is earlier. All shipping, taxes, duties and other expenses in the Territory is the responsibility of EMERGE.

		
	C.
	Price Increase: Beginning on the second year anniversary of the signing of this Agreement (“Effective Date”) and on each succeeding anniversary of the Effective Date during the term of this agreement and in consideration of a varies of economic factors such as for example, costs of 

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

labour, costs of material and costs the price paid by Emerge for Ampligen shall be renegotiated. Any price increase will need to be justified by HEMISPHERX. Both parties shall, in good faith, attempt to agree upon a reasonable price increase. In the event agreement cannot be reached the agreement shall terminate.
		
	D. 
	All payments hereunder will be made by EMERGE in United States Dollars by wire transfer of immediately available funds to an account designated by HEMISPHERX. The following is wire transfer information:

{***}

To manage a possible variation of the USD/AUD exchange rate (the “Exchange Rate”), EMERGE and HEMISPHERX will conduct a review of the evolution of the Exchange Rate over every six-month period (the “Exchange Rate Review”), within 30 days following the end of each such six-month period. 
If the average Exchange Rate taken from the Reserve Bank of Australia (https//www.rba.gov.au/statistics/hist-exchange-rates/) during the previous six-month period (the “Average Exchange Rate”) varies by more than 10% (upwards or downwards) as compared to the Exchange Rate applied by the Parties under this Agreement during the same period, the Purchase Price will be adjusted accordingly to ensure that the EMERGE’s and HEMISPHERX’s margin as per the pricing provided under Clause IV. C. of this Agreement are maintained. The corresponding adjustment, calculated on the basis of the sales invoiced to the EMERGE in the corresponding six-month period, will be invoiced within 45 days following the end of the corresponding six-month period.  

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

VI.    TERM/TERMINATION
		
	A. 
	The Term will be 5 years from Effective Date with an automatic 2 year term extensions unless otherwise advised by one of the Parties. 

B.     Termination for breach will include:
		
	1.
	 Failure of EMERGE achieving less than 50% achievement of the minimum sales as in III B.7. for two (2) consecutive years, 

2.     Insolvency, or the filing for protection under either Parties’ bankruptcy laws.  Upon the filing of a petition in bankruptcy, insolvency or reorganization against or by either Party, or either Party becoming subject to a composition for creditors , whether by law or agreement, or either party going into receivership or otherwise becoming insolvent (such party hereinafter referred to as the "insolvent party"), this Agreement may be terminated by the other Party by giving written notice of termination to the insolvent Party, such termination immediately effective upon the giving of such notice of termination.
		
	C. 
	 Upon the occurrence of a breach or default as to any obligation hereunder by either Party and the failure of the breaching Party to cure (within thirty (30) days after receiving written notice thereof from the non-breaching Party) such breach or default, this Agreement may be terminated by the non- breaching Party by giving written notice of termination to the breaching Party, such termination being immediately effective upon the giving of such notice of termination.

		
	D. 
	 In the event this Agreement is terminated by either Party for any reason whatsoever, HEMISPHERX agrees to reasonable efforts to make Ampligen available to EMERGE for a period of six (6) months after the termination date at the same Transfer Price and under the same terms of payment.

		
	E. 
	In the event of termination of this Agreement, EMERGE will have the right to complete all contracts for the sale or disposition of Ampligen under which EMERGE is obligated on the date of termination, provided EMERGE pays the associated Transfer Price and provided all such sales or dispositions are completed within six (6) months after the date of termination. Thereafter, HEMISPHERX shall purchase from the EMERGE all remaining stock of Ampligen that is of merchantable quality at the same price as was paid by EMERGE.

VII.    ASSIGNMENT
Neither this Agreement nor any rights or obligations or licenses hereunder may be assigned, pledged, transferred or encumbered by either party without the express prior written approval of the other party, except that either HEMISPHERX or EMERGE may assign this Agreement to any successor by merger or sale of substantially all of its business or assets to which this Agreement pertains, without any such consent. Any assignment in violation hereof is void.
VIII.    AUTHORITY
EMERGE and HEMISPHERX each warrant and represent that it has the full right and power to make the promises set forth in this Agreement and that there are no outstanding agreements, assignments, or encumbrances inconsistent with the provisions of this Agreement.

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

IX.    EXCEPT AS EXPRESSLY SET FORTH IN THIS SECTION IX, HEMISPHERX MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED  OR IMPLIED, REGARDING THE DEVELOPMENT, VIABILITY, COMMERCIAL OR OTHER USEFULNESS OR SUCCESS OF AMPLIGEN AND THAT NO WARRANTY OR REPRESENTATION THAT ANYTHING MADE, USED, SOLD OR OTHERWISE PRACTICED OR ANY SERVICE PROVIDED UNDER THIS AGREEMENT WILL NOT INFRINGE ANY PATENT, COPYRIGHT, TRADE SECRET, OR OTHER PROPRIETARY RIGHT, FOREIGN OR DOMESTIC, OF ANY THIRD PARTY AND MAKES NO WARRANTIES OR REPRESENTATIONS AS TO THE VALIDITY, ENFORCEABILITY OR SCOPE OF ANY HEMISPHERX INTELLECTUAL PROPERTY.
X.    INDEMNIFICATION AND WARRANTIES
A.     INDEMNIFICATION 
EMERGE and HEMISPHERX (each an "Indemnifying Party") shall indemnify, defend and hold harmless and the other Party's subsidiaries or affiliates, their agents, directors, officers, employees and assigns (the "Indemnified Parties") from and against all losses, liabilities, damages, demands and expenses (including reasonable attorneys' fees and expenses) arising out of, as a result of, or in connection with (i) the negligent actions of the Indemnifying Party, its employees or any third party acting on behalf of or under authority of the Indemnifying Party in the performance of this Agreement and/or (ii) the violation of any representation or warranty of Indemnifying Party in this Agreement. Each Party's obligations under this provision shall be subject to the other Party providing reasonable notice of any such claim. Each Party shall defend with competent counsel and pay all costs of defence, including attorneys' fees, and any and all damages and court costs awarded in respect to such claim, action or proceeding regarding the claim of infringement. The Indemnified Parties agree to permit the Indemnifying Party to defend, compromise, or settle any such claim, action or proceeding and further agree to provide all available information, and reasonable assistance to enable the other Indemnifying Party to do so. However, neither party will be liable under this indemnity for any losses, liabilities, damages, demands or expenses arising out of the gross negligence or wilful misconduct of the other party or any of its affiliates, agents, directors, officers, employees or assigns. Limitation of Liability. IN NO EVENT WILL EITHER PARTY BE LIABLE FOR ANY INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES RESULTING FROM THE LICENSE GRANTED PURSUANT TO THIS AGREEMENT OR THE USE OR COMMERCIAL DEVELOPMENT OF AMPLIGEN.
B.     WARRANTIES 
Subject as herein provided HEMISPHERX warrants to EMERGE that:

		
	•
	All Products supplied hereunder will comply with the Dossier and with any specification agreed for them in the Quality Agreement;

		
	•
	It is not aware of any rights of any third party in the Territory which would or might render the sale of the Products, or the use of any of the Trademarks on or in relation to the Products, unlawful;

		
	•
	It is the owner or the permitted licensee of all Intellectual Property Rights and it is not aware of any claims of any third party in the Territory or worldwide related to the fact that the Products infringes any intellectual property of such third party.

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

		
	•
	Nothing in this Agreement shall exclude either party’s liability for death or personal injury.

Subject to the above WARRANTIEs, HEMISPHERX shall indemnify and hold harmless EMERGE and its respective employees from any loss, damage or claim made by a third party in respect of (i) the death or personal injury arising from the manufacture or use of the Products in the Territory or (ii) infringement of third party intellectual property, if and to the extent such loss, damage or claim is caused by any act or omission of HEMISPHERX and is not attributable directly or indirectly to the breach of any of the material terms of this Agreement by EMERGE or by any wilful default or negligent act or omission of EMERGE, its employees or its agents.

1.      The indemnity given by HEMISPHERX shall be subject to the following conditions:

		
	•
	No indemnity shall be claimed unless notice is given by EMERGE claiming the indemnity to HEMISPHERX together with details of the claim promptly on notice of such claim being received by the EMERGE;

		
	•
	No admissions of liability or compromise or offer of settlement of any claim shall be made by EMERGE without the prior written consent of HEMISPHERX; and

		
	•
	HEMISPHERX shall have full control over any claim, proceedings or settlement negotiations in respect of which it is providing the indemnity.

Subject to clause X.B 1.), EMERGE shall defend and indemnify HEMISPHERX and its Affiliates and hold each of them harmless against all claims, demands, actions, losses, expenses, damages, liabilities, costs (including interest, penalties and reasonable attorneys' fees) and judgements suffered by each of them, which arise out of EMERGE’s negligent or wilful acts or omissions or which otherwise arise out of EMERGE’s breach of the Agreement. 

Survivability. The obligations set forth in this Section X. shall survive the termination of this Agreement for the legal periods of limitation provided by US law.

XI.    CONFIDENTIALITY
		
	A. 
	 EMERGE  and  HEMISPHERX  agree  to  keep  secret  and  confidential  all confidential, proprietary or non-public information ("Confidential Information") of the other Party .This provision shall survive termination  or expiration  of this Agreement.

		
	B. 
	Such Confidential Information will be kept confidential until 5 years after the expiration of termination of this Agreement.  Notwithstanding the foregoing , Confidential Information of a Party shall not include information which the other Party can establish by written documentation was (a) to have been publicly known prior to disclosure of such information by the disclosing Party to the other Party, (b) to have become publicly known, without fault on the part of the other Party, subsequent to disclosure of such information by the disclosing Party to the other Party , (c) to have been received by the other Party at any time from a source , other than the disclosing Party , rightfully having possession of and the right to disclose such information, (d) to have been otherwise known by the other Party prior to disclosure of such information by the disclosing Party to the other Party, or (e) to have been independently developed by employees or agents of 

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

the other Party without access to or use of such information disclosed by the disclosing Party to the other Party.
		
	C. 
	The confidentiality obligations contained in this section XI shall not apply to the extent that the receiving Party (the "Recipient") is required (a) to disclose information by law, order or regulation of a governmental agency or a court of competent jurisdiction , or (b) to disclose information to any governmental agency for purposes of obtaining approval to test or market a Product , provided in either case that the Recipient shall provide written notice thereof to the other Party and sufficient opportunity to object to any such disclosure or to request confidential treatment thereof.

XII.    PROSECUTION, INFRINGEMENT, AND DEFENSE OF HEMISPHERX INTELLECTUAL PROPERTY
		
	A.
	HEMISPHERX will be responsible for and shall control, at its expense, the preparation, filing, prosecution and maintenance of HEMISPHERX Intellectual Property.

		
	B.
	EMERGE will cooperate in all reasonable ways to establish and protect HEMISPHERX Intellectual Property in the Territory.

		
	C.
	HEMISPHERX, at its expense, will have the right to determine the appropriate course of action to enforce its HEMISPHERX Intellectual Property against infringement or otherwise abate the infringement thereof , to take (or refrain from taking) appropriate action to enforce its HEMISPHERX Intellectual Property, to control any litigation or other enforcement action and to enter into, or permit, the settlement of any such litigation or other enforcement action with respect to its Intellectual Property .

		
	D.
	Each Party shall promptly notify the other Party in writing if any claim, action, demand or other proceeding (a "Claim") is brought against or is threatened to be brought against such Party alleging that the sale of Ampligen violates another party's intellectual property.

		
	E.
	EMERGE will promptly notify HEMISPHERX of any Third party EMERGE knows or believes may be infringing HEMISPHERX Intellectual Property and will, to the greatest extent reasonably possible, provide to HEMISPHERX any information EMERGE has in support of such belief. HEMISPHERX will have the right, but not the obligation, to use such information in an infringement action against such third Party. EMERGE agrees to cooperate with HEMISPHERX in any action for infringement of HEMISPHERX, and HEMISPHERX will reimburse EMERGE for all reasonable costs incurred by it in providing cooperation requested by HEMISPHERX.

F.    HEMISPHERX is the sole legal and registered owner of "Ampligen® ".
		
	G.
	HEMISPHERX hereby grants to EMERGE and EMERGE hereby accepts the right, privilege and exclusive license to use "Ampligen®" solely in connection with the terms of the Sales, Marketing, Distribution and Supply Agreement of Ampligen in the Territory for the Term of this Agreement. Should the Agreement expire or terminate, the right to use the trademark shall also terminate. EMERGE shall use Ampligen at all times for the sole purpose of marketing Ampligen and for no other purpose.

		
	H.
	The terms of the intellectual property license hereby granted shall be effective upon the Effective Date of this Agreement and during the term of this Agreement, unless sooner terminated in 

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

accordance with the provisions of the Sales, Marketing, Distribution and Supply Agreement between the parties.
1.    Good Will. EMERGE recognizes that there exists great value and good will associated with the Trademark and Intellectual Property use of "Ampligen®".
2.     EMERGE agrees that it will not during the term of this Agreement, or thereafter, attack the title or any rights of HEMISPHERX in and to “Ampligen®" or attack the validity of the license granted herein by HEMISPHERX and solely owned by HEMISPHERX.
		
	I. 
	EMERGE agrees to assist HEMISPHERX to the extent necessary in the procurement of any protection or to protect any of HEMISPHERX's right to “Ampligen®" and HEMISPHERX, if it so desires, may commence or prosecute any claims or suits in its own name or in the name of EMERGE or join EMERGE as a party thereto. EMERGE shall notify HEMISPHERX in writing of any infringements or imitations by others of “Ampligen®" which may come to EMERGE 's attention, and HEMISPHERX shall have the sole right to determine whether or not any action shall be taken on account of any such infringements or imitations. EMERGE shall not institute any suit or take any action on account of any such infringements or imitation without first obtaining the written consent of the HEMISPHERX so to do.

		
	J.
	EMERGE agrees to cooperate fully and in good faith with HEMISPHERX for the purpose of securing and preserving HEMISPHERX's rights.

K.    It is agreed that nothing contained in this Sales, Marketing, Distribution, and Supply     Agreement shall be construed as an assignment or grant to the EMERGE of any rights, title or     interest in or to "Ampligen® ".
		
	L. 
	It is further understood that all rights relating thereto are reserved by HEMISPHERX, except for the license hereunder to EMERGE of the right to use and utilize the name Ampligen only as specifically and expressly provided in this Agreement.

		
	M.
	In the event of termination of this license for any reason, EMERGE shall within 6months (as described in the Termination clause), cease all use of the "Ampligen®". EMERGE shall not thereafter use any names, mark or trade name similar thereto belonging to HEMISPHERX. Termination of the license under the provisions of this Agreement shall be without prejudice to any rights which HEMISPHERX may otherwise have against EMERGE.

		
	N. 
	EMERGE  shall, and shall cause its shareholders, officers, directors, and managing personnel to, comply with all laws, rules and government regulations pertaining to its business and shall not violate any laws which would create an adverse effect on the “Ampligen®" in the U.S. and/or the Territory.

		
	O.
	Relationship of Parties. EMERGE shall not in any manner or respect be the legal representative or agent of HEMISPHERX and shall not enter into or create any contracts, Agreements, or obligations on the part of HEMISPHERX, either expressed or implied, nor bind HEMISPHERX in any manner or respect whatsoever regarding its intellectual property; it being understood that this Agreement is only a contract for the licensed use of the product names in connection with the terms in this Agreement.

XIII.    BUYOUT

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

HEMISPHERX will have the option at any time to buy out this Agreement. If exercised within the first two (2) years HEMISPHERX will pay EMERGE three (3) times the Ampligen sales for the preceding 12 months. If exercised after year 3, HEMISPHERX will pay EMERGE two (2) times the Ampligen sales for the preceding 12 months. 
XIV.    MISCELLANEOUS.
		
	A.
	Notices. Notices sent pursuant to this Agreement are valid if in writing and addressed to the parties at the respective addresses given below or at such other addresses as either party shall notify the other in writing and sent by registered or certified mail, postage prepaid and return receipt requested, or by Federal Express or other comparable courier providing proof of delivery, and shall be deemed duly given and received (i) if mailed, on the third business day following the mailing thereof, or (ii) if sent by courier, the date of its receipt (or if not on a business day, the next succeeding business day).

If to HEMISPHERX:
William Carter, MD, Chairman and CEO 
One Penn Center
1617 JFK Boulevard
Suite 500
Philadelphia, PA 19103 United States

If to EMERGE:
Chris Rossidis, Head of Commercial Operations
Suite 3, Level 1
2 Theatre Place, 
Canterbury VIC 3126, Australia
		
	B.
	This Agreement and the transactions contemplated herein shall be governed by, and construed in accordance with, the laws of the State of Delaware, USA and disputes, if not resolved by the Parties, will be settled by binding arbitration in and under the rules of arbitration in London, England.

		
	C.
	This Agreement constitutes the entire understanding of the parties with respect to the purchase and sale of Ampligen and supersedes all prior discussions, agreements, and understandings between HEMISPHERX and EMERGE.

		
	D.
	Each party an independent contractor to the other and the relationship between the parties shall not be construed to be that of an employer and employee, or to constitute a partnership, joint venture, or agency of any kind.

E.    This Agreement may only be amended in a writing signed by both parties hereto.
		
	F.
	If any provision of this Agreement is declared invalid or unenforceable by a court having competent jurisdiction, it is mutually agreed that this Agreement shall endure except for the part declared invalid or unenforceable by order of such court.

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

		
	G.
	This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

		
	H.
	Prior to their release, the parties must agree on press releases or market communication that utilises the other Party’s name.

Counterparts; Integration; Effectiveness; Electronic Execution
This Agreement may be executed in counterparts (and by different parties hereto in different counterparts}, each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Agreement constitutes the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof.
This Agreement shall become effective when it shall have been executed by all parties and upon receipt of all counterparts hereof that, when taken together, bear the signatures of each of the other parties hereto. Delivery of an executed counterpart of a signature page of this Agreement by e-mail and/or telecopy shall be effective as delivery of a manually executed counterpart of this Agreement.
The words "execution," "signed," "signature," and words of like shall be deemed to include electronic signatures or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and  National Commerce Act, and any other similar State laws based on the Uniform Electronic Transactions Act.
IN WITNESS WHEREOF, the parties have executed this Agreement as of the date written above.

EMERGE HEALTH PTY LTD:                      HEMISPHERX BIOPHARMA, INC:                    

_____________________________                      _____________________________                 
Chris Rossidis                     William Carter, MD
Head of Commercial Operations         Chairman and CEO 

Date:                         Date: 

_______________________________                  _______________________________
                        
                        

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

    

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Exhibit 1
{***}

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Exhibit 2
TECHNICAL / QUALITY AGREEMENT 

		
	1.
	Parties

This Quality Agreement is entered by and between Emerge Health Pty Ltd., a pharmaceutical company with its primary offices located at Suite 3, Level 1, 2 Theatre Place, Canterbury VIC 3126, Australia  (“COMPANY”) and Hemispherx Biopharma, Inc. 783 Jersey Avenue, New Brunswick, New Jersey 08901(HEB).

		
	2.
	Purpose

The purpose of this Quality Agreement is to clearly define the quality operating procedures, duties and responsibilities to be employed by COMPANY and HEB in the conduct of activities by COMPANY for Hemispherx Biopharma, Inc.  The objective of these procedures and this Quality Agreement is assurance that services are conducted in a timely, consistent and uniform manner and in accordance with current laws, directives, regulations and guidelines, as may be applicable to the specific project(s).  These requirements may include those defined by the U.S. FDA’s regulations At 21CFR314.80 (Post-marketing reporting of adverse drug experiences for drugs), 21CFR312.32 (IND safety reporting) 21CFR600.80 (Post marketing reporting of adverse experiences for biologics) 21CFR Parts 210 and 211 (“current Good Manufacturing Practices” or “cGMPs”) with particular interest in 21CFR211.1.42 (Warehousing), 21CFR211.150 (Distribution), 21CFR211.204 (Returned drug) and 21CFR211.208 (Drug product salvaging) and/or others that may be appropriate for the particular project. 

3.    Scope

This Quality Agreement is to be applied to the activities  performed by COMPANY, for HEB as specifically defined by the Sales, Marketing, Distribution, and Supply Agreement  March___  (“Agreement”) to which this Quality Agreement is an integral Exhibit.  In the event of a conflict between the terms of the Agreement and this Quality Agreement, the terms of the Agreement shall control.  Unless otherwise stated in these documents, COMPANY shall follow its Standard Operating Procedures (“SOPs”) with respect to the activities it shall carry out in accordance with the Agreement. Copies of all relevant SOPs shall be provided to HEB for review during audits.

4.    Confidentiality

The information and procedures contained in this Quality Agreement are confidential and subject to the terms and conditions of the confidentiality provisions as set forth in the Confidential Disclosure Agreement September 22, 2014  (“CDA”) executed by HEB and COMPANY.

5.    Terms  

This Agreement between HEB and COMPANY shall be in effect beginning the last date of execution set forth on the signature page to the  Agreement (the “Effective Date”) to which this Quality Agreement is Exhibit 2 and remain in effect until HEB and COMPANY terminate the Agreement or it is superseded by a revised Quality Agreement executed by both parties.  This Quality Agreement should be reviewed 

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

periodically by both parties for any needed updating, revisions, amendments, and the like.  Regular periodic review of this Quality Agreement should be conducted to ensure it is up-to-date.  

HEB may perform audits for initial qualification of COMPANY as well as periodic audits and “for cause” audits.  At mutually agreed upon times, HEB may review standard operating and other quality control procedures and records and the records of COMPANY relating to the Agreement.  Such routine and general oversight review is to be requested at least twenty (20) business days in advance, limited to two (2) persons, completed within one (1) to two (2) business days and shall be offered to HEB one (1) time each calendar year.  COMPANY will make every reasonable effort to accommodate the special circumstances that may arise pursuant to “for cause” audits. The following applies to all audits: 

		
	•
	Prior to an audit HEB will communicate to COMPANY the scope of the audit.  

		
	•
	HEB will prepare a written report of the results of the audit and forward a copy to COMPANY. 

COMPANY will provide a written response to HEB’s written audit report within twenty (20) business days of receipt of such report setting forth the corrective actions to be taken by COMPANY, if any, and a timeline for such implementation.

In the event of an inspection by any governmental or regulatory authority concerning the activities carried out under the Agreement, COMPANY shall notify HEB promptly upon learning of such an inspection, shall supply HEB with copies of any correspondence or portions of correspondence relating to HEB’s materials and shall inform HEB of the general findings and outcomes of such inspections.    

COMPANY and HEB shall cooperate with each other during any such inspection, investigation or other inquiry, including applying reasonable effort, as might be practical, at allowing, upon reasonable request, a representative of HEB to be on site during such inspection, investigation or other inquiry, and providing copies of all documents related to the inspection. Each party acknowledges that it may not direct the manner in which the other party fulfills its obligations to permit inspection by governmental entities

6.    Dispute Resolution
If a dispute arises between the parties under this Agreement, the parties agree that, prior to either pursuing other available remedies, decision-making individuals from each party will promptly meet, either in person or by telephone, to attempt in good faith to negotiate a resolution of the dispute.  If, within sixty days after such meeting, the parties are unable to resolve the dispute (or such longer time as the parties may agree) either party is free to pursue its legal remedies.

7.    Definitions

Adverse experience:  Any adverse event associated with the use of a biological or drug product in humans, whether or not considered product related, including the following: an adverse event occurring in the course of the use of a biological or drug product in professional practice; an adverse event occurring from overdose of the product whether accidental or intentional; an adverse event occurring from abuse of the product; an adverse event occurring from withdrawal of the product; and any failure of expected pharmacological action.
Disability:  A substantial disruption of a person’s ability to conduct normal life functions.

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Life-threatening adverse experience:  Any adverse experience that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse experience as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death.
Labeled event:  An adverse experience that is listed on the product insert as having been observed in patients who are receiving the drug product.

Drug Product: A finished dosage form, for example, tablet, capsule, or solution that contains an active ingredient generally, but not necessarily, in association with inactive ingredients
Serious adverse experience:  Any adverse experience occurring at any dose that results in any of the following outcomes:  Death, a life-threatening adverse experience, inpatient hospitalization or prolongation of existing hospitalization, a persistent or significant disability/incapacity, or a congenital anomaly/birth defect.  Important medical events that may not result in death, be life-threatening, or require hospitalization may be considered a serious adverse experience when, based upon appropriate medical judgment, they may jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the outcomes listed in this definition.

Unexpected adverse experience:  Any adverse experience that is not listed in the current labelling for the biological or drug product.  This includes events that may be symptomatically and pathophysiologically related to an event listed in the labelling, but differ from the event because of greater severity or specificity.  
For example, under this definition, hepatic necrosis would be unexpected (by virtue of greater severity) if the labeling only referred to elevated hepatic enzymes or hepatitis. Similarly, cerebral thromboembolism and cerebral vasculitis would be unexpected (by virtue of greater specificity) if the labeling only listed cerebral vascular accidents.  “Unexpected,” as used in this definition, refers to an adverse experience that has not been previously observed (i.e., included in the labeling) rather than from the perspective of such experience not being anticipated from the pharmacological properties of the pharmaceutical product.
Call report:  A list of all questions, requests for circulars, and physician/patient complaints received by COMPANY's Clinical Support Department is prepared monthly by COMPANY staff and is forwarded to HEB RA/QA Department.
Audit: A systematic examination of processes, controls and systems, operating procedures, reports, records and/or data to assess COMPANY’s compliance with standards, regulatory submissions, SOPs; applicable laws, regulations, directives, standards and guidelines; the terms of this Agreement and other contracts in place defining the services being provided and to verify data integrity.  

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Good Manufacturing Practices (“GMPs”): The recognized pharmaceutical regulations and requirements of regulatory authorities such as those defined by the U.S. FDA’s regulations at 21CFR Parts 210 and 211.

Key Contacts:  Persons at COMPANY and HEB assigned to assure proper communication and follow-up in a timely manner within both parties’ organizations.  Names, titles and full contact information for Key Contacts shall be appended to this Agreement as Attachment 1 and should be maintained up-to-date during the course of the project.    

Observation: A statement of fact made during an audit that is substantiated by objective evidence.  HEB categorizes observations as follows: 

		
	◦
	Critical:  May pose risk to patient or consumer or otherwise compromise the integrity or quality of the material, product, process, or service being provided.  Other instances that could be defined as a critical observation include: A practice that poses an immediate safety risk to personnel; Quality System(s) missing or not in compliance with regulations, guidelines, or corporate policies. 

		
	◦
	Major:  Does not fully comply with regulations, guidelines or corporate policies and may pose unnecessary risks to the integrity or quality of material, product, process or service being provided.  Other instances that could be defined as a major observation include: Likely or probable safety risk to personnel; Quality System(s) weak or needing improvement; repeated Minor deficiencies of a similar nature that indicate a systemic problem and therefore may be classified as Major.  

		
	◦
	Minor:  Does not comply with regulations, guidelines, or corporate policies but does not directly impact the integrity or quality of the material, product, process, or service being provided.  

		
	◦
	Comment:  Compliant with regulations, guidelines and/or corporate policies; however, the auditor comment serves as a recommendation relative to maintaining or improving a specific condition noted.  

Out-of-Specification / Out-of-Trend (“OOS / “OOT”):  A result that is not within the established specifications or trend, whether these are qualitative or quantitative.

Standard Operating Procedures (“SOPs”): Procedures in effect at COMPANY that define the processes and controls by and under which activities are to be conducted to assure compliance with the appropriate Code of Federal Regulations.
7.    Communications

To assure proper communication, notification and follow-up in a timely manner by both parties, “Key” contacts are listed in Attachment 1 of this Agreement.  Key contacts shall have access to project managers and technical staff and, upon reasonable notice and as required, facilitate resolution of any issues.  Every effort will be made by COMPANY to accommodate timely communications, including face-to-face meetings, with HEB.  

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

8.    Change of Control 

COMPANY will maintain and follow change control SOP(s) to ensure that changes to equipment, procedures, processes, etc. occur in a controlled manner and in compliance with requirements e defined by the U.S. FDA’s regulations (see Section 2).  The implementation of any change that may directly impact the integrity of the activities conducted or data being supplied for HEB will require prior written approval of HEB.  COMPANY and HEB will advise the appropriate organization’s staff member (See Attachment 1) before implementation of a change, by either party, to equipment, procedures, specifications, processes, clinical protocols, product claims or facilities directly related to HEB’s specific products and processes.  Each party agrees to review the proposed change in a timely manner and, at its discretion, may audit and/or request an alternative or additional change prior to the implementation of the proposed change.  The respective party will review the proposed change, determine if it is reasonably practicable to implement the change and can suggest alternative or additional changes prior to the implementation of the proposed change.   Change control requirements should be articulated within the specific operation’s documentation practices. 
  
HEB is responsible for assuring changes are in accordance with and/or reported to the investigational, marketing and/or any other filing with regulatory agencies (IND, IMPD, CTA, NDA, MA, etc.) and for informing COMPANY of any changes requested by regulatory agencies.  COMPANY agrees to keep HEB fully informed of any and all communications with regulatory agencies that may affect the services being provided to HEB by COMPANY. 

This Agreement is not meant to supersede or replace controlled documents typically used to define and record the work to be conducted by COMPANY for HEB.  Specific requirements of this Agreement and/or any service contracts shall be articulated within COMPANY’s current operating procedures and documentation systems.      

9.    Responsibilities

COMPANY is responsible for:
		
	1)
	case management support services to patients and maintain a 24-hour/365-day a year telephone service for assistance of prescription drug-related medical emergencies to patients

		
	2)
	the distribution of product, including the shipping, handling and storage and all rules and regulations of every governmental authority having jurisdiction over the shipping, handling, storage, distribution, and dispensing of Product

		
	3)
	confirming the product labelling requirements in the territory

		
	4)
	conforming to all labeled specifications concerning the shipping, handling and storage of Product

		
	5)
	notifying HEB of any unacceptable storage or handling deviation within one (1) business day

		
	6)
	inspecting all product shipments received by COMPANY from HEB and reporting any damage, defect, loss in transit, or other shipping errors to HEB within one (1) business days of receipt by COMPANY

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

		
	7)
	administering recalls, field alerts, warning letters, quarantines or withdrawals in accordance with HEB instructions (See Attachment 2)

		
	8)
	administering HEB’s Returned Goods Policy (See Attachment 3)

		
	9)
	immediately notifying HEB of any serious and unexpected side effects (Adverse Experiences reported to COMPANY, as defined by 21CFR 34.80)) 

		
	10)
	providing HEB with written Adverse Experience Reports

		
	11)
	keeping HEB fully informed of any and all communications with regulatory agencies that may affect the services being provided to HEB by COMPANY

		
	12)
	receiving and processing complaints

		
	13)
	notifying HEB of complaints and actions taken or to be taken to address the complaints

		
	14)
	the performance of all services provided by COMPANY’s subcontractors

		
	15)
	communicating to HEB any events of non-conformance that impact the quality of HEB’s product.  Examples of non-conformances may include, but are not limited to:  equipment failure, shipping error or documentation error, labeling error, improper storage, facilities system error, and unplanned study protocol deviations.  When a non-conformance event occurs that is specific to HEB’s product, COMPANY will conduct an investigation and provide copies of all investigation documentation to HEB for review and input

		
	16)
	for initiating, monitoring and completing CAPA tasks related to discrepancies, errors and incidents involving services that are under COMPANY’s control

HEB is responsible for: 
		
	1)
	release of product following review of all manufacturing and quality control testing requirements to confirm the batch has been manufactured according to approved processes and specifications

		
	2)
	supply all necessary quality documentation with shipments to allow product importation and release

		
	3)
	ensuring product intended for supply in territory is labelled accordingly

		
	4)
	assuring changes to the established operations are in accordance with and/or reported to the investigational, marketing and/or any other filing with regulatory agencies (IND, IMPD, CTA, NDA, MA, etc.).

		
	5)
	informing COMPANY of any changes requested by regulatory agencies

		
	6)
	assist with/address any Agencies requests relating to manufacture of product

		
	7)
	providing COMPANY any information that could result in a field alert or recall of a product under a HEB NDA or ANDA immediately, but no more than one (1) business day after discovery. HEB interprets FDA 21 CFR 314.81, “Other Post-Marketing Reports,” to require a Field Alert Report to be made within three (3) days of an occurrence of an OOS result, 

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

whether that result is confirmed or not. The only exception to this would be where the original result was invalidated within the three (3) days. In that case, no field alert would be required
		
	8)
	making the proper reports to the FDA regarding a field alert or recall

		
	9)
	communicating to COMPANY any events of non-conformance that impact the quality of HEB’s product.  Examples of non-conformances may include, but are not limited to: contamination, calculation or documentation error, labeling error.   When a non-conformance event occurs HEB will conduct an investigation and inform COMPANY of any appropriate action to be taken

		
	10)
	for initiating, monitoring and completing CAPA tasks related to discrepancies, errors and incidents involving services that are under HEB’s control

		
	11)
	contribute to customer complaint investigations where possible issues due to manufacturing process may have contributed to complaint

HEB and COMPANY are separately responsible for securing and maintaining all required licenses, permits and certificates applicable to their respective operations and each shall comply with any and all applicable federal, state and local laws, including but not limited to (i) the Federal Food Drug and Cosmetic Act; (ii) the Social Security Act; (iii) HIPPAA; (iv) all federal and state health care anti-fraud and abuse laws, and (v) all state privacy, and consumer protection laws, including those relating to the use of medical and prescription information for commercial purposes.

10.    Subcontractors
COMPANY may enter into agreements between COMPANY and a subcontractor.  COMPANY will identify the services performed by each such subcontractor.  COMPANY is responsible for the performance of all services provided on behalf HEB and the compliance of each subcontractor to the terms of this Agreement.  HEB will be permitted to conduct periodic audits of the subcontractors to assure compliance to applicable GMP’s, GLP’s and federal regulations (CFR’s).

11.    Standard Operating Procedures (SOP’s)
The following HEB SOP’s are relevant to this Quality Agreement and interactions between HEB and COMPANY and affiliates.
		
	A.
	CLN-009 Handling Adverse Event Reports and Records

		
	B.
	QC-006 Investigation of Out of Specification Results

		
	C.
	SR-009 Preparation of Packing Liquid Ampligen (200 and 400 mg Bottles) or Placebo for Shipment to Clinical Sites. 

12.    Laboratory Controls-N/A
 
13    Documentation and Record Maintenance
COMPANY shall preserve all records in accordance with any applicable federal, state or local requirements.  Raw data, documentation, batch records, source documents, product disposition records and reports (collectively, “Documentation”) shall be retained by COMPANY for a minimum period of two (2) years after termination or expiration of the Specialty Distributor Purchase and Service Agreement between HEB and COMPANY.  COMPANY shall, upon written receipt of a written request 

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

from HEB, finish such Documentation in a format reasonably acceptable to HEB with thirty (30) days of receipt of such request.  In this case, the Documentation will be shipped to the Quality Assurance Manager named in this Agreement (see Key Contact List, Attachment 1).  It is the responsibility of HEB to notify COMPANY of any changes in this contact.  During the retention period, documentation shall be available for inspection by HEB, its authorized agents and authorized government agencies.

14.    Complaints

In the event COMPANY is notified of a complaint, COMPANY will receive, investigate and respond to the complaint following its internal procedures.  A copy of all complaint investigation documentation will be provided to HEB.

15.    Contact List of Key Personnel. See Attachment 1

IN WITNESS WHEREOF, the parties hereto have executed this Quality Agreement as of the Effective Date.

Hemispherx Biopharma Inc.    
 
Signature: _____________________________________________________________________

Printed Name:  _________________________________________________________________

Title: _________________________________________________________________________

Date: _________________________________________________________________________

COMPANY.

Signature: _____________________________________________________________________

Printed Name:  _________________________________________________________________

Title: _________________________________________________________________________

Date: _________________________________________________________________________

Attachment 1
List of Key Contacts
	
			
	SUBJECT
	HEB CONTACT
	COMPANY CONTACT

	Regulatory Compliance Requirements

Notification of Regulatory Agencies and Regulatory Submissions
	Victoria Scott
Director/Quality and Regulatory
Phone: 732-249-3550 ext 567
Fax:732-249-6895
Email:Victoria.Scott@Hemispherx.net
	{***}

	Recall of Marketed Product
	Victoria Scott
Director/Quality and Regulatory
Phone: 732-249-3550 ext 567
Fax:732-249-6895
Email:Victoria.Scott@Hemispherx.net
	{***}

	Adverse Drug Events
	David Strayer, MD
Medical Director
Phone:215-988-0880
Fax: 215-988-1739
Email: David.Strayer@Hemispherx.net
	{***}

	Product Complaint
	Victoria Scott
Director/Quality and Regulatory
Phone: 732-249-3550 ext 567
Fax:732-249-6895
Email:Victoria.Scott@Hemispherx.net
	{***}

	Field Alert Reports/Biological Product Deviation Reports
	Victoria Scott
Director/Quality and Regulatory
Phone: 732-249-3550 ext 567
Fax:732-249-6895
Email:Victoria.Scott@Hemispherx.net
	{***}

	Change Control
	Victoria Scott
Director/Quality and Regulatory
Phone: 732-249-3550 ext 567
Fax:732-249-6895
Email:Victoria.Scott@Hemispherx.net
	{***}

	Clinical Study Protocol Changes
	David Strayer, MD
Medical Director
Phone:215-988-0880
Fax: 215-988-1739
Email: David.Strayer@Hemispherx.net
	{***}

	New or Revised Product Clams
	David Strayer, MD
Medical Director
Phone:215-988-0880
Fax: 215-988-1739
Email: David.Strayer@Hemispherx.net
	{***}

	Documentation
Quality Records
Record Retention
	Victoria Scott
Director/Quality and Regulatory
Phone: 732-249-3550 ext 567
Fax:732-249-6895
Email:Victoria.Scott@Hemispherx.net
	{***}

	SUBJECT
	HEB CONTACT
	COMPANY CONTACT

	Product Testing and Release
	Victoria Scott
Director/Quality and Regulatory
Phone: 732-249-3550 ext 567
Fax:732-249-6895
Email:Victoria.Scott@Hemispherx.net
	{***}

	Control of Components,  Labeling and Packaging Materials

	Chris Cavalli
VP Quality Control
Phone: 732-249-3550 ext 559
Email:Chris.Cavalli@Hemispherx.net
Fax:732-249-6895
	{***}

	Product Storage and Shipping
	Victoria Scott
Director/Quality and Regulatory
Phone: 732-249-3550 ext 567
Fax:732-249-6895
Email:Victoria.Scott@Hemispherx.net
	{***}

	Returned Goods
	Victoria Scott
Director/Quality and Regulatory
Phone: 732-249-3550 ext 567
Fax:732-249-6895
Email:Victoria.Scott@Hemispherx.
	{***}

	Deviations/Investigations

Nonconforming or Rejected Material
	Victoria Scott
Director/Quality and Regulatory
Phone: 732-249-3550 ext 567
Fax:732-249-6895
Email:Victoria.Scott@Hemispherx.net
	{***}

	Supplier Qualification
	Victoria Scott
Director/Quality and Regulatory
Phone: 732-249-3550 ext 567
Fax:732-249-6895
Email:Victoria.Scott@Hemispherx.net
	{***}

	Quality Audits & Regulatory Inspections
	Victoria Scott
Director/Quality and Regulatory
Phone: 732-249-3550 ext 567
Fax:732-249-6895
Email:Victoria.Scott@Hemispherx.net
	{***}

Attachment 2
QA-007-Product Recall
                        
                

    

Attachment 3
HEB Return Goods Policy
This Return Goods Policy us for all HEB products, Alferon N® and Ampligen® distributed by COMPANY. 
The following products are eligible for return and reimbursement:
		
	•
	Outdated Product: Product within two (2) months prior or six (6) months past expiration date and noted on product; 

AND
		
	•
	Product in its original container and bearing its original label.

OR
		
	•
	Product which HEB has specified be returned

The following products are not eligible for return and reimbursement: 
		
	•
	Product that is not outdated. 

		
	•
	Product in which the lot number and/or expiration date is missing, illegible, covered, and/or unreadable on original container.

		
	•
	Product that has been damaged due to improper storage handling, fire, flood, or catastrophe. 

		
	•
	Product that has been sold expressly on a non-returnable basis.

		
	•
	Product that is not in its original container and/or not bearing its original label.

		
	•
	Product that is in its original container with a prescription label attached.

		
	•
	Product that has been repackaged

		
	•
	Partial Vials

		
	•
	Product obtained illegally or via diverted means

		
	•
	Product purchased on the “secondary source” market or from a distributor other than COMPANY.

		
	•
	Product that HEB determines, in its sole discretion, is otherwise adulterated, misbranded, or counterfeit.

HEB will only accept returns shipped to COMPANY. All eligible products shall be shipped in a safe, secure, and reliable manner, and in compliance with all applicable federal, state and local laws, regulations and statutes. It is the shipper’s responsibility to securely package all return goods to prevent to prevent breakage during transit and otherwise comply with the laws and regulations applicable to the packaging, shipping, and transport of return goods shipments.
HEB is not responsible for shipments lost and/or damaged in transit. HEB recommends that all customers insure return goods shipments.
HEB will audit the quantities of return goods and final reimbursement will be based on HEB count. All products will be reimbursed based on the price paid Direct purchasing customers reimbursement will be issued in the form of credit or product replacement to the appropriate party.
To assist in accurate credit memo processing, please include the following information: 
		
	1.
	Purchasers Name and Mailing Address

		
	2.
	Date and Quantity 

Return goods shipments which are deemed to be outside of this policy will not be returned to the customer or the third party processor and no reimbursement will be issued by HEB. HEB return goods policy is subject to change at any time and without prior notices to other parties.
    

 
                        
 

Attachment 2
QA-007-Product Recall

Attachment 3
HEB Return Goods Policy
This Return Goods Policy us for all HEB products, Alferon N® and Ampligen® distributed by COMPANY. 
The following products are eligible for return and reimbursement:
		
	•
	Outdated Product: Product within two (2) months prior or six (6) months past expiration date and noted on product; 

AND
		
	•
	Product in its original container and bearing its original label.

OR
		
	•
	Product which HEB has specified be returned

The following products are not eligible for return and reimbursement: 
		
	•
	Product that is not outdated. 

		
	•
	Product in which the lot number and/or expiration date is missing, illegible, covered, and/or unreadable on original container.

		
	•
	Product that has been damaged due to improper storage handling, fire, flood, or catastrophe. 

		
	•
	Product that has been sold expressly on a non-returnable basis.

		
	•
	Product that is not in its original container and/or not bearing its original label.

		
	•
	Product that is in its original container with a prescription label attached.

		
	•
	Product that has been repackaged

		
	•
	Partial Vials

		
	•
	Product obtained illegally or via diverted means

		
	•
	Product purchased on the “secondary source” market or from a distributor other than COMPANY.

		
	•
	Product that HEB determines, in its sole discretion, is otherwise adulterated, misbranded, or counterfeit.

HEB will only accept returns shipped to COMPANY. All eligible products shall be shipped in a safe, secure, and reliable manner, and in compliance with all applicable federal, state and local laws, regulations and statutes. It is the shipper’s responsibility to securely package all return goods to prevent to prevent breakage during transit and otherwise comply with the laws and regulations applicable to the packaging, shipping, and transport of return goods shipments.
HEB is not responsible for shipments lost and/or damaged in transit. HEB recommends that all customers insure return goods shipments.
HEB will audit the quantities of return goods and final reimbursement will be based on HEB count. All products will be reimbursed based on the price paid Direct purchasing customers reimbursement will be issued in the form of credit or product replacement to the appropriate party.
To assist in accurate credit memo processing, please include the following information: 
		
	3.
	Purchasers Name and Mailing Address

		
	4.
	Date and Quantity 

Return goods shipments which are deemed to be outside of this policy will not be returned to the customer or the third party processor and no reimbursement will be issued by HEB. HEB return goods policy is subject to change at any time and without prior notices to other parties.
    

 
                        
 

    
{***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.EX-10.1

 Exhibit 10.1 

EXECUTION VERSION 
  

 
 INDENTURE 

between 
 CCG RECEIVABLES TRUST
2014-1, 
 as Issuer 
 and 

U.S. BANK NATIONAL ASSOCIATION, 

as Indenture Trustee 
 Dated as of
May 14, 2014 
  
  

 TABLE OF CONTENTS 
  

							
	ARTICLE I USAGE AND DEFINITIONS		 	2	  
	 Section 1.1.
		 Certain Defined Terms
		 	2	  
		
	ARTICLE II COLLATERAL		 	22	  
	 Section 2.1.
		 Continuing Security Interest
		 	22	  
	 Section 2.2.
		 Priority of Security Interest
		 	22	  
	 Section 2.3.
		 Protection of Security Interest of the Indenture Trustee
		 	23	  
	 Section 2.4.
		 Release of Collateral
		 	23	  
	 Section 2.5.
		 Effect of Release
		 	23	  
		
	ARTICLE III NOTES		 	24	  
	 Section 3.1.
		 Form
		 	24	  
	 Section 3.2.
		 Execution, Authentication and Delivery
		 	24	  
	 Section 3.3.
		 Book Entry Notes
		 	25	  
	 Section 3.4.
		 Definitive Notes
		 	25	  
	 Section 3.5.
		 Tax Treatment
		 	26	  
	 Section 3.6.
		 Registration; Registration of Transfer and Exchange
		 	26	  
	 Section 3.7.
		 Mutilated, Destroyed, Lost or Stolen Notes
		 	29	  
	 Section 3.8.
		 Persons Deemed Owners
		 	30	  
	 Section 3.9.
		 Payment of Principal and Interest
		 	30	  
	 Section 3.10.
		 Cancellation
		 	31	  
	 Section 3.11.
		 Authenticating Agents
		 	31	  
	 Section 3.12.
		 Note Paying Agents
		 	32	  
	 Section 3.13.
		 Optional Redemption of the Notes
		 	32	  
		
	ARTICLE IV DISTRIBUTIONS		 	33	  
	 Section 4.1.
		 Application of Collections
		 	33	  
	 Section 4.2.
		 Collection Account, Collections
		 	33	  
	 Section 4.3.
		 Reserve Account
		 	33	  
	 Section 4.4.
		 Lock-Box Accounts
		 	34	  
	 Section 4.5.
		 Priority of Distribution
		 	34	  
		
	ARTICLE V REPRESENTATIONS AND WARRANTIES OF THE ISSUER		 	37	  
	 Section 5.1.
		 Representations by the Issuer
		 	37	  
		
	ARTICLE VI COVENANTS		 	43	  
	 Section 6.1.
		 Affirmative Covenants of the Issuer
		 	43	  
	 Section 6.2.
		 Negative Covenants of the Issuer
		 	48	  
		
	ARTICLE VII EVENT OF DEFAULT		 	49	  
	 Section 7.1.
		 Event of Default
		 	49	  
	 Section 7.2.
		 Acceleration Following Event of Default
		 	50	  
	 Section 7.3.
		 Collection of Indebtedness by the Indenture Trustee
		 	51	  
	 Section 7.4.
		 Trustee May File Proofs of Claim
		 	52	  
	 Section 7.5.
		 Trustee May Enforce Claims Without Possession of Notes
		 	52	  
	 Section 7.6.
		 Remedies; Priorities
		 	53	  

  
 i 

							
	 Section 7.7.
		 Optional Preservation of the Collateral
		 	53	  
	 Section 7.8.
		 Limitation of Suits
		 	54	  
	 Section 7.9.
		 Unconditional Rights of Noteholders to Receive Principal and Interest
		 	54	  
	 Section 7.10.
		 Restoration of Rights and Remedies
		 	54	  
	 Section 7.11.
		 Rights and Remedies Cumulative
		 	55	  
	 Section 7.12.
		 Delay or Omission Not a Waiver
		 	55	  
	 Section 7.13.
		 Control by Noteholders
		 	55	  
	 Section 7.14.
		 Waiver of Defaults and Events of Default
		 	55	  
	 Section 7.15.
		 Undertaking for Costs
		 	55	  
	 Section 7.16.
		 Waiver of Stay or Extension Laws
		 	56	  
	 Section 7.17.
		 Performance and Enforcement of Certain Obligations
		 	56	  
	 Section 7.18.
		 Power of Attorney
		 	56	  
		
	ARTICLE VIII THE INDENTURE TRUSTEE		 	57	  
	 Section 8.1.
		 Duties of Indenture Trustee
		 	57	  
	 Section 8.2.
		 Rights of Indenture Trustee
		 	58	  
	 Section 8.3.
		 Individual Rights of Indenture Trustee
		 	59	  
	 Section 8.4.
		 Indenture Trustee’s Disclaimer
		 	59	  
	 Section 8.5.
		 Notice of Defaults
		 	60	  
	 Section 8.6.
		 Reports by Indenture Trustee
		 	60	  
	 Section 8.7.
		 Compensation and Indemnity
		 	61	  
	 Section 8.8.
		 Replacement of Indenture Trustee
		 	62	  
	 Section 8.9.
		 Successor Indenture Trustee by Merger
		 	63	  
	 Section 8.10.
		 Appointment of Separate Indenture Trustee or Co-Indenture Trustee
		 	63	  
	 Section 8.11.
		 Eligibility; Disqualification
		 	65	  
	 Section 8.12.
		 Audits of the Indenture Trustee
		 	65	  
	 Section 8.13.
		 Representations and Warranties of the Indenture Trustee
		 	66	  
	 Section 8.14.
		 Covenants for Reporting of Repurchase Demands due to Breaches of Representations and Warranties
		 	67	  
	 Section 8.15.
		 Indenture Trustee May Own Notes
		 	68	  
		
	ARTICLE IX SUPPLEMENTAL INDENTURES		 	68	  
	 Section 9.1.
		 Supplemental Indentures Without Consent of Noteholders
		 	68	  
	 Section 9.2.
		 Supplemental Indentures Without Consent of Noteholders
		 	68	  
	 Section 9.3.
		 Execution of Supplemental Indentures
		 	69	  
	 Section 9.4.
		 Effect of Supplemental Indenture
		 	70	  
	 Section 9.5.
		 Reference in Notes to Supplemental Indentures
		 	70	  
	 Section 9.6.
		 Indenture Trustee to Consent
		 	70	  
		
	ARTICLE X SATISFACTION AND DISCHARGE		 	70	  
	 Section 10.1.
		 Satisfaction and Discharge of Indenture
		 	70	  
		
	 ARTICLE XI MISCELLANEOUS
		 	71	  
	 Section 11.1.
		 Notices
		 	71	  
	 Section 11.2.
		 Governing Law; Submission to Jurisdiction
		 	71	  
	 Section 11.3.
		 Integration
		 	72	  
	 Section 11.4.
		 Severability of Provisions
		 	72	  

  
 ii 

							
	 Section 11.5.
		 Counterparts; Facsimile Delivery
		 	72	  
	 Section 11.6.
		 Headings
		 	72	  
	 Section 11.7.
		 Issuer Obligation
		 	72	  
	 Section 11.8.
		 Subordination of Claims against the Depositor
		 	73	  
	 Section 11.9.
		 Non-Petition
		 	74	  

  

							
	Schedule I		Schedule of Pool Receivables		 	SI-1	  
	Schedule II		Notice Addresses		 	SII-1	  
	Schedule III		Bank Accounts		 	SIII-1	  
	Schedule IV		List of Equipment Types		 	SIV-1	  
			
	Exhibit A		Form of Class A/B Note		 	EA-1	  

  
 iii 

 INDENTURE, dated as of May 14, 2014 (this “Indenture”), between CCG
RECEIVABLES TRUST 2014-1, a Delaware statutory trust, as Issuer (the “Issuer”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as Indenture Trustee (the “Indenture Trustee”) for the benefit of
the Noteholders. 
 Each party agrees as follows for the benefit of the other party and for the equal and ratable benefit of the
Noteholders. 
 The Issuer Grants to the Indenture Trustee at the Closing Date, as Indenture Trustee for the benefit of the Noteholders, all
of the Issuer’s right, title and interest in, to and under, whether now owned or hereafter acquired, the Collateral. The foregoing Grant is made in trust to secure (a) the payment of principal of, interest on and any other amounts owing in
respect of the Notes as provided in this Indenture and (b) compliance by the Issuer with the provisions of this Indenture for the benefit of the Noteholders. 

The Indenture Trustee acknowledges such Grants, accepts the trusts under this Indenture in accordance with this Indenture and agrees to
perform the duties required in this Indenture so that the interests of the Noteholders may be adequately and effectively protected. 

ARTICLE I 
 USAGE AND DEFINITIONS

 Section 1.1. Certain Defined Terms. Capitalized terms used but not defined in this Indenture are defined in the Sale and
Servicing Agreement. As used in this Indenture, the following terms shall have the following meanings: 
 “Affiliate”
means, as to any Person, any other Person which, directly or indirectly, owns, is in control of, is controlled by, or is under common control with, such Person, in each case whether beneficially, or as a trustee, guardian or other fiduciary. A
Person shall be deemed to control another Person if the controlling Person possesses, directly or indirectly, the power to direct or cause the direction of the management and policies of the other Person, whether through the ownership of voting
securities or membership interests, by contract, or otherwise. 
 “Applicable Law” means for any Person or property of such
Person, all applicable Laws, rules, regulations (including temporary and final income tax regulations), statutes, treaties, codes, ordinances, permits, certificates, orders and licenses of and interpretations by any Official Body (including, without
limitation, usury laws, Laws relating to truth in lending, fair credit billing, fair credit reporting, equal credit opportunity, fair debt collection practices and privacy, the Federal Truth in Lending Act, and Regulation Z and Regulation B of the
Board of Governors of the Federal Reserve System), and applicable judgments, decrees, injunctions, writs, awards, orders, or action of any court, arbitrator or other administrative, judicial, or quasi-judicial tribunal or agency of competent
jurisdiction. 
 “Authenticating Agent” has the meaning set forth in Section 3.11(a). 

“Available Amount” means, without duplication, 

	 	(a)	the aggregate Collections on the Pool Receivables received during the related Collection Period, including, without duplication, proceeds of Liquidated Receivables obtained through the sale or other disposition of the
related Equipment or from any other means in accordance with the related Contract, net of expenses incurred by the Servicer in connection with such liquidation and any amount required by law to be remitted to the related Obligor; 

 

	 	(b)	amounts transferred to the Collection Account on the related Payment Date from the Reserve Account in accordance with Section 4.3 and the Sale and Servicing Agreement; 

 

	 	(c)	the aggregate purchase prices for any Pool Receivables repurchased by the Originator, the Depositor or the Servicer; 

  

	 	(d)	earnings on investment of funds held in the Collection Account and the Reserve Account; and 

  

	 	(e)	any Servicer Advances deposited into the Collection Account during the related Collection Period. 

“Back-Up Servicer” means Portfolio Financial Servicing Company, a Delaware corporation, and its successors and permitted
assigns. 
 “Back-Up Servicing Fee” means an amount equal to $24,000 per annum, payable in equal monthly installments. 

“Bankruptcy Code” means the Bankruptcy Reform Act of 1978, 11 U.S.C. §§ 101 et seq., as amended. 

“Book-Entry Note” means a beneficial interest in any of the Notes issued in book-entry form as described in Section 3.3.

 “Business Day” means any day excluding Saturday, Sunday and any day on which banks in New York, New York, Houston,
Texas, Charlotte, North Carolina, Chicago, Illinois, Wilmington, Delaware, St. Paul, Minnesota or Atlanta, Georgia are authorized or required by Law to close. 

“Casualty Payment” means, with respect to any Equipment, any payment pursuant to a Contract on account of the loss, theft,
condemnation, governmental taking, destruction, or damage beyond repair of any item of Equipment subject thereto. 
 “CCG”
means Commercial Credit Group Inc., a Delaware corporation, and its successors and assigns. 
 “Certificate Register” and
“Certificate Registrar” have the meaning assigned to such terms in the Trust Agreement. 

“Certificateholder” has the meaning assigned to such term in the Trust Agreement. 

  
 3 

 “Class” means any of the group of Notes identified herein as, as applicable, the
Class A-1 Notes, the Class A-2 Notes or the Class B Notes. 
 “Class A Notes” means, collectively, the
Class A-1 Notes and the Class A-2 Notes. “Class A Note Balance” means, as of any determination date, the sum of the Class A-1 Note Balance and the Class A-2 Note Balance. 

“Class A-1 Maturity Date” means May 14, 2015. 

“Class A-1 Note Balance” means, as of any determination date, the amount Outstanding under the Class A-1 Notes,
determined as of the Payment Date in the immediately preceding month. 
 “Class A-1 Note Rate” means 0.27000% and shall be
calculated on the basis of the actual number of days in the applicable Interest Period and a 360-day year. 
 “Class A-1
Noteholder” means the Person in whose name a Class A-1 Note is registered in the Note Register. 
 “Class A-1
Notes” means the $72,400,000 asset-backed Class A-1 Notes secured by the Collateral, substantially in the form attached as Exhibit A hereto. 

“Class A-2 Maturity Date” means November 15, 2021. 

“Class A-2 Note Balance” means, as of any determination date, the amount Outstanding under the Class A-2 Notes
determined as of the Payment Date in the immediately preceding month. 
 “Class A-2 Note Rate” means 1.06% and shall be
calculated on the basis of a 30-day month and a 360-day year. 
 “Class A-2 Noteholder” means the Person in whose name a
Class A-2 Note is registered in the Note Register. 
 “Class A-2 Notes” means the $177,170,000 asset-backed
Class A-2 Notes secured by the Collateral, substantially in the form attached as Exhibit A hereto. 
 “Class B Maturity
Date” means November 15, 2021. 
 “Class B Note Balance” means, as of any determination date, the amount
Outstanding under the Class B Notes determined as of the Payment Date in the immediately preceding month. 
 “Class B Note
Rate” means 2.15% and shall be calculated on the basis of a 30-day month and a 360-day year. 
 “Class B
Noteholder” means the Person in whose name a Class B Note is registered in the Note Register. 

  
 4 

 “Class B Notes” means the $15,810,000 asset-backed Class B Notes secured by the
Collateral, substantially in the form attached as Exhibit A hereto. 
 “Clearing Agency” means an organization registered
as a “clearing agency” pursuant to Section 17A of the Exchange Act. 
 “Closing Date” means May 14,
2014. 
 “Controlling Class” means, so long as the Class A Notes remain Outstanding, the Class A Notes and after
the Class A Notes have been paid in full and for so long as the Class B Notes remain Outstanding, the Class B Notes. 

“Collateral” means (a) the Pool Receivables and Related Security, (b) the Collections, (c) any security
interest in the Equipment, (d) the rights to proceeds from casualty insurance policies covering the Equipment, (e) all amounts on deposit in the Reserve Account and Collection Account, (f) the Depositor’s rights under the
Purchase Agreement, (g) the Issuer’s rights under the Sale and Servicing Agreement, (h) all present and future claims, demands, causes of actions in respect of the foregoing and (i) all proceeds of the foregoing. 

“Collection Account” means the segregated trust account or accounts, including any sub-accounts, established and maintained
pursuant to Section 4.1(a) of the Sale and Servicing Agreement. 
 “Collection Period” means, with respect to any
Payment Date or Determination Date, the period from and including the first day of the calendar month preceding the month in which such Payment Date or Determination Date, as applicable, occurs to and including the close of business on the last day
of such calendar month. 
 “Collections” means, with respect to any Pool Receivable, all funds that (a) are received
by the Issuer or Servicer from or on behalf of the related Obligor after the Cut-Off Date in payment of any amount owed (including purchase price, rentals, principal payments, interest and other charges) in respect of such Pool Receivable, or
applied to such other charges in respect of such Pool Receivable in accordance with the Contract from which such Pool Receivable arises, or applied to such amounts owed by such Obligor (including Casualty Payments, Insurance Proceeds and Liquidation
Proceeds), (b) are required to be paid to the Issuer by the Depositor, the Originator or the Servicer pursuant to any provision of any Transaction Document or (c) are proceeds of any sale, transfer or other disposition of such Pool
Receivable by the Issuer or the Servicer on behalf of the Issuer; provided, that Collections shall not include any Excluded Amounts. 

“Contract” means, in relation to any Pool Receivable, any and all of the contracts, instruments, agreements, leases, notes,
or other writings pursuant to which such Pool Receivable arises or which evidence such Pool Receivable or under which an Obligor becomes or is obligated to make payment in respect of such Pool Receivable. 

  
 5 

 “Contract Residual Value” means, with respect to any Contract that is a lease in
form, the dollar amount so designated as such by the Servicer as of the origination date of the Contract. 
 “Contract
Yield” means, for any Contract and any date of determination, the calculated yield of such Contract based on the Net Book Value as of such date and the remaining Scheduled Payments. 

“Corporate Trust Office” means, with respect to the Indenture Trustee 60 Livingston Avenue, EP-MN-WS3D, St. Paul, MN, 55107,
or at such other address as the Indenture Trustee may designate by notice to the Owner Trustee, the Noteholders and the Servicer. 

“Credit and Collection Policy” means, for so long as CCG is the Servicer, the Originator’s credit and collection policy
or policies and customary servicing practices relating to the Contracts and Receivables as in effect on the Closing Date and set forth in Exhibit B of the Sale and Servicing Agreement, as modified, from time to time, in compliance with
Section 6.2(a)(v) of the Sale and Servicing Agreement. Any Successor Servicer hereunder may, to the extent agreed to by the Indenture Trustee (at the written direction of the Majority Holders), use credit and collection policies and practices
other than those attached as Exhibit B to the Sale and Servicing Agreement. 
 “Cumulative Net Loss Ratio” means, with
respect to a Determination Date, the ratio, expressed as a percentage, of (a) the aggregate cumulative amount of Realized Losses on the Pool Receivables since the Cut-Off Date through the last day of the related Collection Period, to
(b) the Original Pool Balance. 
 “Custodial Agreement” means that certain Custodial Agreement dated as of
May 14, 2014, among the Issuer, the Indenture Trustee and the Custodian, as the same may be amended or restated from time to time, and any Custodial Agreements entered into in replacement for such Custodial Agreement. 

“Custodian” means Portfolio Financial Servicing Company, a Delaware corporation, and its successors and assigns. 

“Custodian Fee” means the amount set forth in Schedule 6 of the Custodial Agreement. “Custodian File” has the
meaning set forth in the Custodial Agreement. 
 “Cut-Off Date” means close of business on April 30, 2014, and, with
respect to any Substituted Receivable, close of business on the last day of the month immediately preceding the related Substitution Date. 

“DBRS” means DBRS, Inc. or any successor that is a nationally recognized statistical rating organization. 

“Default” means any occurrence that with notice or the lapse of time or both would become an Event of Default. 

  
 6 

 “Defaulted Receivable” means a Pool Receivable (a) as to which any payment,
or part thereof, remains unpaid for 121 days or more from its original scheduled due date; (b) as to which an Event of Bankruptcy has occurred and is continuing with respect to the Obligor thereof; (c) that has been identified by the
Servicer (in accordance with the Credit and Collection Policy) as uncollectible; or (d) that is written off, in whole or in part, as uncollectible by the Servicer pursuant to the Credit and Collection Policy; provided, however,
that any Pool Receivable that becomes a Defaulted Receivable solely under clause (a) above shall cease to be considered a Defaulted Receivable if all installments then due and owing on the Pool Receivable are paid in full and, after the payment
of such amounts, the Pool Receivable satisfies all of the eligibility criteria set forth in the definition of Eligible Receivable. 

“Definitive Notes” has the meaning set forth in Section 3.3. 

“Depositor” means CCG Receivables IV, LLC, a Delaware limited liability company, and its successors and assigns. 

“Determination Date” means the close of business on the second Business Day prior to each Payment Date. 

“Eligible Investments” means book-entry securities, negotiable instruments or securities represented by instruments in bearer
or registered form that evidence: 
  

	 	(a)	obligations of, or guaranteed as to the full and timely payment of principal and interest by, the United States or obligations of any agency or instrumentality thereof, when such obligations are backed by the full faith
and credit of the United States; 

  

	 	(b)	repurchase agreements on obligations specified in clause (a); provided, that the short-term debt obligations of the party agreeing to repurchase are rated in the highest rating category by each Rating Agency.

  

	 	(c)	federal funds, certificates of deposit, demand deposits, time deposits and bankers’ acceptances (which shall each have an original maturity of not more than 90 days or, in the case of bankers’ acceptances,
shall in no event have an original maturity of more than 365 days) of any United States depository institution or trust company incorporated under the laws of the United States or any State thereof or of any United States branch or agency of a
foreign commercial bank; provided, that the short-term debt obligations of such depository institution or trust company are rated in the highest rating category by each Rating Agency; 

 

	 	(d)	commercial paper (having original maturities of not more than 30 days) which on the date of acquisition are rated in the highest rating category by each Rating Agency; 

 

	 	(e)	securities of money market funds rated “AAA(m)” by S&P (if S&P is a Rating Agency) and in the highest rating category by each other Rating Agency; and 

 

	 	(f)	any other investment for which the Issuer has received Rating Agency Confirmation. 

  
 7 

 “Eligible Receivable” means, as of the Closing Date or a Substitution Date, as
applicable, a Pool Receivable: 
  

	 	(a)	which was originated by the Originator in the ordinary course of its business and with respect to which all material obligations of the Originator have been performed on or prior to the date on which the related Pool
Receivable was sold or contributed to the Issuer in accordance with the Sale and Servicing Agreement and pledged to the Indenture Trustee hereunder; 

  

	 	(b)	which has, under the related Contract, not more than 84 remaining Scheduled Payments; 

  

	 	(c)	which was originated by the Originator in accordance with the Credit and Collection Policy; 

  

	 	(d)	which is secured by a perfected first priority security interest (as such term is defined in Section 1-201(37) of the UCC) in the Equipment (other than Equipment with an aggregate invoiced cost of $25,000 or less)
which was financed with the extension of credit described in such Contract and the proceeds thereof and with respect to which all of the Originator’s right, title and interest in any related Equipment has been sold or contributed to the
Depositor pursuant to the Purchase Agreement; 

  

	 	(e)	which was selected by the Originator for sale to the Issuer and which was not subject to any adverse selection unfavorable to the Indenture Trustee or the Noteholders; 

 

	 	(f)	which has been sold or contributed to the Issuer in accordance with the Sale and Servicing Agreement, which does not arise from the sale or lease of any inventory or Equipment subject to any Lien (other than Permitted
Liens), and to which the Issuer has good and marketable title, free and clear of all Liens (other than Permitted Liens); 

  

	 	(g)	the Obligor of which: (i) is a United States resident, (ii) is not an Affiliate or employee of the Originator, the Depositor or the Issuer, and (iii) is not an Official Body; 

 

	 	(h)	the Obligor of which has been directed in writing to make all payments to the Lock-Box Account; 

  

	 	(i)	which, under the related Contract and Applicable Law, is assignable without the consent of, or notice to, the Obligor thereunder unless such consent has been obtained in writing and is in effect or such notice has been
given; 

  
 8 

	 	(j)	with respect to which the related Contract is in full force and effect and constitutes the legal, valid and binding obligation of the related Obligor enforceable against such Obligor in accordance with its terms,
subject to the effect of bankruptcy, insolvency, reorganization, preference, fraudulent transfer, moratorium or other similar Laws relating to or affecting the rights and remedies of creditors or the effect of general principles of equity, whether
considered in a proceeding in equity or at law (including the possible unavailability of specific performance or injunctive relief), and is not subject to any right of rescission, setoff, counterclaim or defense (including the defense of usury) or
to any repurchase obligation or return right; 

  

	 	(k)	which is denominated and payable only in U.S. dollars, and which relates to an Obligor residing in the United States and Equipment located and remaining in the United States; 

 

	 	(l)	which is not a Defaulted Receivable; 

  

	 	(m)	which, as of the Cut-Off Date, is not more than 61 days past due; 

  

	 	(n)	which does not contravene in any respect any Applicable Laws (including Laws relating to truth in lending, fair credit billing, fair credit reporting, equal credit opportunity, fair debt collection practices and
privacy) and with respect to which no part of the Pool Receivable related thereto is in violation of any Applicable Law in any material respect; 

  

	 	(o)	the assignment of which under the Purchase Agreement by the Originator to the Depositor and under the Sale and Servicing Agreement by the Depositor to the Issuer and the grant of a security interest therein and in the
other Collateral by the Issuer to the Indenture Trustee on behalf of the Noteholders hereunder does not violate, conflict or contravene any Applicable Law or any contractual or other restriction, limitation or encumbrance; 

 

	 	(p)	with respect to which the sale, transfer, assignment and conveyance contemplated by the Purchase Agreement and the Sale and Servicing Agreement is not subject to and will not result in any tax, fee or governmental
charge payable by the Originator, the Depositor or the Issuer to any Official Body other than transfer taxes which have been or will be paid by the Originator as due; 

 

	 	(q)	payments of which are payable in consecutive monthly Scheduled Payments (before giving effect to Permitted Servicer Adjustments), other than pursuant to Permitted Skips; 

 

	 	(r)	which, with respect to a Contract that is a lease in form, has an original term equal to or greater than the remaining economic life of the related Equipment and is non-cancellable other than for payment in full of the
principal amount then due plus any other charges or prepayment penalties applicable thereto, and with respect to any other Contract, is not pre-payable unless the terms of such Pool Receivable require all remaining principal plus prepayment penalty
be paid in full at the time of such pre-payment; 

  
 9 

	 	(s)	the Scheduled Payments for which were calculated using a fixed Contract Yield; 

  

	 	(t)	a fully executed original Contract of which (including any related promissory notes and any Contracts or promissory notes issued in connection with any assumption, consolidation, extension, modification or waiver of
such Contract) has been delivered to the Custodian; 

  

	 	(u)	for which the related Contract is “chattel paper”, an “account,” an “instrument” or a “general intangible” within the meaning of Article 9 of the UCC of all applicable
jurisdictions; 

  

	 	(v)	for which CCG has not received prepayment in full from the Obligor on the related Contract; 

  

	 	(w)	which is of a “triple net” type, in which the Obligor is solely responsible for the payment of maintenance costs, insurance costs and any applicable taxes relating to the ownership and/or use of the related
Equipment; and 

  

	 	(x)	with respect to which either (i) the related Obligor has made a payment or (ii) the Originator has received a delivery and acceptance or a proceeds payment letter related to such Pool Receivable.

 “Equipment” means any equipment or other tangible personal property financed or leased by an Obligor
pursuant to a Contract, of a type specified in Schedule IV hereto. If the Equipment is a vehicle, the Originator’s Lien in such Equipment is noted on the applicable title certificate or application for title. 

“ERISA” means the Employee Retirement Income Security Act of 1974, as amended. 

“ERISA Affiliate” means, with respect to any Person, any corporation, limited liability company, partnership, trust, sole
proprietorship or trade or business which, together with such Person, is treated as a single employer under Section 414(b) or (c) of the Internal Revenue Code or, with respect to any liability for contributions under Section 302(c) of
ERISA or Section 414(m) of the Internal Revenue Code. 
 “Estimated Recovery Value” means, for any Defaulted
Receivable, the estimated realizable value of the Equipment related to such Defaulted Receivable, as determined by the Servicer in accordance with its then-written servicing procedures. 

“Event of Default” has the meaning set forth in Section 7.1. 

“Event of Bankruptcy” means, with respect to any Person, (a) that such Person (i) shall admit in writing its
inability to pay its debts generally or (ii) shall make a general assignment for the benefit of creditors; (b) any proceeding shall be instituted by or against such Person seeking to adjudicate it as bankrupt or insolvent, or seeking
liquidation, winding up, reorganization, 

  
 10 

 
arrangement, adjustment, protection, relief or composition of it or its debts under any law relating to bankruptcy, insolvency or reorganization or relief of debtors, or seeking the entry of an
order for relief or the appointment of a receiver, trustee or other similar official for it or any substantial part of its property and, in the case of any such proceeding instituted against such Person, such proceeding has continued undismissed or
unstayed for at least sixty (60) days since its commencement; or (c) that such Person shall take any corporate, limited liability company, partnership or other similar appropriate action to authorize any of the actions set forth in the
preceding clauses (a) or (b). 
 “Exceptions Report” has the meaning set forth in the Custodial Agreement. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended. 

“Excluded Amounts” means, with respect to a Pool Receivable, (a) any payments received from the related Obligor in
connection with any application fees, tax processing fees, wire transfer fees, express mail fees, filing fees, delivery fees, document preparation fees, insurance premiums, taxes, or other charges imposed by any Official Body, (b) any indemnity
payments made by the related Obligor for the benefit of the obligee under the related Contract, (c) any non-rental charges reimbursable to the Servicer in accordance with the Servicer’s customary policies and procedures, and
(d) Servicer Charges. 
 “Fiscal Year” shall mean, with respect to the Issuer and the Servicer, the twelve consecutive
months ending on March 31. 
 “Fitch” means Fitch Ratings, Inc., or any successor that is a nationally recognized
statistical rating organization. 
 “GAAP” means generally accepted accounting principles set forth in the opinions and
pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the U.S. Financial Accounting Standards Board or in such other statements by such accounting profession,
in effect from time to time. 
 “Grant” means to mortgage, pledge, assign and to grant a Lien upon and a security interest
in the relevant property. 
 “Indebtedness” means, without duplication, with respect to any Person such Person’s
(a) obligations for borrowed money, (b) obligations representing the deferred purchase price of property other than accounts payable arising in the ordinary course of such Person’s business on terms customary in the trade,
(c) obligations, whether or not assumed, secured by Liens or payable out of the proceeds or products of property now or hereafter owned or acquired by such Person, (d) obligations under each lease of property, real or personal, the
obligations of the lessee in respect of which are required in accordance with GAAP to be capitalized on a balance sheet of the lessee, (e) obligations which are evidenced by notes, acceptances (including bankers acceptances), or other
instruments, (f) obligations for which such Person is obligated pursuant to a guaranty, and (g) reimbursement obligations with respect to any letters of credit. 

“Indenture Trustee” has the meaning set forth in the preamble. 

  
 11 

 “Indenture Trustee Fee” means an amount equal to $8,000 per annum. 

“Indemnified Person” has the meaning set forth in Section 8.7(b). 

“Independent” means that the relevant Person (a) is independent of the Issuer, the Depositor and their Affiliates,
(b) does not have any direct financial interest or any material indirect financial interest in the Issuer, the Depositor or their Affiliates, and (c) is not an officer, employee, promoter, underwriter, trustee, partner, director or person
performing similar functions of or for the Issuer, the Depositor or their Affiliates. 
 “Initial Purchasers” means J.P.
Morgan Securities LLC, BMO Capital Markets GKST Inc. and SunTrust Robinson Humphrey, Inc. in their respective capacities as such under the Note Purchase Agreement. 

“Initial Overcollateralization Amount” means $9,620,205.03. 

“Insurance Policy” means, with respect to any Receivable, any insurance policy covering physical damage to or loss of the
related Equipment, but solely to the extent such insurance policy relates to such Equipment. 
 “Insurance Proceeds” means
any amount payable, or any payments made, to the Originator, the Servicer, the Depositor or the Issuer under an Insurance Policy in connection with any Equipment the financing of which gave rise to a Pool Receivable. 

“Intercreditor Agreement” means, the Amended and Restated Acknowledgment and Intercreditor Agreement, dated as of
February 15, 2013, by and among CCG, SunTrust Robinson Humphrey, Inc., BMO Capital Markets Corp. and Wells Fargo Capital Finance, LLC. 

“Intercreditor Master Agent” means Wells Fargo Capital Finance, LLC, as “Master Agent” under the
Intercreditor Agreement and any successor “Master Agent” appointed pursuant to the terms thereof. 
 “Internal Revenue
Code” means the Internal Revenue Code of 1986, as amended. 
 “Interest Period” means (a) in the case of the
Class A-1 Notes, the period from and including the preceding Payment Date (or, in the case of the first Payment Date, from and including the Closing Date) to but excluding the following Payment Date; or (b) in the case of the
Class A-2 Notes and the Class B Notes, the period from and including the fourteenth day of each calendar month (or, in the case of the first Payment Date, from and including the Closing Date) to but excluding the fourteenth day of the
succeeding calendar month calculated on the basis of 30-day months. 
 “Issuer” has the meaning set forth in the preamble.

 “Issuer Order” or “Issuer Request” mean, in connection with any order or
request by the Issuer to the Indenture Trustee to take any action under this Indenture (a) a written order or a written request, respectively, signed in the name of the Issuer by any one of its Responsible Officers and delivered to the
Indenture Trustee, (b) an Officer’s Certificate stating that all 

  
 12 

 
conditions precedent provided for in this Indenture relating to the proposed action have been complied with, and (c) to the extent required upon request of the Indenture Trustee, an Opinion
of Counsel to the effect that in the opinion of such counsel all such conditions precedent have been complied with. However, in the case of any such application or request as to which the furnishing of such documents is specifically required by this
Indenture, no additional certificate or opinion need be furnished. 
 “Law” means any law (including common law),
constitution, statute, treaty, regulation, rule, ordinance, order, injunction, writ, decree, judgment or award of any Official Body. 

“Lien” means a security interest, lien, charge, pledge or encumbrance or other right or claim in, of or on any Person’s
assets or properties in favor of any other Person (including any UCC financing statement or any similar instrument filed against such Person’s assets or properties). 

“Liquidated Receivable” means a Defaulted Receivable in respect of which all financed or leased Equipment has been sold or
otherwise disposed of, or in respect of which the related Obligor has otherwise satisfied all its obligations under the related Contract. 

“Liquidation Expenses” means, with respect to any Pool Receivable, the aggregate amount of all out of pocket expenses
(including, without limitation, reasonable attorney fees and disbursements) reasonably incurred by the Servicer (including amounts paid to any subservicer) in accordance with the Servicer’s customary procedures in connection with the
repossession, refurbishing and disposition of any related Equipment upon or after the expiration or early termination of such Pool Receivable or after such Pool Receivable has become a Defaulted Receivable and other out of pocket costs related to
the liquidation of any such Equipment, including the attempted collection of any amount owing pursuant to such Pool Receivable if it is a Defaulted Receivable. 

“Liquidation Proceeds” means, with respect to any Liquidated Receivable, the amounts collected in respect thereof from
whatever source (including Insurance Proceeds, and any post-default payments made by the Obligor) at the time of liquidation of the underlying equipment or other security related thereto or at any time thereafter, net of Liquidation Expenses and any
amounts to be remitted to the Obligor on such Liquidated Receivable or any creditor of such Obligor to the extent required by applicable law or agreement. 

“Lock-Box Account” means the account maintained by the Servicer at the Lock-Box Bank for the purposes of receiving
Collections. 
 “Lock-Box Agreement” means the Lock-Box Operating Procedural Agreement dated as of February 28, 2007
among Wachovia Bank, National Association, Wells Fargo Foothill, LLC and Commercial Credit Group Inc. 
 “Lock-Box Bank”
means the bank set forth in Schedule III, as such Schedule III may be modified pursuant to Section 5.1(o). 
 “Lock-Box
Intercreditor Agreement” means that certain Third Amended and Restated Lockbox Control and Intercreditor Agreement, dated as of March 31, 2010, by and among CCG, 

  
 13 

 
Wells Fargo Capital Finance, LLC, CCG Receivables, LLC, Wells Fargo Capital Finance, LLC, the Back-Up Servicer, CCG Receivables II, LLC, CCG Receivables III, LLC, SunTrust Robinson Humphrey,
Inc., Citibank, N.A. and each other person that becomes a joined party thereto. 
 “Majority Holders” means, so long as the
Class A Notes remain Outstanding, the applicable Class A Noteholders that together own Class A Notes evidencing in excess of 50% of the Class A Note Balance (voting as a single Class) and after the Class A Notes have been
paid in full and for so long as the Class B Notes remain Outstanding, the applicable Class B Noteholders that together own Class B Notes evidencing in excess of 50% of the Class B Note Balance. 

“Material Adverse Effect” means any event or condition which would have a material adverse effect on (a) the
collectability of the Pool Receivables, (b) the condition (financial or otherwise), businesses or properties of the Issuer, Depositor or Originator, or (c) the ability of the Servicer to collect on the Pool Receivables or perform its other
duties and obligations under the Sale and Servicing Agreement. 
 “Maturity Date” means, as applicable, the Class A-1
Maturity Date, Class A-2 Maturity Date, or Class B Maturity Date. 
 “Moody’s” means Moody’s Investors
Service, Inc., or any successor that is a nationally recognized statistical rating organization. 
 “Net Book Value” means,
with respect to any Receivable and any Determination Date, an amount equal to (a) the gross amount of all Scheduled Payments due or to become due, but unpaid, with respect to the applicable Pool Receivable as of the end of the most recent
Collection Period; plus (b) in case of any Pool Receivable that is a lease in form, 50% of the Contract Residual Value; minus (c) any Unearned Income with respect to such Pool Receivable; minus (d) the amount of
any security deposit related to such Receivable; minus (e) the Write-Down Amount; and minus (f) any Liquidation Proceeds. 

“Note Balance” means, as of any date, the aggregate Outstanding principal amount of all Notes of one Class or of all Classes,
as the case may be, as determined as of the immediately preceding Payment Date. 
 “Note Depository Agreement” means the
agreement, dated as of the Closing Date, executed by the Issuer and delivered to DTC, as the initial Clearing Agency relating to the Notes, as the same may be amended or supplemented from time to time. 

“Note Owner” means, for a Book-Entry Note, the Person who is the beneficial owner of a Book-Entry Note as reflected on the
books of the Clearing Agency or on the books of a Person maintaining an account with such Clearing Agency (as a direct participant or as an indirect participant, in each case in accordance with the rules of such Clearing Agency). 

“Note Paying Agent” means the Indenture Trustee or any other Person that meets the eligibility standards for the Indenture
Trustee specified in Section 8.11 and is authorized by the Issuer to make payments to and distributions from the Collection Account, including payments of principal of or interest on the Notes on behalf of the Issuer. 

  
 14 

 “Note Purchase Agreement” means the note purchase agreement, dated as of
May 6, 2014, by and among CCG, the Depositor, and J.P. Morgan Securities LLC, on its own behalf and as representative of the Initial Purchasers, as amended, modified, supplemented or otherwise modified from time to time. 

“Note Rate” means, as the context may require, the Class A-1 Note Rate, the Class A-2 Note Rate and the Class B
Note Rate, or any of them. 
 “Note Register” and “Note Registrar” have the meanings specified in
Section 3.6(a). 
 “Note Transfer” has the meaning set forth in Section 3.6(i). 

“Noteholder” means the Person in whose name a Note is registered on the Note Registrar. 

“Notes” means, collectively, the Class A-1 Notes, the Class A-2 Notes and the Class B Notes. 

“Obligor” means, as to each Pool Receivable, any Person who owes payments under the terms of the related Contract. 

“Offering Memorandum” means either or both of (i) the preliminary offering memorandum, dated as of April 30, 2014,
and (ii) the final offering memorandum, dated as of May 6, 2014. 
 “Officer’s Certificate” means
(a) for the Owner Trustee, Issuer, Depositor, Servicer or Originator, a certificate signed by a Responsible Officer of the Owner Trustee, Issuer, Depositor, Servicer or Originator, as applicable, and (b) for the Indenture Trustee, a
certificate signed by any officer of the Indenture Trustee. 
 “Official Body” means any government or political
subdivision or any agency, authority, bureau, central bank, commission, department or instrumentality of any such government or political subdivision, or any court, tribunal, grand jury or arbitrator, or any accounting board or authority (whether or
not a part of government) which is responsible for the establishment or interpretation of national or international accounting principles, in each case whether foreign or domestic. 

“Opinion of Counsel” means a written opinion of counsel which counsel is reasonably acceptable to the Indenture Trustee, the
Owner Trustee and each Rating Agency, as applicable. 
 “Original Pool Balance” means an amount equal to $275,000,205.03.

 “Originator” means CCG. 

  
 15 

 “Other Assets” means any assets or interests in any assets (other than the
Collateral) conveyed or purported to be conveyed by the Depositor to any Person other than the Issuer, whether by way of a sale, capital contribution, the Grant of a Lien or otherwise. 

“Outstanding” means, as of any date, all Notes authenticated and delivered under this Indenture on or before such date except
(a) Notes that have been cancelled by the Note Registrar or delivered to the Note Registrar for cancellation, (b) Notes or portions of Notes to the extent an amount necessary to pay all or a portion of such Notes has been deposited with
the Indenture Trustee or on or before such date; provided, that if such Notes are to be redeemed, notice of such redemption has been given pursuant to this Indenture or provision for such notice has been made in a manner satisfactory to the
Indenture Trustee, and (c) Notes in exchange for or in lieu of which other Notes have been authenticated and delivered pursuant to this Indenture unless proof satisfactory to the Indenture Trustee is presented that any such Notes are held by a
bona fide purchaser; provided, that in determining (i) whether Noteholders evidencing the required Note Balance have given any request, demand, authorization, direction, notice, consent or waiver under any Transaction Documents, Notes
owned by the Issuer, the Depositor, the Servicer or their Affiliates will be deemed not to be Outstanding, and (ii) whether the Indenture Trustee is protected in relying on any such request, demand, authorization, direction, notice, consent or
waiver, only Notes that a Responsible Officer of the Indenture Trustee knows to be so owned will be deemed not to be Outstanding; provided, however, that notwithstanding the foregoing, Notes owned by the Issuer, the Depositor, the
Servicer or their Affiliates will be treated as Outstanding if (i) no other Notes remain Outstanding or (ii) such Notes have been pledged in good faith and the pledgee establishes to the satisfaction of the Indenture Trustee the
pledgee’s right to act with respect to such Notes and that the pledgee is not the Issuer, the Depositor, the Servicer or their Affiliate. 

“Owner Trust Estate” has the meaning assigned to such term in the Trust Agreement. 

“Owner Trustee” means Wilmington Trust, National Association, a national banking association, not in its individual capacity
but solely as Owner Trustee under the Trust Agreement. 
 “Owner Trustee Fees” means an amount equal to $4,000 per annum.

 “Payment Date” means the fourteenth day of the calendar month or, if such day is not a Business Day, the next Business
Day, commencing on June 16, 2014. 
 “Perfection Representations” means the representations, warranties and covenants
set forth in Section 5.1(s). 
 “Permitted Liens” means (a) the Lien created hereunder and under any other
Transaction Documents; (b) Liens for taxes not yet delinquent or being contested in good faith by appropriate proceedings for which adequate reserves determined in accordance with GAAP have been established (and as to which the property subject
to such Lien is not yet subject to a material risk of imminent foreclosure, sale or loss on account thereof); (c) only with respect to Equipment, Liens imposed by Law arising in the ordinary course of business such as materialmen’s,
mechanics’, warehousemen’s and other and other similar Liens arising in the ordinary course of 

  
 16 

 
business that secure payment of obligations not more than sixty (60) days past due or that are being contested in good faith and as to which adequate reserves have been provided in
accordance with GAAP (and as to which the property subject to such Lien is not yet subject to a material risk of imminent foreclosure, sale or loss on account thereof); and (d) the right of use and quiet enjoyment of the Obligor as lessee under
any Contract in respect of the related Equipment. 
 “Permitted Servicer Adjustments” has the meaning assigned to such term
in Section 3.2(b) of the Sale and Servicing Agreement. 
 “Permitted Skip” means, with respect to any Contract (prior
to giving effect to Permitted Servicer Adjustments), a period not to exceed four calendar months during any twelve consecutive month period in which no Scheduled Payments are due in respect of such Contract under the terms of the applicable
Contract; provided, that the sum of Scheduled Payments made throughout the twelve month period shall at least equal the same total amount of Scheduled Payments over the same period had no Permitted Skips been made with respect to such
Contract. 
 “Person” means an individual, partnership, limited liability company, corporation, joint stock company, trust
(including a business trust), unincorporated association, joint venture, firm, enterprise, Official Body or any other entity. 

“Pool Balance” means, as of any date of determination, the aggregate Net Book Value of all remaining Pool Receivables
excluding Defaulted Receivables. 
 “Pool Receivable” means each Receivable listed on Schedule I hereto (as amended from
time to time) that (a) has been or is contemporaneously being sold, contributed or otherwise transferred by the Originator to the Depositor under the Purchase Agreement and from the Depositor to the Issuer under the Sale and Servicing
Agreement, or is a Substituted Receivable, (b) is subject to first priority security interest in favor of the Indenture Trustee hereunder, and (c) has not been repurchased by the Depositor or the Originator from the Issuer pursuant to the
Sale and Servicing Agreement or Purchase Agreement. 
 “Proceeding” means any suit in equity, action at law or other
judicial or administrative proceeding, or governmental investigation. 
 “Purchase Agreement” means that certain Purchase
Agreement dated as of May 14, 2014, between the Originator, as seller, and the Depositor, as purchaser, as amended, supplemented or otherwise modified from time to time in accordance with the terms thereof. 

“Qualified Institution” means (a) any bank or depository institution organized under the laws of the United States or
any State or any United States branch or agency of a foreign bank or depository institution that (i) is subject to supervision and examination by federal or State banking authorities, (ii) has a short-term deposit rating of “A-1”
from S&P or, if S&P is not a Rating Agency, an equivalent rating from S&P, Moody’s, DBRS or Fitch, (iii) if such institution holds any Bank Accounts other than as segregated trust accounts and the deposits are to be held in
such accounts more than thirty (30) days, has a long-term unsecured debt rating or issuer rating of “A+” or better from S&P or, if S&P is not a Rating Agency, an equivalent rating or better from S&P, Moody’s, DBRS or
Fitch, and (iv) if such institution is organized under the 

  
 17 

 
laws of the United States, whose deposits are insured by the Federal Deposit Insurance Corporation, or (b) the corporate trust department of U.S. Bank National Association or any other bank
or depository institution organized under the laws of the United States or any State or any United States branch or agency of a foreign bank or depository institution that is subject to supervision and examination by federal or State banking
authorities that (x) is authorized under such laws to act as a trustee or in any other fiduciary capacity, and (y) has a long-term deposit rating of “BBB” or better from S&P or, if S&P is not a Rating Agency, an
equivalent rating or better from S&P, Moody’s, DBRS or Fitch. 
 “Rating Agency” means S&P, DBRS, or any
nationally recognized statistical rating organization hired by the Originator to rate the Notes and then rating the Notes. 

“Rating Agency Confirmation” means, with respect to any event or circumstance and with respect to each Rating Agency, written
confirmation (which may be in the form of a letter, a press release or other publication, or a change in such Rating Agency’s published criteria to this effect) by such Rating Agency that the occurrence of such event or circumstance will not
cause such Rating Agency to downgrade, qualify or withdraw its rating assigned to the Notes. 
 “Realized Losses” means, as
of any Determination Date, the sum of (a) with respect to any Defaulted Receivable that has become a Liquidated Receivable, the difference (which may be negative) of (i) the Net Book Value of such Pool Receivable as of the date it became a
Defaulted Receivable, minus (ii) the Liquidation Proceeds for such Pool Receivable and (b) with respect to any Defaulted Receivable that has not yet become a Liquidated Receivable, the Write-Down Amount plus any losses and minus any
gains realized on any items of Equipment sold or otherwise disposed of in any Collection Period. 
 “Receivable” means any
and all indebtedness and other obligations owed by any Obligor to the Originator (prior to giving effect to any transfer under the Purchase Agreement) under a Contract and outstanding after the related Cut-Off Date or any right of the Originator or
the Issuer to payment from or on behalf of an Obligor after the related Cut-Off Date arising in connection with the making of loans or the sale of goods or the rendering of services by the Originator, and includes the obligation to pay any finance
charges, fees and other charges with respect thereto. 
 “Record Date” means, for a Payment Date and a Book-Entry Note, the
close of business on the day before such Payment Date and, for a Payment Date and a Definitive Note, the last day of the calendar month preceding the month in which such Payment Date occurs. 

“Registered Noteholder” means the Person in whose name a Note is registered on the Note Register on the applicable Record
Date. 
 “Regulation AB” means Subpart 229.1100 – Asset Backed Securities, 17 C.F.R. §§229.1100-229.1123.

  
 18 

 “Related Security” means, with respect to any Pool Receivable, all of the
rights, title and interest in, to and under: 
  

	 	(a)	the Equipment and any other property securing the Obligor’s obligations under any Pool Receivable, and any guarantees or similar credit enhancement for the Obligor’s obligations under such Pool Receivable,
including, without limitation, (i) all rights of the Originator in any security deposits, (ii) all UCC financing statements or other filings relating thereto, (iii) all rights and remedies against any vendor (including the Originator)
of the Equipment and (iv) all Insurance Policies; 

  

	 	(b)	all other security interests or Liens, if any, purporting to secure payment of such Pool Receivable, whether pursuant to the Contract related to such Pool Receivable or otherwise, together with all financing statements
and other filings signed by an Obligor relating thereto; 

  

	 	(c)	all guarantees, indemnities, warranties, insurance (and proceeds and premium refunds thereof) or other agreements or arrangements of any kind from time to time supporting or securing payment of such Pool Receivable,
whether pursuant to the Contract related to such Pool Receivable or otherwise; 

  

	 	(d)	all records related to such Pool Receivable; 

  

	 	(e)	all present and future claims, demands, causes of action and choses in action in respect of any of the foregoing; and 

  

	 	(f)	all proceeds of any of the foregoing. 

 “Request for Release” has the meaning
set forth in the Custodial Agreement. 
 “Required Reserve Account Amount” means 1.00% of the Original Pool Balance. 

“Reserve Account” means the segregated trust account or accounts established and maintained pursuant to Section 4.1(b)
of the Sale and Servicing Agreement. 
 “Responsible Officer” means, (a) with respect to the Depositor, the President,
the Chief Financial Officer, the Vice President or the Treasurer and (b) with respect to the Originator or the Servicer (for so long as the Servicer is CCG), the President, the Chief Executive Officer, the Chief Financial Officer, the
Treasurer, the Chief Accounting Officer and the Vice President of Accounting, (c) with respect to the Issuer, any president, vice-president, assistant vice president, secretary or assistant secretary of the Owner Trustee or the Servicer or any
other officer of the Owner Trustee or customarily performing functions similar to those performed by any of the above, or (d) with respect to the Owner Trustee or the Indenture Trustee, any president, vice-president, assistant vice president,
secretary or assistant secretary of the Owner Trustee or Indenture Trustee, or any other officer of the Owner Trustee or Indenture Trustee in each case having direct responsibility for the administration of this Indenture. 

“Rule 144A” means Rule 144A under the Securities Act, as in effect from time to time. 

“Rule 144A Information” has the meaning set forth in Section 3.6(1). 

  
 19 

 “Rule 17g-5” has the meaning set forth in Section 5.1(t). 

“S&P” means Standard & Poor’s Ratings Services, a Standard and Poor’s Financial Services LLC business,
or any successor that is a nationally recognized statistical rating organization. 
 “Sale and Servicing Agreement” means
that certain Sale and Servicing Agreement dated as of May 14, 2014, among the Depositor, the Issuer, the Servicer, the Originator, the Back-Up Servicer and the Indenture Trustee, as amended, supplemented or otherwise modified from time to time.

 “Scheduled Investor Principal Amount” means, with respect to a Payment Date, an amount equal to the amount by which the
Note Balance of the Notes (after giving effect to payments made on such Payment Date in priorities Sixth and Eighth under Section 4.5(a)) exceeds the amount of (i) the Pool Balance as of the last day of the related Collection
Period minus (ii) the Target Overcollateralization Amount as of the last day of the related Collection Period; provided, however, that in no event shall the Scheduled Investor Principal Amount be less than the amount needed
to repay any Class of Notes on or after the Maturity Date for such Class of Notes. 
 “Scheduled Payment” means
(i) with respect to a Pool Receivable that is a loan, that portion of the payment required to be made by the related Obligor during any Collection Period sufficient to amortize the principal balance over the term of the Pool Receivable and to
provide interest at the Contract Yield and (ii) with respect to a Pool Receivable that is a lease, the full payment required under the related Contract to be made by the related Obligor during any Collection Period. 

“Securities Act” means the Securities Act of 1933, as amended. 

“Servicer” means CCG. 

“Servicer Charges” has the meaning set forth in the Sale and Servicing Agreement. 

“Servicing Fee” means, with respect to any Payment Date, an amount equal to the product of (i) 0.75%, multiplied
by (ii) the Pool Balance as of the first day of the immediately preceding Collection Period, multiplied by (iii) a fraction, the numerator of which equals one and the denominator of which each equals 12. 

“Subordinated Debt” means any indebtedness of CCG and its Affiliates which is subordinated in right of payment to the prior
payment of any other indebtedness of CCG and its Affiliates. 
 “State” means any state or commonwealth of the United
States, or the District of Columbia. 
 “Subsidiary” means, with respect to any Person, any corporation, limited liability
company, or other Person (a) of which securities or other ownership interests having ordinary voting power to elect a majority of the board of directors or other Persons performing similar 

  
 20 

 
functions are at the time directly or indirectly owned by such Person or (b) that is directly or indirectly controlled by such Person within the meaning of control under Section 15 of
the Securities Act. 
 “Tangible Net Worth” means, with respect to CCG, the amount calculated in accordance with GAAP (but
without giving effect to any adjustments related to the valuation of any interest rate swaps or similar derivative instruments required pursuant to the Statement of Financial Accounting Standards No. 133 issued by the U.S. Financial Accounting
Standards Board) as (i) the consolidated net worth of such Person and its consolidated Subsidiaries, minus (ii) the amount of prepaid expenses (if any), minus (iii) any amounts attributable to the consolidated
intangibles of such Person and its consolidated Subsidiaries, including, without limitation, goodwill, trademarks, tradenames, copyrights, patents, patent allocations, licenses and rights in any of the foregoing and other items treated as
intangibles in accordance with GAAP, plus (iv) the principal amount of any Subordinated Debt. 
 “Target
Overcollateralization Amount” means, as of any Determination Date, the greater of (a) 1.50% of the Original Pool Balance and (b) the lesser of (i) the Initial Overcollateralization Amount and (ii) 4.50% of the Pool
Balance as of the end of the related Collection Period. 
 “Transaction Documents” means, collectively, this Indenture, the
Sale and Servicing Agreement, the Purchase Agreement, the Trust Agreement, the Lock-Box Agreement, the Custodial Agreement, the Lock-Box Intercreditor Agreement, the Intercreditor Agreement, the Note Purchase Agreement and all of the other
instruments, documents and other agreements executed and delivered by the Servicer, the Originator, the Depositor, the Back-Up Servicer, the Custodian, the Indenture Trustee or the Issuer in connection with any of the foregoing. 

“Trigger Event” means, with respect to any Determination Date, (a) the Cumulative Net Loss Ratio as of the end of the
related Collection Period exceeds 1.00% within the first six Collection Periods from the Closing Date, 2.50% within the seventh through twelfth Collection Periods from the Closing Date, 3.50% within the thirteenth through eighteenth Collection
Periods from the Closing Date, and 4.50% at any time after the eighteenth Collection Period following the Closing Date, or (b) a Servicer Default has occurred and is continuing. If a Trigger Event occurs solely related to clause (a) above
and is subsequently cured and remains below the related trigger levels for three consecutive Collection Periods, a Trigger Event shall no longer exist. 

“Trust Agreement” means the Amended and Restated Trust Agreement, dated as of May 14, 2014, between the Depositor and
the Owner Trustee. 
 “Unearned Income” means, with respect to any Pool Receivable as of any date of determination, the
gross amount of any interest or other income (each to the extent that such other income is reflected on the Servicer’s books as unearned income) due and payable by the relevant Obligor under the terms of the related Contract (or recognized in
respect of the Pool Receivable) to the extent that such interest or other income has not been received by the Depositor, the Issuer or the Servicer as of the relevant date of determination. 

“UCC” means the Uniform Commercial Code as in effect in any relevant jurisdiction. 

  
 21 

 “Void Note Transfer” has the meaning set forth in Section 3.6(i). 

“Write-Down Amount” means, for any Defaulted Receivable as of the date such Pool Receivable became a Defaulted Receivable and
as adjusted periodically in accordance with the Credit and Collection Policy, the difference between (i) the Net Book Value of such Pool Receivable as of the date such Pool Receivable became a Defaulted Receivable, and (ii) the Estimated
Recovery Value of the related Equipment. 
 ARTICLE II 

COLLATERAL 
 Section 2.1.
Continuing Security Interest. This Indenture shall create a valid and continuing security interest (as defined in the applicable UCC) in the Collateral in favor of the Indenture Trustee on behalf of the Noteholders, which security interest is
prior to all other Liens (other than Permitted Liens described clause (c) of the definition thereof and Equipment with an aggregate invoiced cost of $25,000 or less) and shall: 

 

	 	(a)	remain in full force and effect until the Indenture Trustee’s interest in the Collateral shall have been released in accordance with Section 2.4; 

 

	 	(b)	be binding upon the Issuer, and its successors, transferees and assigns; and 

  

	 	(c)	inure, together with the rights and remedies of the Indenture Trustee hereunder, to the benefit of the Noteholders and its respective successors, transferees and assigns. 

Section 2.2. Priority of Security Interest. The Issuer has or will have caused (at its own expense) within ten (10) days of
the Closing Date, the filing of all appropriate financing statements (including describing the Collateral as “all assets” of the Issuer) in the proper filing office in the appropriate jurisdictions under Applicable Law in order to perfect
the security interest in the Collateral granted to the Indenture Trustee, for the benefit of the Noteholders hereunder (provided, however, that the security interest in Equipment with an aggregate invoiced cost of $25,000 or less may
not be perfected). The Indenture Trustee shall have all the rights, remedies and recourse with respect to the Collateral afforded a secured party under the UCC in the applicable jurisdiction and all other Applicable Laws in addition to, and not in
limitation of, the other rights, remedies and recourse granted to the Indenture Trustee by this Indenture or any other Law relating to the creation and perfection of Liens on, and security interests in, the Collateral. 

  
 22 

 Section 2.3. Protection of Security Interest of the Indenture Trustee. The Issuer
agrees that it shall, from time to time, at its expense, promptly execute and deliver all instruments and documents and take all actions as may be necessary or as the Indenture Trustee may reasonably request in order to perfect or protect the
Indenture Trustee’s security interest in the Collateral or to enable the Indenture Trustee (at the written direction of the Majority Holders) to exercise or enforce any of its rights hereunder. Without limiting the foregoing, the Issuer shall,
upon the request of the Indenture Trustee on behalf of the Noteholders: 
  

	 	(a)	execute and file such financing or continuation statements or amendments thereto or assignments thereof (as otherwise permitted to be executed and filed pursuant hereto) as may be requested by the Indenture Trustee on
behalf of the Noteholders covering the Collateral or any part thereof, including financing statements describing the Collateral as “all assets” or “all personal property” or words of like meaning (provided, however,
that the Issuer may in its discretion, but is not required to, file such financing or continuation statements or amendments thereto with respect to Equipment with an aggregate invoiced cost of $25,000 or less); and 

 

	 	(b)	take all commercially reasonable actions necessary to remove any Liens (other than Permitted Liens) on the Collateral, including, but not limited to, releasing financing statements. The Issuer shall, upon request of the
Indenture Trustee on behalf of the Noteholders, obtain such additional search reports as the Indenture Trustee on behalf the Noteholders shall reasonably request. To the fullest extent permitted by Applicable Law, the Indenture Trustee (at the
expense of the Issuer) shall be permitted to sign and file continuation statements and amendments thereto and assignments thereof without the Issuer’s signature. Carbon, photographic or other reproduction of this Indenture or any financing
statement shall be sufficient as a financing statement. The Servicer may perform the foregoing obligations on behalf of the Issuer. 

Section 2.4. Release of Collateral. Anything contained in this Indenture to the contrary notwithstanding, following the payment of
the Notes in full, the Payment Date on which the Notes are redeemed in full pursuant to Section 3.13 or in connection with a sale permitted under Sections 3.3 or 3.4 of the Sale and Servicing Agreement, and in each case, payment of all other
amounts due and owing under the terms of this Indenture, the Indenture Trustee shall (at the written request of the Servicer) promptly release its security interest in the Collateral. 

Section 2.5. Effect of Release. When the release of the Collateral is effective in accordance with Section 2.4, all right,
title and interest of the Indenture Trustee in, to and under the Collateral shall terminate and shall revert to the Issuer, its successors and assigns, and the right, title and interest of the Indenture Trustee therein shall thereupon cease,
terminate and become void; and, upon the written request of the Issuer, its successors or assigns, and at the cost and expense of the Issuer, its successors or assigns, the Indenture Trustee shall execute such UCC-3 financing statements or such
other instruments as are provided to it as necessary or desirable to terminate and remove record of any documents constituting public notice of this Indenture and, in any case, the security interests and assignments granted hereunder with respect to
the Collateral and shall assign and transfer, or cause to be assigned and transferred, and shall deliver or cause to be delivered to the Issuer, all property, including all moneys, instruments and securities, of the Issuer then held by the Indenture
Trustee with respect to the Collateral. 

  
 23 

 ARTICLE III 

NOTES 
 Section 3.1.
Form. 
  

	 	(a)	The Notes, together with the Indenture Trustee’s certificate of authentication, will be in substantially the form set forth in Exhibit A with such variations as are required or permitted by this Indenture. The
Notes may have such marks of identification and such legends or endorsements placed on them as may be determined, consistent with this Indenture, by the Responsible Officer of the Issuer executing such Notes, as evidenced by their execution of such
Notes. The physical Notes will be produced by any method as determined by the Responsible Officer of the Issuer executing such Notes, as evidenced by their execution of such Notes. 

 

	 	(b)	Each Note will be dated the date of its authentication. The terms of the Notes set forth in Exhibit A are part of this Indenture and are incorporated into this Indenture by reference. 

Section 3.2. Execution, Authentication and Delivery. 
  

	 	(a)	A Responsible Officer of the Issuer will execute the Notes on behalf of the Issuer. The signature of such Responsible Officer on the Notes may be manual or facsimile. Notes bearing the manual or facsimile signature of
an individual who was a Responsible Officer of the Issuer will bind the Issuer, notwithstanding that such individual has ceased to hold such office before the authentication and delivery of such Notes or did not hold such office at the date of
issuance of such Notes. 

  

	 	(b)	The Indenture Trustee will, upon Issuer Order, authenticate and deliver the Notes for original issue at the applicable Note Rate and with the initial Class A-1 Note Balance, Class A-2 Note Balance and Class B
Note Balance as set forth below. 

  

									
	 Note
	  	Note Rate	 	 	Initial Note Balance	 
			
	 Class A-1 Notes
	  	 	0.27000	% 	 	$	72,400,000	  
			
	 Class A-2 Notes
	  	 	1.06	% 	 	$	117,170,000	  
			
	 Class B Notes
	  	 	2.15	% 	 	$	15,810,000	  

  

	 	(c)	The Notes will be issuable in minimum denominations of $100,000 and in multiples of $1,000 in excess thereof. Notwithstanding the foregoing, one Note may fail to be in such minimum denominations due to the difference
between such minimum denomination requirement and the initial Class A-1 Note Balance, Class A-2 Note Balance and Class B Note Balance. 

  

	 	(d)	No Note will be entitled to any benefit under this Indenture or be valid for any purpose, unless it bears a certificate of authentication substantially in the form provided for in this Indenture executed by the
Indenture Trustee by the manual signature of one of its authorized signatories, and such certificate upon any Note will be conclusive evidence, and the only evidence, that such Note has been duly authenticated and delivered under this Indenture.

  
 24 

 Section 3.3. Book Entry Notes. The Notes will be issued as Book-Entry Notes on the
Closing Date. The Book-Entry Notes, upon original issuance, will be issued in the form of typewritten Notes representing the Book-Entry Notes and delivered to The Depository Trust Company, the initial Clearing Agency, by, or on behalf of, the
Issuer. The Book-Entry Notes will be registered initially on the Note Register in the name of Cede & Co., the nominee of the Clearing Agency, and no Note Owner will receive a Definitive Note representing such Note Owner’s interest in
such Note, except as provided in Section 3.4. Unless and until definitive, fully registered Notes (the “Definitive Notes”) have been issued to Note Owners pursuant to Section 3.4: 

 

	 	(a)	With respect to Book-Entry Notes, the Note Registrar and the Indenture Trustee will be entitled to deal with the Clearing Agency for all purposes of this Indenture (including the payment of principal of and interest on
the Book-Entry Notes and the giving of notices, instructions or directions under this Indenture) as the sole Noteholder of the Book-Entry Notes, and will have no obligation to the Note Owners; 

 

	 	(b)	the Clearing Agency will make book-entry transfers among its participants and receive and transmit payments of principal of and interest on the Book-Entry Notes to such participants; 

 

	 	(c)	to the extent that the provisions of this Section 3.3 conflict with any other provisions of this Indenture, the provisions of this Section 3.3 will control; 

 

	 	(d)	the rights of Note Owners may be exercised only through the Clearing Agency and will be limited to those established by law and agreements between such Note Owners and the Clearing Agency and/or its participants
pursuant to the Note Depository Agreement; and 

  

	 	(e)	whenever this Indenture requires or permits actions to be taken based upon written instructions or written directions of Noteholders of a specified percentage of the Note Balance, the Clearing Agency will be deemed to
represent such percentage only to the extent that it has received instructions to such effect from Note Owners and/or the Clearing Agency’s participants owning or representing, respectively, such required percentage of the beneficial interest
of the Note Balance and has delivered such instructions to the Indenture Trustee. 

 Section 3.4. Definitive
Notes. With respect to any Class or Classes of Book-Entry Notes, if (a) the Issuer, or the Servicer on its behalf, notifies the Indenture Trustee that the Clearing Agency is no longer willing or able to properly discharge its
responsibilities as 

  
 25 

 
depository for the Book-Entry Notes and the Issuer, or the Servicer on its behalf, is unable to locate a qualified successor, (b) the Issuer, or the Servicer on its behalf, at its option,
advises the Indenture Trustee in writing that it elects to terminate the book-entry system and, the participants holding beneficial interests in the Notes agree to initiate a termination or (c) after the occurrence of an Event of Default or a
Servicer Event of Default, the Majority Holders notify the Indenture Trustee through the Clearing Agency that the continuation of a Book-Entry system through the Clearing Agency with respect to the Notes is no longer in their best interest, then the
Indenture Trustee shall notify all Note Owners of the occurrence of such event and of the availability of Definitive Notes to Note Owners requesting the same. Upon surrender to the Indenture Trustee of the typewritten Notes representing the
Book-Entry Notes by the Clearing Agency, accompanied by registration and transfer instructions from the Clearing Agency for registration, the Issuer shall execute, and the Indenture Trustee shall authenticate, the Definitive Notes in accordance with
the instructions of the Clearing Agency. None of the Issuer, the Note Registrar or the Indenture Trustee shall be liable for any delay in delivery of such instructions and may conclusively rely on, and shall be protected in relying on, such
instructions. Upon the issuance of Definitive Notes, all references herein to obligations imposed upon or to be performed by the Clearing Agency shall be deemed to be imposed upon and performed by the Issuer, to the extent applicable with respect to
such Definitive Notes, and the Issuer shall recognize the holders of the relevant Definitive Notes as Noteholders hereunder. 

Section 3.5. Tax Treatment. The Issuer intends that Notes that are owned or beneficially owned by a Person other than CCG or its
Affiliates will be indebtedness of the Issuer, secured by the Collateral, for U.S. federal, state and local income and franchise tax purposes. The Issuer, by entering into this Indenture, and each Noteholder, by its acceptance of a Note (and each
Note Owner by its acceptance of an interest in the applicable Book-Entry Note), agree to treat the Notes for U.S. federal, state and local income and franchise tax purposes as indebtedness of the Issuer. 

Section 3.6. Registration; Registration of Transfer and Exchange. 

 

	 	(a)	The Issuer appoints the Indenture Trustee to be the Note Registrar (in such capacity, the “Note Registrar”) and to keep a register (the “Note Register”) for the purpose of registering
Notes and transfers of Notes as provided in this Indenture. Upon any resignation of the Note Registrar, the Issuer will promptly appoint a successor or, if it elects not to make such an appointment, assume the duties of Note Registrar. If the Issuer
appoints a Person other than the Indenture Trustee as Note Registrar, (i) the Issuer will notify the Indenture Trustee of such appointment, (ii) the Indenture Trustee will have the right to inspect the Note Register at all reasonable times
and to obtain copies of the Note Register and (iii) the Indenture Trustee will have the right to rely upon a certificate executed by an officer of the Note Registrar as to the names and addresses of the Noteholders and the principal amounts and
number of the Notes. 

  

	 	(b)	Upon surrender for registration of transfer of any Note at the office or agency of the Issuer maintained under Section 5.1(h), if the requirements of Section 8-401(a) of the applicable UCC are met, the Issuer
will execute, the Indenture Trustee will authenticate and the Noteholder will obtain from the Indenture Trustee, in the name of the designated transferee or transferees, one or more new Notes, in any authorized denomination, in the same aggregate
principal amount. 

  
 26 

	 	(c)	A Noteholder may exchange Notes for other Notes, in any authorized denominations, in the same aggregate principal amount, by surrendering the Notes to be exchanged at the office or agency of the Issuer maintained under
Section 5.1(h). If the requirements of Section 8-401(a) of the applicable UCC are met, the Issuer will execute, the Indenture Trustee will authenticate and the Noteholder will obtain from the Indenture Trustee the Notes that the Noteholder
making such exchange is entitled to receive. 

  

	 	(d)	All Notes issued upon any registration of transfer or exchange of Notes will be the valid obligations of the Issuer, evidencing the same debt, and entitled to the same benefits under this Indenture as the Notes
surrendered upon such registration of transfer or exchange. 

  

	 	(e)	Every Note presented or surrendered for registration of transfer or exchange will be (i) duly endorsed by, or be accompanied by a written instrument of transfer in form satisfactory to the Note Registrar or the
Indenture Trustee duly executed by, the Noteholder of such Note or such Noteholder’s attorney duly authorized in writing, with such signature guaranteed by an “eligible guarantor institution” meeting the requirements of the Note
Registrar which requirements include membership or participation in Securities Transfer Agents Medallion Program or such other “signature guarantee program” as may be determined by the Note Registrar in addition to, or in substitution for,
the Securities Transfer Agents Medallion Program, all in accordance with the Exchange Act, and (ii) accompanied by such other documents as the Indenture Trustee may require. 

 

	 	(f)	None of the Issuer, the Note Registrar or the Indenture Trustee will impose a service charge on a Noteholder for any registration of transfer or exchange of Notes. The Issuer, the Note Registrar or the Indenture Trustee
may require such Noteholder to pay an amount sufficient to cover any tax or other governmental charge that may be imposed in connection with such registration of transfer or exchange of the Notes. 

 

	 	(g)	Neither the Issuer nor the Note Registrar will be required to register transfers or exchanges of Notes selected for redemption or Notes for which the next Payment Date is not more than 15 days after the requested date
of such transfer or exchange. 

  

	 	(h)	 The Notes have not been registered under the Securities Act or any state securities law. None of the Issuer, the Note Registrar or the Indenture
Trustee is obligated to register the Notes under the Securities Act or any other securities or “blue sky” laws or to take any other action not otherwise required under this Indenture or the Trust Agreement to permit the transfer of any
Note without registration. The Issuer, at the direction of the Depositor, may elect to register, or cause the registration of, the Notes under the Securities Act and any applicable state

  
 27 

	 	
securities law, in which case the Issuer will deliver, or cause to be delivered, to the Indenture Trustee and the Note Registrar such Opinions of Counsel, Officer’s Certificates and other
information as determined by the Depositor as necessary to effect such registration. 

  

	 	(i)	Until such time as any such Notes has been registered under the Securities Act and any applicable state securities law pursuant to Section 3.6(h), no Note may be sold, transferred, assigned, participated, pledged,
or otherwise disposed of (any such act, a “Note Transfer,”) to any Person except in accordance with the provisions of this Section 3.6, and any attempted Note Transfer in violation of this Section 3.6 will be null and void
(each a “Void Note Transfer”). 

  

	 	(j)	Each Note will bear a legend to the effect of the legend contained in Exhibit A unless determined otherwise by the officers executing such Note consistent with applicable law. As a condition to the registration of any
Note Transfer, the prospective transferee of such Note will be deemed to represent to the Indenture Trustee, the Note Registrar and the Issuer the following: 

  

	 	(i)	It understands that the Notes have not been and will not be registered under the Securities Act or any state or other applicable securities or “blue sky” law. 

 

	 	(ii)	It understands that Note Transfers are only permitted if made in compliance with the Securities Act and other applicable laws and only to a person that the holder reasonably believes is a “qualified institutional
buyer” within the meaning of Rule 144A under the Securities Act (a “QIB”). 

  

	 	(iii)	It (A) is a QIB, (B) is aware that the sale to it is being made in reliance on Rule 144A under the Securities Act and if it is acquiring such Notes or any interest or participation in the Notes for the account
of another QIB, such other QIB is aware that the sale is being made in reliance on Rule 144A under the Securities Act and (C) is acquiring such Notes or any interest or participation in the Notes for its own account or for the account of
another QIB. 

  

	 	(iv)	It is purchasing the Notes for its own account or for one or more investor accounts for which it is acting as fiduciary or agent, in each case for investment, and not with a view to offer, transfer, assign, participate,
pledge or otherwise dispose of such Notes in connection with any distribution of such Notes that would violate the Securities Act. 

  

	 	(k)	 By acceptance of any Note, the Noteholder specifically agrees with and represents to the Depositor, the Issuer and the Note Registrar, that no Note
Transfer will be made unless (i) the registration requirements of the Securities Act and any applicable state securities laws have been complied with in respect of such class in accordance with Section 3.6(h), (ii) such Note Transfer
is to the Depositor or its Affiliates, or (iii) such Note Transfer is exempt from the registration requirements under the Securities Act because such Note Transfer is in compliance with

  
 28 

	 	
Rule 144A under the Securities Act, to a transferee who the transferor reasonably believes is a Qualified Institutional Buyer (as defined in the Securities Act) that is purchasing for its
own account or for the account of a Qualified Institutional Buyer and to whom notice is given that such Note Transfer is being made in reliance upon Rule 144A under the Securities Act. The Issuer will make available to the prospective transferor and
transferee of a Note information requested to satisfy the requirements of paragraph (d)(4) of Rule 144A (the “Rule 144A Information”). The Rule 144A Information will include any or all of the following items requested by the
prospective transferee: 

  

	 	(i)	the Servicer Report for each Payment Date preceding such request; and 

  

	 	(ii)	such other information as is reasonably available to the Issuer in order to comply with requests for information pursuant to Rule 144A. 

Section 3.7. Mutilated, Destroyed, Lost or Stolen Notes. 
  

	 	(a)	If a mutilated Note is surrendered to the Indenture Trustee or the Indenture Trustee receives evidence to its satisfaction of the destruction, loss or theft of a Note, then the Issuer will execute and, upon Issuer
Request, the Indenture Trustee will authenticate and deliver a replacement Note of the same principal amount in exchange for or in lieu of such Note so long as (i) the Indenture Trustee receives such security or indemnity as may be required by
it to hold the Issuer and the Indenture Trustee harmless, (ii) none of the Issuer, the Note Registrar or the Indenture Trustee have received notice that such Note has been acquired by a protected purchaser, as defined in Section 8-303 of
the applicable UCC and (iii) the requirements of Section 8-405 of the applicable UCC are met. However, if any such destroyed, lost or stolen Note (but not a mutilated Note) is due and payable within fifteen (15) days or has been
called for redemption, instead of issuing a replacement Note, the Issuer may pay such destroyed, lost or stolen Note when so due or payable or upon the Payment Date on which the Note has been redeemed pursuant to Section 3.13 without surrender
of such Note. If a protected purchaser of the original Note in lieu of which such replacement Note was issued (or such payment made) presents for payment such original Note, the Issuer and the Indenture Trustee will be entitled to recover such
replacement Note (or such payment) from the Person to whom it was delivered or any Person taking such replacement Note (or such payment) from such Person to whom such replacement Note (or such payment) was delivered or any assignee of such Person,
except a protected purchaser, and will be entitled to recover upon the security or indemnity provided for such replacement Note (or such payment) for any cost, expense, loss, damage, claim or liability incurred by the Issuer or the Indenture Trustee
in connection with such replacement Note (or such payment). 

  

	 	(b)	Upon the issuance of any replacement Note under Section 3.7(a), the Issuer may require the Noteholder of such Note to pay an amount sufficient to cover any tax or other governmental charge imposed.

  
 29 

	 	(c)	Each replacement Note issued pursuant to Section 3.7(a) will constitute an original additional contractual obligation of the Issuer, whether or not the mutilated, destroyed, lost or stolen Note will be enforceable
by anyone and, except as otherwise provided in this Indenture, will be entitled to all the benefits of this Indenture. 

  

	 	(d)	The provisions of this Section 3.7 are exclusive and preclude (to the extent lawful) all other rights and remedies with respect to the replacement or payment of mutilated, destroyed, lost or stolen Notes.

 Section 3.8. Persons Deemed Owners. With respect to any date of determination, the Issuer, the Indenture
Trustee and any agent of the Issuer or the Indenture Trustee may treat the Person in whose name any Note is registered as of such date as the owner of such Note for the purpose of receiving payments of principal of and any interest on such Note and
for all other purposes, and none of the Issuer, the Indenture Trustee or any agent of the Issuer or the Indenture Trustee will be affected by notice to the contrary. 

Section 3.9. Payment of Principal and Interest. 
  

	 	(a)	The Notes will accrue interest at the applicable Note Rate. Interest on the Note will be due and payable on each Payment Date as specified in such Note. Interest on the Class A-1 Notes will be computed on the basis
of actual days elapsed in the related Interest Period and a 360-day year. Interest on the Class A-2 Notes and the Class B Notes will be computed on the basis of a 360-day year consisting of twelve 30-day months. 

 

	 	(b)	 Interest and principal payments on the Notes will be made ratably to the Noteholders entitled to such payments. On each Payment Date, distributions to
be made with respect to interest on and principal of the Definitive Notes will be paid to the Registered Noteholder (i) if such Noteholder has provided to the Note Registrar appropriate instructions at least five Business Days before such
Payment Date (which instructions will remain in effect until the Noteholder provides new instructions to the Note Registrar in accordance with this Section) and the aggregate original principal amount of such Noteholder’s Notes is at least
$1,000,000, by wire transfer in immediately available funds to the account of such Noteholder or (ii) by check mailed first class mail, postage prepaid, to such Registered Noteholder’s address as it appears on the Note Register on the
related Record Date. Distributions to be made with respect to interest on and principal of Book-Entry Notes will be paid to the Registered Noteholder by wire transfer in immediately available funds to the account designated by the nominee of the
Clearing Agency. However, the final installment of principal (whether payable by wire transfer or check) of each Note on the Payment Date on which the Notes are being redeemed pursuant to Section 3.13 or the applicable Maturity Date will be
payable only upon presentation and surrender of such Note. The Indenture Trustee will notify each Registered Noteholder of the date on which the Issuer expects that the final installment of principal of and interest on such Registered
Noteholder’s Notes will be paid not later than ten days before such date. Such 

  
 30 

	 	
notice will specify the place where such Notes may be presented and surrendered for payment of such installment. All funds paid by wire transfers or checks that are returned undelivered will be
held in accordance with Section 4.5(c). 

  

	 	(c)	The principal of each Note will be payable in installments on each Payment Date as specified in such Note. The entire unpaid Note Balance for any Class will be due and payable on the earlier of the applicable Maturity
Date and the Payment Date on which the Notes are being redeemed pursuant to Section 3.13. Notwithstanding the foregoing, the entire unpaid principal amount of the Notes will be due and payable on the date on which the Notes are declared to be
immediately due and payable in the manner provided in Section 7.2. 

  

	 	(d)	All amounts applied as principal payments on the Notes will be paid sequentially to the Class A-1 Noteholders until the Note Balance of the Class A-1 Notes has been reduced to zero, then to the Class A-2
Noteholders until the Note Balance of the Class A-2 Notes has been reduced to zero, and then to the Class B Noteholders until the Note Balance of the Class B Notes has been reduced to zero. 

Section 3.10. Cancellation. Any Person seeking to surrender a Note for payment, registration of transfer, exchange or redemption
will deliver such Note to the Indenture Trustee. The Indenture Trustee will promptly cancel all Notes it receives that have been surrendered for payment, registration of transfer or exchange, or redemption. The Issuer may deliver to the Indenture
Trustee for cancellation any Notes previously authenticated and delivered under this Indenture which the Issuer may have acquired in any manner, and the Indenture Trustee will promptly cancel such Notes. No Notes will be authenticated in lieu of or
in exchange for any Notes cancelled as provided in this Section 3.10. The Indenture Trustee may hold or dispose of all cancelled Notes in accordance with its standard retention or disposal policy unless the Issuer directs, by Issuer Order, that
they be destroyed or returned to it (so long as such Notes have not been disposed of previously by the Indenture Trustee). 

Section 3.11. Authenticating Agents. 
  

	 	(a)	The Indenture Trustee may appoint one or more Persons (each, an “Authenticating Agent”) with the power to act on its behalf and subject to its direction in the authentication of Notes in connection with
issuances, transfers and exchanges under Sections 3.2, 3.6, 3.7 and 9.5, as though each such Authenticating Agent had been expressly authorized by those Sections to authenticate such Notes. For all purposes of this Indenture, the authentication of
Notes by an Authenticating Agent pursuant to this Section 3.11 is deemed to be the authentication of Notes “by the Indenture Trustee.” 

  

	 	(b)	Any Person into which an Authenticating Agent may be merged or converted or with which it may be consolidated, or any Person resulting from any merger, consolidation or conversion to which an Authenticating Agent is a
party, or any Person succeeding to all or substantially all of the corporate trust business of an Authenticating Agent, will be the successor of such Authenticating Agent under this Indenture without the execution or filing of any document or any
further act. 

  
 31 

	 	(c)	An Authenticating Agent may resign by giving notice of resignation to the Indenture Trustee and the Owner Trustee. The Indenture Trustee may terminate the agency of an Authenticating Agent by giving notice of
termination to such Authenticating Agent and the Owner Trustee. Upon receiving such notice of resignation or upon such a termination, the Indenture Trustee may appoint a successor Authenticating Agent and will notify the Owner Trustee of any such
appointment. 

  

	 	(d)	Sections 8.2 and 8.4 will apply to each Authenticating Agent. 

 Section 3.12. Note
Paying Agents. 
  

	 	(a)	The Indenture Trustee may appoint one or more Note Paying Agents that meet the eligibility standards for the Indenture Trustee specified in Section 8.11(a). The Note Paying Agents will have the power to make
distributions from the Collection Account and Reserve Account. 

  

	 	(b)	Any Person into which a Note Paying Agent may be merged or converted or with which it may be consolidated, or any Person resulting from any merger, consolidation or conversion to which a Note Paying Agent is a party, or
any Person succeeding to all or substantially all of the corporate trust business of a Note Paying Agent, will be the successor of such Note Paying Agent under this Indenture without the execution or filing of any document or any further act.

  

	 	(c)	A Note Paying Agent may resign by giving notice of resignation to the Indenture Trustee, the Depositor and the Issuer. The Indenture Trustee may terminate the agency of a Note Paying Agent by giving notice of
termination to such Note Paying Agent, the Depositor and the Issuer. Upon receiving such notice of resignation or upon such a termination, the Indenture Trustee may appoint a successor Note Paying Agent and will notify the Depositor and the Issuer
of any such appointment. 

  

	 	(d)	Sections 8.2 and 8.4 will apply to each Note Paying Agent. 

 Section 3.13. Optional
Redemption of the Notes. 
  

	 	(a)	The Notes are subject to redemption in whole, but not in part, at the written direction of the Servicer on any Payment Date on which the Servicer exercises its option to purchase the Collateral pursuant to
Section 3.4 of the Sale and Servicing Agreement. After the Servicer notifies the Indenture Trustee that it will exercise its option pursuant to Section 3.4 of the Sale and Servicing Agreement, the Indenture Trustee will promptly notify the
Noteholders: 

  

	 	(i)	of the outstanding Note Balance to be prepaid as of the most recent Payment Date and that the Notes plus accrued and unpaid interest on such Notes at the applicable Note Rate to the Payment Date on which the Notes will
be redeemed will be paid in full; 

  
 32 

	 	(ii)	of the place where such Notes are to be surrendered for final payment (which will be the office or agency of the Issuer maintained as provided in Section 5.1(h) or the Corporate Trust Office of the Indenture
Trustee; and 

  

	 	(iii)	that on the date that the Notes are redeemed, the Note Balance together with accrued interest thereon and all other sums due under this Indenture will become due and payable upon the Notes and that interest on the Notes
will cease to accrue from and after the date that the Notes are redeemed, unless the Issuer defaults in the payment of the Notes on such date. 

  

	 	(b)	The Issuer will cause the Servicer to deposit in the Collection Account, by 10:00 a.m. (New York City time) on the Payment Date that the Notes are to be redeemed, the Purchase Price, whereupon all such Notes will be
paid in full on the date that the Notes are redeemed. 

  

	 	(c)	On the date that the Notes are redeemed, the Note Balance of the Notes will be due and payable and interest on the Notes will cease to accrue from and after the date that the Notes are redeemed, unless the Issuer
defaults in the payment of the Notes on the such date. Upon redemption, the Indenture Trustee agrees to execute (at the written request and expense of the Issuer) any and all instruments reasonably requested of it to release the Collateral from the
Lien of this Indenture and release to the Issuer or any other Person entitled to any funds then on deposit in the Collection Account or Reserve Account under this Indenture. 

ARTICLE IV 
 DISTRIBUTIONS 

Section 4.1. Application of Collections. The Indenture Trustee will apply all Collections received by it as provided in this
Indenture and the Sale and Servicing Agreement. 
 Section 4.2. Collection Account, Collections. A Collection Account has been
established pursuant to Section 4.1(a) of the Sale and Servicing Agreement. The Indenture Trustee shall have control over the Collection Account and all monies, instruments and other property from time to time in the Collection Account within
the meaning of the applicable UCC. On each Payment Date, all interest and earnings (net of losses and reasonable investment expenses) on funds on deposit in the Collection Account shall be applied as Collections in accordance with Sections 4.5(a)
and (b). On the applicable Maturity Date or any date on which the Notes are redeemed pursuant to Section 3.13, any funds remaining on deposit in the Collection Account shall be paid to the Certificateholder. The Indenture Trustee shall make
payments to the Certificateholder pursuant to Section 4.5 in accordance with payment instructions delivered to the Indenture Trustee by Certificate Register on the Closing Date and from time to time thereafter. 

Section 4.3. Reserve Account. A Reserve Account has been established pursuant to Section 4.1(b) of the Sale and Servicing
Agreement. The Indenture Trustee shall have control over the Reserve Account and all monies, instruments and other property from time to time in the Reserve Account within the meaning of the applicable UCC. On or before each Payment

  
 33 

 Date, the Indenture Trustee will withdraw from the Reserve Account the Reserve Account Withdrawal Amount and
deposit such amount into the Collection Account as indicated on the related Servicer Report delivered pursuant to Section 3.7 of the Sale and Servicing Agreement. On the latest Maturity Date for all Classes, any date on which the Notes are
redeemed pursuant to Section 3.13 or upon the acceleration of the entire unpaid principal amount of the Notes following an Event of Default, the Indenture Trustee will withdraw from the Reserve Account any funds remaining on deposit in the
Reserve Account and deposit such amounts into the Collection Account to be applied in accordance with Section 4.5. 
 Section 4.4.
Lock-Box Accounts. All Obligors in respect of Pool Receivables sold or contributed to the Issuer pursuant to the Sale and Servicing Agreement and pledged under this Indenture have been instructed to make payment to the Lock-Box Account
pursuant to Section 6.2(f) of the Sale and Servicing Agreement. The names and addresses of the Lock-Box Bank, together with the account number of the Lock-Box Account at the Lock-Box Bank, are specified on Schedule III, as such schedule may be
updated by notice from the Issuer to the Indenture Trustee as provided in Section 5.1(o) hereof. 
 Section 4.5. Priority of
Distribution. 
  

	 	(a)	Prior to the occurrence of an Event of Default and an acceleration of the entire unpaid principal amount of the Notes and so long as the Indenture Trustee has received the Servicer Report by the related Determination
Date or, in any event, not later than the opening of business on the related Payment Date, the Indenture Trustee, based on information contained in the most recent Servicer Report, will make the following withdrawals from the Collection Account on
such Payment Date and make deposits and payments on each Payment Date, to the extent of Available Amounts on deposit in the Collection Account with respect to such Payment Date, in the following order of priority (pro rata to the Persons within each
priority level based on the amounts due except as otherwise specified): 

  

	 	First	to the Servicer, any unreimbursed Servicer Advances, as defined in Section 3.6 of the Sale and Servicing Agreement, in respect of a prior Collection Period; 

 

	 	Second	if a successor servicer is being appointed, or if the Back-Up Servicer is assuming the duties of the Servicer, to the successor servicer or the Back-Up Servicer, as applicable, the costs and expenses associated with the
appointment of such successor servicer and the transition relating thereto (which amount shall not, taken in the aggregate with all other amounts withdrawn for such purpose, exceed $50,000 in aggregate for the life of the transaction);

  

	 	Third	to the Servicer, (i) the Servicing Fee then due, together with any accrued and unpaid Servicing Fees from prior Collection Periods and (ii) expenses of the Servicer, such expenses not to exceed $50,000 in the aggregate
for the life of the transaction; 

  
 34 

	 	Fourth	to the Indenture Trustee, Back-Up Servicer, Owner Trustee and Custodian, pro rata based on the amounts so due, (i) the Indenture Trustee Fees, Back-Up Servicing Fees, Owner Trustee Fees and Custodian Fees then due,
together with any unpaid Indenture Trustee Fees, Back-Up Servicing Fees, Owner Trustee Fees and Custodian Fees from prior Collection Periods and (ii) expenses and indemnities of the Indenture Trustee, Back-Up Servicer, Owner Trustee and Custodian,
such expenses and indemnities not to exceed, $100,000 per party per annum (with the Back-Up Servicer and Custodian deemed to be one party for purposes of this priority Fourth for so long as one Person is serving in both such capacities);

  

	 	Fifth	to pay accrued and unpaid interest on the Class A Notes ratably based on the amount of accrued and unpaid interest due and owing on the Class A-1 and Class A-2 Notes on such Payment Date; 

 

	 	Sixth	to pay principal on the Notes in an amount equal to the amount by which the Note Balance of the Class A Notes as of the prior Payment Date (or as of the Closing Date in the case of the first Payment Date) exceeds the
Pool Balance at the end of the related Collection Period, in the priority described in Section 3.9(d); provided, that on and after the Maturity Date for each class of Class A Notes, this amount will equal the Note Balance of that Class of
Class A Notes until paid in full; 

  

	 	Seventh	to pay accrued and unpaid interest on the Class B Notes; 

  

	 	Eighth	to pay principal on the Notes in an amount equal to the amount by which the Note Balance of the Class A and Class B Notes as of the prior Payment Date (or as of the Closing Date in the case of the first Payment Date)
(after giving effect to the payments made pursuant to priority Sixth above) exceeds the Pool Balance at the end of the related Collection Period, in the priority described in Section 3.9(d); provided, that on and after the Maturity
Date for the Class B Notes, this amount will equal the Note Balance of the Class B Notes until paid in full; 

  

	 	Ninth	to the Reserve Account, an amount equal to the excess of the Required Reserve Account Amount over the remaining balance in the Reserve Account after giving effect to any payments made on such Payment Date;

  

	 	Tenth	to pay (a) prior to the occurrence and continuation of a Trigger Event, the Scheduled Investor Principal Amount or (b) during the continuation of a Trigger Event, all remaining amounts, if any, in each case, as payments
of principal on each Class of Notes in the priority specified in Section 3.9(d) (after giving effect to the payments made pursuant to priorities Sixth and Eighth above); 

  
 35 

	 	Eleventh	to the Indenture Trustee, Back-Up Servicer, Custodian and Owner Trustee all amounts due and not paid pursuant to priority Fourth by reason of the limitation in such clause, pro rata, based on the amounts
due and not paid; and 

  

	 	Twelfth	to the Certificateholder, all remaining amounts, if any. 

  

	 	(b)	Following the acceleration of the entire unpaid principal amount of the Notes after the occurrence of an Event of Default, the proceeds of the liquidation of the Collateral and any amounts on deposit in the Reserve
Account will be deposited into the Collection Account, and all amounts on deposit in the Collection Account will be distributed in the following priority on the related Payment Date: 

 

	 	First	to the Servicer, any unreimbursed Servicer Advances in respect of a prior Collection Period; 

  

	 	Second	if a successor servicer has been appointed, or if the Back-Up Servicer has assumed the duties of the Servicer, to the successor servicer or the Back-Up Servicer, as applicable, the reasonable costs and expenses
associated with the appointment of such successor servicer and the transition relating thereto; 

  

	 	Third	to the Servicer, the Servicing Fee then due, together with any accrued and unpaid Servicing Fees from prior Collection Periods; 

  

	 	Fourth	to the Indenture Trustee, Back-Up Servicer, Owner Trustee and Custodian, pro rata based on the amounts so due, (i) first, the Indenture Trustee Fees, Back-Up Servicing Fees, Owner Trustee Fees and Custodian Fees then
due, together with any unpaid Indenture Trustee Fees, Back-Up Servicing Fees, Owner Trustee Fees and Custodian Fees from prior Collection Periods and (ii) second, expenses and indemnities of the Indenture Trustee, Back-Up Servicer, Owner Trustee and
Custodian; provided, that following the acceleration of the maturity of the Notes after the occurrence of an Event of Default described in Section 7.1(d) or (e), such expenses and indemnities shall not exceed, with respect to the Indenture
Trustee, $300,000 per annum and with respect to the Back-Up Servicer, Owner Trustee and Custodian, $100,000 per party per annum (with the Back-up Servicer and Custodian deemed to be one party for purposes of this priority Fourth for so long
as one person is serving in both such capacities); 

  

	 	Fifth	to pay accrued and unpaid interest on the Class A Notes ratably based on the amount of accrued and unpaid interest due and owing on the Class A-1 Notes and Class A-2 Notes; 

  
 36 

	 	Sixth	to pay accrued and unpaid interest on the Class B Notes; 

  

	 	Seventh	to pay principal on the Notes in the priority described in Section 3.9(d); 

  

	 	Eighth	to the Indenture Trustee, Back-Up Servicer, Owner Trustee and Custodian, expenses and indemnities of the Indenture Trustee, Back-Up Servicer, Owner Trustee and Custodian, pro rata based on the amounts so due and
not paid above, all amounts due and not paid pursuant to priority Fourth above by reason of any limitation in such clause; and 

  

	 	Ninth	to the Certificateholder, all remaining amounts, if any. 

  

	 	(c)	All amounts payable by the Issuer under this Indenture and the other Transaction Documents shall be subject to, and all funds available to the Issuer shall be applied in accordance with, the priorities set forth in
Section 4.5(a) and (b), provided, however, that the foregoing provision shall not affect or constitute a waiver of any Event of Default if such funds are insufficient to pay in full when due any amount which is payable by the Issuer hereunder
or under any other Transaction Document. 

  

	 	(d)	Collections Held in Trust. (i) If at any time the Issuer shall receive any Collections other than through payment into the Lock-Box Account, the Issuer shall promptly (but in any event within two
(2) Business Days of receipt thereof) remit or cause to be remitted all such Collections to the applicable Lock-Box Account. All Collections received by the Issuer and all Collections held by the Servicer in the Lock-Box Account pursuant to the
Sale and Servicing Agreement, shall be held by such Person in trust for the exclusive benefit of the Indenture Trustee and the Noteholders. No portion of the Note Balance shall be deemed repaid by any amount of the Collections held in trust by the
Issuer or the Servicer, as applicable, unless such amount is finally paid by the Indenture Trustee in accordance with Sections 4.5(a) or (b). 

ARTICLE V 
 REPRESENTATIONS AND
WARRANTIES OF THE ISSUER 
 Section 5.1. Representations by the Issuer. Unless otherwise provided herein, the Issuer represents
and warrants to the Indenture Trustee and the Noteholders that on the Closing Date: 
  

	 	(a)	Corporate Existence and Power. The Issuer: 

  

	 	(i)	 will keep in full effect its existence, rights and franchises as a statutory trust under the Delaware Statutory Trust Act (12 Del. C. §
3801 et seq.) (unless it becomes, or any successor Issuer under this Indenture is or becomes, organized under the laws of any other state or of the United States, in which the Issuer will keep in full effect its existence, rights and
franchises under the laws of such other jurisdiction) and will obtain and preserve its qualification 

  
 37 

	 	
in each jurisdiction in which such qualification is or will be necessary to protect the validity and enforceability of this Indenture, the Notes, the Collateral and each other instrument or
agreement included in the Collateral; 

  

	 	(ii)	is not organized under the Laws of any other jurisdiction or governmental authority; 

  

	 	(iii)	has all power and all licenses, authorizations, consents and approvals of all Official Bodies required to own or lease its properties and to carry on its business in each jurisdiction in which its business is conducted
(except where the failure to have any such licenses, authorizations, consents and approvals would not individually or in the aggregate have a Material Adverse Effect); and 

 

	 	(iv)	is duly qualified to do business and is in good standing in every other jurisdiction in which the nature of its business or ownership or lease of its properties requires it to be so qualified, except where the failure
to be so qualified or in good standing would not have a Material Adverse Effect. 

  

	 	(b)	Corporate and Governmental Authorization; Contravention. The execution, delivery and performance by it of this Indenture and the other Transaction Documents to which it is a party: (i) are within its powers,
(ii) have been duly authorized, (iii) require no action by or in respect of, or filing with, any Official Body or official thereof (except as contemplated by this Indenture which have been (or as of the Closing Date will have been) duly
made and in full force and effect), (iv) do not contravene or constitute a default under (1) its formation documents, (2) any Law applicable to it, (3) any material contractual restriction binding on or affecting it or its
property or (4) any order, writ, judgment, award, injunction or decree binding on or affecting it or its property and (v) will not result in the creation or imposition of any Lien (other than Permitted Liens created under the Transaction
Documents) upon or with respect to its property, except as contemplated hereby and by the other Transaction Documents, which could reasonably be expected to have a Material Adverse Effect. 

 

	 	(c)	Binding Effect. Each of this Indenture and the other Transaction Documents to which it is a party has been duly executed and delivered and constitutes its legal, valid and binding obligation, enforceable against
it in accordance with the respective terms of such agreement, subject to applicable bankruptcy, insolvency, moratorium or other similar laws affecting the rights of creditors generally and by general principles of equity, regardless of whether such
enforceability is considered in a Proceeding in equity or at law. 

  

	 	(d)	 Accuracy of Information. All written information heretofore furnished by it to any Noteholder, the Indenture Trustee or in connection with this
Indenture or any transaction contemplated hereby is, and all such written information furnished by it to the Noteholders or the Indenture Trustee is, true, complete and accurate in every material respect, on the date such information is stated or
certified, and no 

  
 38 

	 	
such item contains or will contain any untrue statement of a material fact or omits to state a material fact necessary in order to make the statements contained therein, in the light of the
circumstances under which they were made, not materially misleading. 

  

	 	(e)	Tax Status. It has (i) filed all tax returns (federal, state and local) required to be filed, (ii) paid or made adequate provision for the payment of all taxes, assessments and other governmental
charges except for taxes, assessments and other governmental charges that are being contested in good faith through appropriate Proceedings and with respect to which adequate reserves are being maintained in accordance with GAAP and (iii) no
tax lien has been filed and to its knowledge, no tax lien claim is being asserted against any of its properties which could reasonably be expected to have a Material Adverse Effect. 

 

	 	(f)	Action, Suits. It is not in violation of any order of any Official Body or arbitrator. There are no actions, suits, litigation, investigations or Proceedings pending, or to its knowledge, threatened, against or
affecting it or any of its Affiliates or their respective properties, in or before any Official Body or arbitrator, which could reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

 

	 	(g)	Use of Proceeds. No proceeds in connection of the Notes shall be used by it (i) to acquire any security in any transaction which is subject to Section 13 or 14 of the Exchange Act, (ii) to acquire
any equity security of a class which is registered pursuant to Section 12 of such act or (iii) for any other purpose that violates Applicable Law, including Regulations T, U or X of the Federal Reserve Board. 

 

	 	(h)	Maintenance of Office or Agency. The Issuer will maintain an office or agency in St. Paul, Minnesota, where Notes may be surrendered for registration of transfer or exchange, and where notices and demands to or
upon the Issuer in respect of the Notes and this Indenture may be served. The Issuer initially appoints the Indenture Trustee to serve as its agent for such purposes. The Issuer will promptly notify the Indenture Trustee of any change in the
location of such office or agency. If the Issuer fails to maintain any such office or agency or fails to furnish the Indenture Trustee with the address of such office or agency, such surrenders, notices and demands may be made or served at the
Corporate Trust Office, and the Issuer appoints the Indenture Trustee as its agent to receive all such surrenders, notices and demands 

  

	 	(i)	Subsidiaries; Tradenames, Etc. As of the Closing Date: (i) it has no Subsidiaries and divisions; and (ii) it has not operated under any tradenames and has not changed its name, merged with or into or
consolidated with any other Person or been the subject of any Proceeding under the Bankruptcy Code. 

  

	 	(j)	Security Interest. On the Closing Date, the Indenture Trustee shall acquire and hold a valid and enforceable first priority perfected security interest in each Pool Receivable and all other Collateral free and
clear of any Lien, other than Permitted Liens. 

  
 39 

	 	(k)	Nature of Pool Receivable. Each Pool Receivable satisfied the definition of Eligible Receivable set forth herein on the Closing Date or on a Substitution Date. 

 

	 	(l)	No Event of Default. No event exists and no condition exists, or would constitute a Default, Event of Default or Servicer Default. 

 

	 	(m)	Not an Investment Company. It is not, and is not controlled by, an “investment company” within the meaning of the Investment Company Act of 1940, or is exempt from all provisions of such act.

  

	 	(n)	ERISA. Neither the Issuer nor any ERISA Affiliate (i) maintains any “pension plan” (as defined in Section 3(2) of ERISA) or (ii) contributes to any “multiemployer plan” (as
defined in Sections 3(37) and 4001(a)(3) of ERISA). 

  

	 	(o)	Lock-Box Accounts. The names and addresses of all the Lock-Box Banks, together with the account numbers of the Lock-Box Accounts at such Lock-Box Banks are specified in Schedule III, as updated by the Issuer from
time to time by notice from the Issuer or the Servicer to the Indenture Trustee. To the extent that there is more than one Lock-Box Account, Schedule III will indicate, by Contract number, to which Lock-Box Account funds received on a related Pool
Receivable will be deposited. All Obligors have been instructed to make payment in respect of the Pool Receivables to a Lock-Box Account. The Issuer shall at all times have the ability to identify and segregate, in accordance with the terms of the
Lock-Box Intercreditor Agreement, all of the Collections from other funds on deposit in each Lock-Box Account within five (5) Business Days after receipt of such Collections. 

 

	 	(p)	Transfers Under Sale and Servicing Agreement. Each Pool Receivable has been purchased by it from the Depositor pursuant to, and in accordance with, the terms of the Sale and Servicing Agreement.

  

	 	(q)	Preference; Voidability. The Issuer shall have given reasonably equivalent value to the Depositor in consideration for the transfer to it of the Pool Receivables under the Sale and Servicing Agreement and such
transfer shall not have been made for or on account of an antecedent debt owed by the Depositor to it and no such transfer is or may be voidable under any section of the Bankruptcy Code. 

 

	 	(r)	Representations and Warranties in other Transaction Documents. Each of the representations and warranties made by the Issuer contained in the Transaction Documents (other than this Indenture) is true, complete
and correct in all respects and it hereby makes each such representation and warranty to, and for the benefit of, the Indenture Trustee and the Noteholders as if the same were set forth in full herein. 

  
 40 

	 	(s)	Perfection Representations. The Issuer is the owner of all of the Pool Receivables listed on Schedule I and other Collateral, free and clear of all Liens (other than Permitted Liens). The Issuer further
represents: 

  

	 	(i)	General. 

  

	 	(1)	The Pool Receivables constitute “accounts,” “instruments,” “general intangibles,” or “tangible chattel paper” within the meaning of the applicable UCC. 

 

	 	(2)	The Issuer has taken all steps or commenced procedures necessary to perfect its security interest against the Obligors and the Equipment securing the Pool Receivables; provided, however, that the security
interest in Equipment with an aggregate invoiced cost of $25,000 or less may not be perfected. 

  

	 	(3)	The Issuer has received all consents and approvals required by the terms of the Pool Receivables to the pledge of a security interest in the Pool Receivables hereunder to the Indenture Trustee (for the benefit of the
Noteholders). 

  

	 	(ii)	Creation. The Issuer owns and has good and marketable title to the Collateral free and clear of any Lien of any Person, excepting other Permitted Liens and liens for taxes, assessments or similar governmental
charges or levies that are not yet due and payable or as to which any applicable grace period shall not have expired, or that are being contested in good faith by proper proceedings and for which adequate reserves have been established in accordance
with GAAP, but only so long as foreclosure with respect to such a Lien is not imminent and the use and value of the property to which the Lien attaches is not impaired during the pendency of such proceeding. 

 

	 	(iii)	Perfection. 

  

	 	(1)	The Issuer has caused or commenced procedures for the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under Applicable Law and taken all other action or
commenced procedures necessary in order to perfect (i) the sale of the Collateral from the Depositor to the Issuer, and (ii) the first priority security interest in the Collateral granted to the Indenture Trustee (for the benefit of the
Noteholders) hereunder (provided, that no representation is made herein with respect to creation, ownership or perfection of any security interest in goods or other assets pledged by an Obligor (other than the Equipment); provided,
however, that the security interest in Equipment with an aggregate invoiced cost of $25,000 or less may not be perfected. 

  

	 	(2)	With respect to the Collection Account and the Reserve Account, the Issuer has taken all steps or commenced procedures necessary to cause the Indenture Trustee (for the benefit of the Noteholders) to become the account
holder of such accounts. 

  
 41 

	 	(iv)	Priority. 

  

	 	(1)	Other than the transfer of the Sold Assets (as defined in the Purchase Agreement) from the Originator to the Depositor under the Purchase Agreement and the transfer of the Sold Assets (as defined in the Sale and
Servicing Agreement) from the Depositor to the Issuer under the Sale and Servicing Agreement and the security interest granted to the Indenture Trustee (for the benefit of the Noteholders) pursuant to this Indenture, the Issuer has not pledged,
assigned, sold, granted a security interest in, or otherwise conveyed any of the Collateral. The Issuer has not authorized the filing of, nor is aware of any financing statements against the Issuer, the Depositor or the Originator that include a
description of collateral covering the Collateral other than any financing statement relating to the transfer of Sold Assets under the Purchase Agreement and the transfer of Sold Assets under the Sale and Servicing Agreement or the security interest
granted to the Indenture Trustee (for the benefit of the Noteholders) hereunder or that has been or is being terminated in connection with the execution of this Indenture. The Issuer is not aware of any judgment or tax lien filings against the
Issuer. Accordingly, the Indenture Trustee holds a first priority perfected security interest in all of the Collateral. 

  

	 	(2)	With respect to Collateral which constitute “tangible chattel paper” or “instruments” within the meaning of the applicable UCC, the Custodian, as agent for the Issuer, has in its possession all
original copies of the instruments that constitute or evidence the Collateral and the Issuer has received a written acknowledgement from the Custodian that the Custodian is holding such Collateral solely on behalf of and for the benefit of the
Indenture Trustee (for the benefit of the Noteholders). The Contracts and instruments that constitute or evidence the Collateral do not have any marks or notation indicating that they have been pledged, assigned or otherwise conveyed to any Person
other than the Indenture Trustee (for the benefit of the Noteholder). All financing statements filed or to be filed against the Issuer in favor of the Indenture Trustee (for the benefit of the Noteholder) in connection herewith describing the
Collateral contain a statement to the following effect: “A purchase of or security interest in any collateral described in this financing statement which is not permitted under this Indenture will violate the rights of the Indenture Trustee
(for the benefit of the Noteholders).” 

  

	 	(v)	Survival of Perfection Representations. Notwithstanding any other provision of this Indenture or any other Transaction Document, the Perfection Representations shall be continuing, and remain in full force and
effect, until the occurrence of the Maturity Date for all Classes. 

  

	 	(vi)	No Waiver. The Issuer: (i) shall not, without obtaining the consent of the Indenture Trustee waive any of the Perfection Representations; (ii) shall provide the Indenture Trustee and each Rating Agency
with prompt written notice of any breach of these perfection representations, and shall not, without obtaining the consent of the Indenture Trustee waive a breach of any of these perfection representations. 

  
 42 

	 	(t)	Rule 17g-5. Each of CCG and the Issuer has complied with the representations, certifications and covenants made by each of them to each Rating Agency in connection with the engagement of each Rating Agency to
issue and monitor a credit rating on the Notes, including any certification provided to each Rating Agency in connection with Rule 17g-5(a)(iii) of the Exchange Act (“Rule 17g-5”). CCG and the Issuer are the parties responsible for
compliance with Rule 17g-5 in connection with the issuance and monitoring of the credit ratings on the Notes. 

  

	 	(u)	Compliance with Law. It has complied with all Applicable Laws to which it may be subject (including, without limitation, laws, rules and regulations relating to truth in lending, fair credit billing, fair credit
reporting, equal credit opportunity, fair debt collection practices and privacy) except where the failure to comply would not have a Material Adverse Effect. 

  

	 	(v)	Schedule of Pool Receivables. The schedule of Pool Receivables listed on Schedule I hereto is true and correct as of the date hereof. 

ARTICLE VI 
 COVENANTS 

Section 6.1. Affirmative Covenants of the Issuer. At all times from the Closing Date to the latest Maturity Date for any Class,
unless the Noteholders shall otherwise consent in writing, the Issuer hereby covenants and agrees with the Noteholders and the Indenture Trustee: 
  

	 	(a)	Payment of Principal and Interest. The Issuer will duly and punctually pay the principal of and interest on the Notes in accordance with the Notes and this Indenture. Amounts withheld under the Internal Revenue
Code or any State or local tax law by any Person from a payment to any Noteholder will be considered as having been paid by the Issuer to such Noteholder. 

  

	 	(b)	 Reporting Requirements. On each Determination Date (or, in any event no later than the opening of business on the related Payment Date), the
Issuer, or the Servicer on its behalf, shall deliver a monthly Servicer Report to (i) the Issuer and the Indenture Trustee, (ii) each Rating Agency, and (iii) the Back-up Servicer detailing, among other things, (a) the
Servicer’s Tangible Net Worth, calculated as of the end of the preceding calendar quarter and updated in the second Servicer Report delivered following the end of each calendar quarter and (b) amounts

  
 43 

	 	
received on the Pool Receivables in respect of the immediately preceding Collection Period and available for payment on the Payment Date. Upon receipt of the Servicer Report, the Indenture
Trustee shall make available such Servicer Report to the Noteholders through the Indenture Trustee’s website, which is initially located at www.usbank.com/abs. 

 

	 	(c)	Compliance Certificate. Together with the financial statements required hereunder, a compliance certificate signed by the Issuer’s or Servicer’s (and, if the Originator is not the Servicer, the
Originator), as applicable, Responsible Officer stating that (1) the attached financial statements have been prepared in accordance with GAAP and accurately reflect the financial condition of the Issuer, Servicer (and, if the Originator is not
the Servicer, the Originator) and its Subsidiaries as applicable and (2) to the best of such Person’s knowledge, no Event of Default or Servicer Default exists, or if any Event of Default or Servicer Default exists, stating the nature and
status thereof. 

  

	 	(d)	Notice of Event of Defaults or Potential Event of Defaults; Etc. (1) As soon as possible and in any event within two (2) Business Days after the Issuer obtains knowledge of the occurrence of an Event of
Default or a potential Event of Default, the Issuer shall provide a statement of a Responsible Officer of the Issuer setting forth details of such Event of Default and the action which the Issuer proposes to take with respect thereto, which
information shall be updated promptly from time to time; (2) promptly and in any event within two (2) Business Days after the Issuer obtains knowledge thereof, notice of any litigation, investigation or Proceeding that may exist at any
time between the Issuer and any Person that could reasonably be expected to result in a Material Adverse Effect or any litigation or Proceeding relating to any Transaction Document; and (3) promptly and in any event within two (2) Business
Days after the Issuer obtains knowledge thereof, notice of a Material Adverse Effect. 

  

	 	(e)	Change in Credit and Collection Policy. Within five (5) Business Days of the date on which any material amendment to the Credit and Collection Policy is made, the Servicer shall provide the Issuer, each
Rating Agency and the Indenture Trustee with a copy of the Credit and Collection Policy then in effect indicating such change or amendment, provided, however, that no such material amendment or modification to the Credit and Collection Policy shall
be effective without the prior written consent of the Majority Holders. Section 6.3(c) of the Sale and Servicing Agreement provides guidance as regards “material” for this purpose. 

 

	 	(f)	Change in Accountants or Accounting Policy. Promptly, the Issuer shall provide prior notice to the Indenture Trustee of any change in the accountants or material change in the accounting policy of the Issuer.

  

	 	(g)	Other Information. Such other information (including non-financial information) as the Indenture Trustee may from time to time reasonably request with respect to the Originator, the Issuer or any Subsidiary of
the Originator, in order to perform its duties and obligations under this Indenture. 

  
 44 

	 	(h)	SEC Filings. Promptly upon the filing thereof, copies of all registration statements and annual, quarterly, monthly or other regular reports which the Servicer (if the Servicer is CCG), or any of its
Subsidiaries, filed with the Securities and Exchange Commission and provided to the Issuer pursuant to the Sale and Servicing Agreement. 

  

	 	(i)	Conduct of Business; Ownership. The Issuer shall carry on and conduct its business as set forth in the Trust Agreement and do all things necessary to remain duly organized, validly existing and in good standing
as a Delaware statutory trust and maintain all requisite authority to conduct its business in each jurisdiction in which its business is conducted except where failure to have such authority would not have a Material Adverse Effect.

  

	 	(j)	Compliance with Laws, Etc. The Issuer shall comply with all Laws to which it or its respective properties may be subject and preserve and maintain its corporate existence as a Delaware statutory trust, rights,
franchises, qualifications and privileges except where failure to so comply would not have a Material Adverse Effect. 

  

	 	(k)	Furnishing of Information and Inspection of Records. The Issuer shall at any time during regular business hours, upon reasonable notice, as requested, permit the Indenture Trustee to, (i) examine and make
copies of and take abstracts from all books, records and documents (including computer tapes and disks) relating to the Pool Receivables or other Collateral or (ii) visit the offices and properties of the Issuer for the purpose of examining
such materials described in clause (i), and to discuss matters relating to the Collateral or the Issuer’s performance hereunder, under the Pool Receivables and under the other Transaction Documents to which such Person is a party with any of
the officers, directors, or in the presence of an officer, employees or independent public accountants, of the Issuer, having knowledge of such matters. Prior to the occurrence of an Event of Default, such audits shall be limited to one audit per
calendar year and all expenses related to such audit shall be borne by the party conducting the audit. 

  

	 	(l)	Keeping of Records and Books of Account. The Issuer shall maintain and implement administrative and operating procedures (including an ability to recreate records evidencing Contracts in the event of the
destruction of the originals thereof), and keep and maintain, all documents, books, computer tapes, disks, records and other information reasonably necessary or advisable for the collection of all Pool Receivables (including records adequate to
permit the daily identification of substantially all new Contracts and all Collections of and adjustments to each existing Contract). The Servicer may perform the foregoing obligations on behalf of the Issuer. 

 

	 	(m)	 Performance and Compliance with Contracts and Credit and Collection Policy. The Issuer shall, at its own expense, timely and fully perform and
comply with all material provisions, covenants and other promises required to be observed by it under the Contracts as is customary for its business practices and the Issuer 

  
 45 

	 	
shall timely and fully comply in all material respects with the Credit and Collection Policy in regard to each Contract. The Servicer may perform the foregoing obligations on behalf of the
Issuer. 

  

	 	(n)	Instructions to the Obligors. The Issuer shall instruct all Obligors to cause all Collections to be deposited directly to a Lock-Box Account or to post office boxes to which only Lock-Box Banks have access and
shall cause all items and amounts relating to such Collections received in such post office boxes to be removed by the applicable Lock-Box Bank and deposited into a Lock-Box Account on a daily basis. The Servicer may perform the foregoing
obligations on behalf of the Issuer. 

  

	 	(o)	Sale Treatment. The Issuer shall not account for, or otherwise treat, the purchase and sale contemplated by the Sale and Servicing Agreement in any manner other than as a sale by the Depositor to the Issuer
(except to the extent otherwise required (i) for United States federal income tax purposes under the Internal Revenue Code or (ii) by the application of consolidated financial reporting principles under GAAP). 

 

	 	(p)	Separate Business; Nonconsolidation. The Issuer shall not (i) engage in any business not permitted by the Trust Agreement or (ii) conduct its business or act in any other manner which is inconsistent
with the Transaction Documents. The officers and directors of the Issuer (as appropriate) shall make decisions with respect to the business and daily operations of the Issuer independent of and not dictated by the Originator or any other controlling
Person except as contemplated by the servicing arrangements under the Transaction Documents. 

  

	 	(q)	Organizational Documents. The Issuer shall only amend, alter, change or repeal the Trust Agreement and any formation documents with the prior written consent of the Indenture Trustee or the Noteholders. The
Issuer shall maintain its organizational documents in conformity with this Indenture, such that its organizational documents, at all times that this Indenture is in effect, provide for not less than three (3) days’ prior written notice to
the Indenture Trustee of the replacement or appointment of any Owner Trustee. 

  

	 	(r)	Ownership Interest, Etc. The Issuer shall, at its expense, take all action necessary or desirable to establish and maintain a perfected security interest in favor of the Indenture Trustee for the benefit of the
Noteholders in the Collateral free and clear of any Lien (other than Permitted Liens), including taking such action to perfect, protect or more fully evidence the security interest of the Indenture Trustee, as the Indenture Trustee may reasonably
request. 

  

	 	(s)	 Enforcement of Sale and Servicing Agreement; Amendment to Sale and Servicing Agreement. The Issuer, on its own behalf and on behalf of the
Indenture Trustee and the Noteholders, shall promptly enforce all covenants and obligations of the Depositor and Servicer contained in the Sale and Servicing Agreement. The Issuer shall not, without prior written consent of the Noteholders, give any

  
 46 

	 	
consents, approvals, directions, notices, waivers or otherwise take other similar actions under the Sale and Servicing Agreement or cancel, terminate, amend, modify, or supplement the Sale and
Servicing Agreement or waive any provision thereof; nor shall the Issuer take any other action under the Sale and Servicing Agreement; in each case that would have a Material Adverse Effect on the Indenture Trustee or the Noteholders or which would
violate the terms of this Indenture. 

  

	 	(t)	Notes. Until such time as the UCC of each state of the United States is amended in order to permit perfection of security interests in promissory notes and other instruments executed by Obligors in connection
with each Contract by the filing of financial statements under the applicable UCC, (i) the Issuer shall maintain, or cause to be maintained, all of the promissory notes and other instruments evidencing the Contracts in the state of North
Carolina, Illinois, New York and the state in which the Custodian maintains the Custodian Files, except as necessary to enforce any such notes or instruments; and (ii) the Issuer will deliver all such notes and instruments to the Custodian.

  

	 	(u)	Deposits to Collection Account. The Issuer shall not deposit or otherwise credit, or cause or permit to be so deposited or credited, to the Collection Account cash or cash proceeds other than Collections or
Excluded Amounts (or misdirected funds, which shall be removed as soon as practicable) in respect of the Pool Receivables. The Issuer shall at all times direct the Intercreditor Master Agent, and provide written disbursement instructions to the
Intercreditor Master Agent directing it, to disburse funds from the Lock-Box Account which is subject to the Lock-Box Intercreditor Agreement to the Collection Account in accordance with Section 4(f) of the Lock-Box Intercreditor Agreement.

  

	 	(v)	Use of Proceeds. The Issuer will use the proceeds of the Notes only to acquire the Pool Receivables and the Related Security in accordance with the terms of the Sale and Servicing Agreement and to pay expenses
related to such acquisitions and the pledge hereunder. 

  

	 	(w)	Taxes. The Issuer will file all tax returns and reports required by law to be filed by it and will promptly pay all taxes and governmental charges at any time owing by it (other than any amount of tax the
validity of which is currently being contested in good faith by appropriate proceedings and with respect to which reserves in accordance with GAAP have been provided on the books of such the Issuer). 

 

	 	(x)	Insurance. The Issuer will, or will cause the Servicer to, cause the related Obligors to maintain the following types of insurance: with respect to a Pool Receivable that is a lease, liability and property damage
and with respect to a Pool Receivable that is a loan, property damage on the Equipment in accordance commensurate with insurance maintained by companies engaged in similar lines of business. 

  
 47 

	 	(y)	Custodian File. By the Closing Date or within ten Business Days following any related Substitution Date, the Issuer, or the Servicer on its behalf, shall cause to be delivered to the Custodian an accurate and
complete Custodian File for each Receivable which was sold or substituted, as applicable, on the Closing Date or Substitution Date. Each Custodian File shall be clearly marked with a Contract number, which shall be used by the Issuer and the
Indenture Trustee to identify such Contract. 

  

	 	(z)	Rule 17g-5. Each of CCG and the Issuer will comply with the representations, certifications and covenants made by it in the engagement letter with each Rating Agency, including any representation, certification
or covenant provided by it to each Rating Agency in connection with Rule 17g-5, and will make accessible to any non-hired nationally recognized statistical rating organization all information provided by it to each Rating Agency in connection with
the issuance and monitoring of the credit ratings on the Notes in accordance with Rule 17g-5. 

 Section 6.2. Negative
Covenants of the Issuer. At all times from the Closing Date to the latest Maturity Date for any Class, unless the Noteholders shall otherwise consent in writing, the Issuer hereby covenants and agrees with the Indenture Trustee as follows: 

 

	 	(a)	No Sales, Liens, Etc. 

  

	 	(i)	Except as otherwise provided herein, the Issuer shall not sell, assign (by operation of law or otherwise) or otherwise dispose of, or create or suffer to exist any Lien (other than Permitted Liens) upon, or file any
financing statement with respect to: (1) any of the Collateral, or (2) any inventory or goods (including the Equipment), the sale or lease of which gave rise to a Related Security, or assign any right to receive income in respect thereof;
provided, that the Issuer may substitute Pool Receivables in accordance with Section 3.3 of the Sale and Servicing Agreement; provided, that any Substituted Receivable is an Eligible Receivable as of the related Substitution Date;
and 

  

	 	(ii)	the Issuer shall not issue any security to, or sell, transfer or otherwise dispose of any of its property or other assets (including the property sold to it by the Depositor pursuant to the Sale and Servicing Agreement)
to, any Person other than as otherwise expressly provided for in the Transaction Documents. 

  

	 	(b)	No Subsidiaries, Mergers, Etc. The Issuer shall not consolidate or merge with or into, or sell, lease or transfer all or substantially all of its assets to, any other Person or dissolve or terminate; or create,
acquire, have, maintain or hold or own any equity interest in any other Person; or acquire or own any material assets other than the Collateral. 

  

	 	(c)	 Change in Payment Instructions to Obligors. The Issuer shall not add or terminate any bank as a Lock-Box Bank or any account as a Lock-Box
Account to or from those listed in Schedule III or make any change in its instructions to Obligors 

  
 48 

	 	
regarding payments to be made to any Lock-Box Account, unless (i) such instructions are to deposit such payments to another existing Lock-Box Account or to the Collection Account, and
(ii) the Indenture Trustee and the Noteholders shall have received written notice of such addition, termination or change at least thirty (30) days prior thereto and the Noteholders shall not have objected thereto. 

 

	 	(d)	Change of Name, Etc. The Issuer shall not change its name, identity, jurisdiction of formation or structure (including through a merger) or the location of its chief executive office or any other change which, in
the case of any of the foregoing, could render any UCC financing statement filed in connection with this Indenture or any other Transaction Document to become “seriously misleading” under the applicable UCC or change its jurisdiction of
organization, unless at least thirty (30) days prior to the effective date of any such change the Issuer delivers to the Indenture Trustee such documents, instruments or agreements, executed by the Issuer, as are necessary to reflect such
change and to continue the perfection of the Indenture Trustee’s security interests in the Collateral. The Issuer will not become or seek to become organized under the laws of more than one jurisdiction. 

 

	 	(e)	Other Debt. Except as provided herein, the Issuer shall not create, incur, assume or suffer to exist any Indebtedness or any other liability (whether direct or contingent, including guaranteeing any obligation),
whether current or funded, other than (i) Indebtedness of the Issuer representing fees, expenses and indemnities arising hereunder or under the Sale and Servicing Agreement or for the purchase price of the Pool Receivables and other Collateral
under the Sale and Servicing Agreement, or (ii) taxes and expenses incurred in the ordinary course of business. 

  

	 	(f)	Payment to the Depositor. The Issuer shall not purchase any Pool Receivable other than through, under, and pursuant to the terms of, the Sale and Servicing Agreement. 

 

	 	(g)	Restricted Payments. The Issuer shall not (i) lend or advance any funds or (ii) repay any loans or advances to, for or from any Person. 

ARTICLE VII 
 EVENT OF DEFAULT 

Section 7.1. Event of Default. The occurrence of any one or more of the following events shall constitute an “Event of
Default”: 
  

	 	(a)	failure of the Issuer to pay interest due on any of the Class A Notes, or if no Class of Class A Notes is Outstanding, the Class B Notes in accordance with Section 4.5(a) when the same becomes due and
payable on each Payment Date, and such failure continues for a period of five (5) Business Days or more after the related Payment Date; 

  
 49 

	 	(b)	failure of the Issuer to pay the Note Balance of any Note by the applicable Maturity Date or on any Payment Date on which the Notes are to be redeemed in full pursuant to Section 3.13; 

 

	 	(c)	the occurrence of an Event of Bankruptcy with respect to the Issuer; 

  

	 	(d)	the Issuer becomes an “investment company” within the meaning of the Investment Company Act of 1940, as amended; and 

  

	 	(e)	any representation or warranty made by the Issuer in this Indenture incorrect in any material respect when made and continues to be incorrect in any material respect, or the Issuer breaches any covenant of the Issuer in
this Indenture and such breach continues, in each case, for a period of 60 days after written notice from the Indenture Trustee or the Majority Holders and as a result of which the Majority Holders’ interests are materially and adversely
affected; provided, that, the Indenture Trustee shall not be obligated to determine materiality for purposes of this Section 7.1(e). 

Section 7.2. Acceleration Following Event of Default. 
  

	 	(a)	Upon the occurrence of an Event of Default, the Indenture Trustee may and, at the written direction of holders of at least 66.67% of the Note Balance of the Controlling Class, shall, by notice to the Issuer, declare all
amounts due under the Notes and all accrued interest thereof, immediately due and payable. If an Event of Default specified in Section 7.1(c) occurs, all unpaid principal of and accrued and unpaid interest on the Notes, and all other amounts
payable under this Indenture, will automatically become due and payable without any declaration or other act on the part of the Indenture Trustee or any Noteholder. Upon any such declaration or automatic acceleration, the Indenture Trustee will
promptly notify each Noteholder and each Qualified Institution (if not the Indenture Trustee) maintaining a Bank Account. 

  

	 	(b)	 Upon any such declaration, the Indenture Trustee shall have, in addition to all other rights and remedies under this Indenture or otherwise, all other
rights and remedies provided under the UCC of the applicable jurisdiction and other Applicable Laws, including, without limitation, the right to liquidate and realize on the Collateral or any portion thereof or rights or interest therein, at one or
more sales called and conducted in any manner permitted by law. However, the Indenture Trustee is prohibited from selling the Collateral or any portion thereof following an Event of Default and acceleration of the maturity of the Notes (unless such
Event of Default relates to a default described in Sections 7.1(a) and (b) and the holders of at least 66.67% of the Note Balance of the Controlling Class consent to or direct the Indenture Trustee in writing to make such sale, or the proceeds
of such sale would not be less than the sum of all amounts due under the Indenture), unless (i) the holders of all the Outstanding Notes consent to the sale, (ii) the anticipated proceeds of the sale are sufficient to pay in full the
principal of and the accrued interest on the Notes at the date of such sale or (iii) the Indenture Trustee 

  
 50 

	 	
determines that the proceeds of the Collateral would not be sufficient on an ongoing basis to make all payments on the Notes as those payments would have become due if those obligations had not
been declared due and payable, and the Indenture Trustee obtains the consent of the holders of at least 66.67% of the Note Balance of the Notes. 

  

	 	(c)	Holders of at least 66.67% of the Note Balance of the Controlling Class, by written notice to the Issuer and the Indenture Trustee, may rescind and annul the declaration of acceleration of maturity and its consequences
before a judgment or decree for payment of the amount due has been obtained by the Indenture Trustee if: 

  

	 	(i)	the Issuer has paid or deposited with the Indenture Trustee an amount sufficient to (A) pay all payments of principal of and interest on the Notes and all other amounts that would then be due under this Indenture
or upon the Notes if the Event of Default giving rise to such acceleration had not occurred, (B) pay all amounts owed to the Indenture Trustee and (C) pay all other outstanding fees and expenses of the Noteholder; and 

 

	 	(ii)	all Events of Default, other than the nonpayment of principal of the Notes that has become due solely by such acceleration, have been cured or waived as provided by Section 7.14. 

No rescission will affect any subsequent default or impair any right resulting from such rescission. 

Section 7.3. Collection of Indebtedness by the Indenture Trustee. 

 

	 	(a)	The Issuer covenants that if an Event of Default under Section 7.1(a) or (b) occurs and continues, the Issuer, upon demand of the Indenture Trustee, will pay to the Indenture Trustee for the benefit of the
Noteholders, such overdue amount with interest on any overdue principal at the applicable Note Rate and, to the extent lawful, with interest on any overdue interest at the applicable Note Rate. In addition, the Issuer covenants to pay, or to cause
the Servicer to pay, the costs and expenses of collection, including all amounts owed to the Indenture Trustee under Section 8.7. 

  

	 	(b)	If the Issuer fails to pay such amounts upon such demand, the Indenture Trustee, in its own name and as trustee of an express trust, may institute a Proceeding for the collection of the sums so due and unpaid, and may
prosecute such Proceeding to judgment or final decree, and may enforce the same against the Issuer and collect the monies adjudged or decreed to be payable in the manner provided by law out of the Collateral. 

  
 51 

 Section 7.4. Trustee May File Proofs of Claim. 

 

	 	(a)	In case there is pending, relative to the Issuer, Proceedings under the Bankruptcy Code or any other federal or State bankruptcy, insolvency or other similar law, or in case a trustee, liquidator, receiver or similar
official has been appointed for or taken possession of the Issuer or its property, the Indenture Trustee, irrespective of whether the Indenture Trustee has made any demand pursuant to Section 7.3, may: 

 

	 	(i)	file and prove a claim or claims for the whole amount of principal and interest owing and unpaid in respect of the Notes and file such other papers or documents as may be necessary or advisable in order to have the
claims of the Indenture Trustee on behalf of the Noteholders allowed in such Proceedings (including any amounts due to the Indenture Trustee pursuant to Section 8.7); 

 

	 	(ii)	unless prohibited by applicable law, vote on behalf of the Noteholders in any election of a trustee, a standby trustee or a Person performing similar functions in any such Proceedings; 

 

	 	(iii)	collect and receive any monies or other property payable or deliverable on any such claims and pay all amounts received with respect to the claims of the Noteholders, including such claims asserted by the Indenture
Trustee on their behalf; and 

  

	 	(iv)	file such proofs of claim and other papers or documents as may be necessary or advisable in order to have the claims of the Indenture Trustee or the Noteholders allowed in any judicial proceedings relative to the
Issuer, its creditors and its property. 

 Any trustee, liquidator, receiver or similar official in any such Proceeding is authorized by each
Noteholder to make payments to the Indenture Trustee and, if the Indenture Trustee consents to the making of payments directly to such Noteholders, to pay to the Indenture Trustee an amount sufficient to cover all amounts owed to the Indenture
Trustee under Section 8.7. 
  

	 	(b)	Except as provided in Section 7.4(a)(ii), this Indenture does not authorize the Indenture Trustee to authorize or consent to or vote for or accept or adopt on behalf of any Noteholder any plan of reorganization,
arrangement, adjustment or composition affecting the Notes or the rights of any Noteholder to authorize the Indenture Trustee to vote in respect of the claim of any Noteholder in any such Proceeding. 

Section 7.5. Trustee May Enforce Claims Without Possession of Notes. 

 

	 	(a)	All rights of action and claims under this Indenture, or under any of the Notes, may be enforced by the Indenture Trustee without the possession of any of the Notes or the production of any of the Notes in any
Proceeding relative to any of the Notes, and any such Proceeding instituted by the Indenture Trustee will be brought in its own name as trustee of an express trust, and any recovery of judgment, subject to the amounts owed to the Indenture Trustee
under Section 8.7, will be for the benefit of the Noteholders in respect of which such judgment has been recovered. 

  

	 	(b)	In any Proceeding brought by the Indenture Trustee (and any Proceeding involving the interpretation of this Indenture to which the Indenture Trustee is a party), the Indenture Trustee will be held to represent all the
Noteholders, and it will not be necessary to make any Noteholder a party to any such Proceeding. 

  
 52 

 Section 7.6. Remedies; Priorities 

 

	 	(a)	If the Notes have been accelerated under Section 7.2(a) the Indenture Trustee may do one or more of the following (subject to Section 7.7), and will upon written direction of the Majority Holders:

  

	 	(i)	institute a Proceeding in its own name and as trustee of an express trust for the collection of all amounts then payable on the Notes or under this Indenture with respect to the Notes, enforce any judgment obtained and
collect from the Issuer monies adjudged due; 

  

	 	(ii)	institute a Proceeding for the complete or partial foreclosure of this Indenture with respect to the Collateral; 

  

	 	(iii)	exercise any remedies of a secured party under the applicable UCC and take any other action to protect and enforce the rights and remedies of the Indenture Trustee and the Noteholders; and 

 

	 	(iv)	sell or otherwise liquidate the Collateral or any portion of the Collateral or rights or interest in the Collateral at one or more public or private sales called and conducted in any manner permitted by law.

  

	 	(b)	Any money or property collected by the Indenture Trustee following the occurrence of an Event of Default and an acceleration of the unpaid principal amount of the Notes, will be deposited into the Collection Account for
distribution in accordance with Section 4.5(b) on the Payment Date following the Collection Period during which such amounts are collected. 

  

	 	(c)	Upon any sale or liquidation of the Collateral described in this Section 7.6, the Indenture Trustee will provide the Servicer with a right of first refusal to purchase such Collateral and the Servicer may purchase
such Collateral for an amount equal to the aggregate principal balance of the Pool Receivables, provided, that such amount is sufficient to pay in full all amounts owed by the Issuer to the Noteholders including all principal of and accrued
interest on the Note Balance. 

 Section 7.7. Optional Preservation of the Collateral. If the Notes have been
accelerated under Section 7.2(a) and such declaration and its consequences have not been rescinded and annulled in accordance with Section 7.2(b), the Indenture Trustee may elect to maintain possession of the Collateral. It is the
intention of the parties to this Indenture and the Noteholders that there at all times be sufficient funds for the payment of principal of and interest on the Notes. The Indenture Trustee will take such intention into account when determining
whether or not to maintain possession of the Collateral. In determining whether to maintain possession of the Collateral, the Indenture Trustee may (at the expense of the Issuer) obtain and 

  
 53 

 
rely upon an opinion of a nationally recognized independent investment banking firm or firm of certified public accountants as to the feasibility of such proposed action and as to the sufficiency
of the Collateral for such purpose; provided, that the Indenture Trustee shall act at all times at the written direction of holders of at least 66.67% of the Note Balance of the Controlling Class. 

Section 7.8. Limitation of Suits 
  

	 	(a)	No Noteholder has any right to institute any Proceeding with respect to this Indenture or for the appointment of a receiver or trustee, or for any other remedy under this Indenture, unless: 

 

	 	(i)	such Noteholder has given notice to the Indenture Trustee of a continuing Event of Default; 

  

	 	(ii)	the Noteholders of at least 25% of the Note Balance of the Controlling Class have requested the Indenture Trustee to institute such Proceeding in respect of such Event of Default in its own name as Indenture Trustee
under this Indenture and offered indemnity satisfactory to the Indenture Trustee; 

  

	 	(iii)	the Indenture Trustee has not received a direction not to take legal action from the Noteholders of at least 25% of the Note Balance of the Controlling Class; and 

 

	 	(iv)	the Indenture Trustee has failed to institute such Proceedings for 60 days after its receipt of such notice, request and offer of indemnity. 

 

	 	(b)	No Noteholder has any right to affect, disturb or prejudice the rights of any other Noteholder or to obtain or to seek to obtain priority or preference over any other Noteholder or to enforce any right under this
Indenture, except in the manner provided in this Indenture. 

 Section 7.9. Unconditional Rights of Noteholders to
Receive Principal and Interest. Notwithstanding any other provision in this Indenture, each Noteholder has an absolute and unconditional right to receive payment of principal of and any interest on its Note on or after the respective due dates
expressed in such Note or in this Indenture (or, in the case of redemption, on or after the date of redemption) in accordance with the provisions of this Indenture and of the other Transaction Documents and to institute a Proceeding for the
enforcement of any such payment in accordance with Section 7.8. Such rights may not be impaired or affected without the consent of such Noteholder. 

Section 7.10. Restoration of Rights and Remedies. If the Indenture Trustee or any Noteholder has instituted any Proceeding to
enforce any right or remedy under this Indenture and such Proceeding has been discontinued or abandoned for any reason or has been determined adversely to the Indenture Trustee or to such Noteholder, then the Issuer, the Indenture Trustee and the
Noteholders, subject to any determination in such Proceeding, will be restored severally and respectively to their former positions under this Indenture, and thereafter all rights and remedies of the Indenture Trustee and the Noteholders will
continue as though no such Proceeding had been instituted. 

  
 54 

 Section 7.11. Rights and Remedies Cumulative. No right or remedy conferred upon or
reserved to the Indenture Trustee or to the Noteholders in this Indenture is intended to be exclusive of any other right or remedy, and every right and remedy, to the extent permitted by law, will be cumulative and in addition to every other right
and remedy given under this Indenture or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy under this Indenture, or otherwise, will not prevent the concurrent assertion or employment of
any other appropriate right or remedy. The Indenture Trustee’s right to seek and recover judgment on the Notes or under this Indenture will not be affected by the seeking, obtaining or application of any other relief under or with respect to
this Indenture. Neither the Lien of this Indenture nor any rights or remedies of the Indenture Trustee or the Noteholders will be impaired by the recovery of any judgment by the Indenture Trustee against the Issuer or by the levy of any execution
under such judgment upon any portion of the Collateral or upon any of the assets of the Issuer. 
 Section 7.12. Delay or Omission
Not a Waiver. No delay or omission of the Indenture Trustee or any Noteholder to exercise any right or remedy accruing upon any potential Event of Default or Event of Default will impair any such right or remedy, or constitute a waiver of any
such potential Event of Default or Event of Default. Every right and remedy conferred by this Article VII or by law to the Indenture Trustee or to the Noteholders may be exercised from time to time, and as often as may be deemed expedient, by the
Indenture Trustee or by the Noteholders, as the case may be. 
 Section 7.13. Control by Noteholders. The Majority Holders have
the right to direct the time, method and place of conducting any Proceeding for any remedy available to the Indenture Trustee with respect to the Notes or exercising any trust or power conferred on the Indenture Trustee; provided, that: 

 

	 	(a)	such direction does not conflict with any law or with this Indenture; and 

  

	 	(b)	the Indenture Trustee may take any other action deemed proper by the Indenture Trustee that is not inconsistent with such direction from the Majority Holders. 

Unless the context otherwise requires, any reference herein, or in any other Transaction Document to the direction, request or consent of “the
Noteholders” shall be construed as referencing the Majority Holders. 
 Section 7.14. Waiver of Defaults and Events of
Default. 
  

	 	(a)	The Majority Holders may waive any potential Event of Default or Event of Default and its consequences described in Sections 7.1(d) and (e). 

 

	 	(b)	Upon any such waiver, such potential Event of Default or Event of Default will be deemed not to have occurred for every purpose of this Indenture. No such waiver will extend to any other potential Event of Default or
Event of Default or impair any right relating to any other potential Event of Default or Event of Default. 

Section 7.15. Undertaking for Costs. All parties to this Indenture agree, and each Noteholder by such Noteholder’s acceptance
of a Note will be deemed to have agreed, that a 

  
 55 

 
court may in its discretion require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Indenture Trustee for any action taken, suffered or
omitted by it as Indenture Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such suit, and that such court may in its discretion assess reasonable costs, including reasonable attorneys’ fees, against
any party litigant in such suit. This Section 7.15 will not apply to (a) any suit instituted by the Indenture Trustee (at the written direction of holders of at least 66.67% of the Note Balance of the Controlling Class), (b) any suit
instituted by any Noteholder or group of Noteholders holding more than 10% of the Note Balance, or (c) any suit instituted by any Noteholder for the enforcement of the payment of principal of or interest on any Note on or after the respective
due dates expressed in such Note and in this Indenture (or, in the case of redemption, on or after the date that the Notes are redeemed pursuant to Section 3.13). 

Section 7.16. Waiver of Stay or Extension Laws. The Issuer covenants (to the extent that it may lawfully do so) that it will not
insist upon, or plead or in any manner whatsoever, claim or take the benefit or advantage of, any stay or extension that may affect the covenants or the performance of this Indenture, and the Issuer (to the extent that it may lawfully do so) waives
all benefit or advantage of any such law, and covenants that it will not hinder, delay or impede the execution of any power in this Indenture granted to the Indenture Trustee, but will suffer and permit the execution of every such power as though no
such law had been enacted. 
 Section 7.17. Performance and Enforcement of Certain Obligations. 

 

	 	(a)	At the Servicer’s expense, the Issuer will promptly take all such lawful action as the Indenture Trustee may request to (i) compel the performance by (A) the Depositor and the Servicer of their
obligations to the Issuer under the Sale and Servicing Agreement, or (B) the Depositor and the Originator of their obligations under the Purchase Agreement and (ii) exercise any and all rights, remedies, powers, privileges and claims
lawfully available to the Issuer under such agreements to the extent and in the manner directed by the Indenture Trustee. 

  

	 	(b)	If an Event of Default has occurred and is continuing, the Indenture Trustee may, and at the written direction of holders of at least 66.67% of the Note Balance of the Controlling Class shall, exercise all rights,
remedies, powers, privileges and claims of the Issuer against (i) the Depositor or the Servicer under the Sale and Servicing Agreement, or (ii) the Depositor or the Originator under the Purchase Agreement, including the right or power to
take any action to compel or secure performance or observance by such Persons of their obligations to the Issuer under such agreements, and to give any consent, request, notice, direction, approval, extension or waiver under such agreements, and any
right of the Issuer to take such action will be suspended. 

 Section 7.18. Power of Attorney. The Issuer hereby
authorizes the Indenture Trustee, and irrevocably appoints the Indenture Trustee, during the existence of a Default or an Event of Default, as its attorney-in-fact with full power of substitution and with full authority in the place and stead of the
Issuer which appointment is coupled with an interest, to take any and all steps in the name of the Issuer as necessary or desirable, in the determination of the Indenture Trustee, to 

  
 56 

 
collect any and all amounts or portions thereof due under any and all Pool Receivables or Related Security, including endorsing the name of the Issuer on checks and other instruments representing
Collections and enforcing such Pool Receivables and Related Security. Notwithstanding anything to the contrary contained in this Section 7.18, none of the powers conferred upon such attorney-in-fact pursuant to the immediately preceding
sentence shall subject such attorney-in-fact to any liability if any action taken by it shall prove to be inadequate or invalid, nor shall they confer any obligations upon such attorney-in-fact in any manner whatsoever. 

ARTICLE VIII 
 THE INDENTURE
TRUSTEE 
 Section 8.1. Duties of Indenture Trustee. 
  

	 	(a)	If an Event of Default has occurred and the Notes have been accelerated under Section 7.2(a), the Indenture Trustee will exercise the rights and powers vested in it by this Indenture and use the same degree of care
and skill in their exercise as a prudent Person would use under the circumstances in the conduct of such Person’s own affairs. 

  

	 	(b)	Except during the continuance of an Event of Default and an acceleration of the Notes under Section 7.2(a): 

  

	 	(i)	the Indenture Trustee undertakes to perform such duties and only such duties as are specifically set forth in this Indenture and no implied covenants or obligations are to be read into this Indenture against the
Indenture Trustee; and 

  

	 	(ii)	in the absence of bad faith on its part, the Indenture Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions furnished to it, upon any certificates or opinions furnished to
it and, if required by the terms of this Indenture, conforming to the requirements of this Indenture; provided, that the Indenture Trustee will examine any such certificates and opinions to determine whether or not they conform to the
requirements of this Indenture. 

  

	 	(c)	The Indenture Trustee will not be relieved from liability for its own willful misconduct, negligent action or negligent failure to act, except that: 

 

	 	(i)	this Section 8.1(c) does not limit the effect of Section 8.1(b); 

  

	 	(ii)	the Indenture Trustee will not be liable for any error of judgment made in good faith by a Responsible Officer unless it is proved that the Indenture Trustee was negligent in ascertaining the pertinent facts; and

  

	 	(iii)	the Indenture Trustee will not be liable for any action it takes or omits to take in good faith in accordance with a written direction received by it pursuant to Sections 7.13 and 7.17(b). 

  
 57 

	 	(d)	The Indenture Trustee will not be liable for interest on any money received by it except in accordance with this Indenture. 

  

	 	(e)	Money held in trust by the Indenture Trustee need not be segregated from other funds except to the extent required by law, this Indenture or the Sale and Servicing Agreement. 

 

	 	(f)	Every provision of this Indenture relating to the conduct of, affecting the liability of or affording protection to the Indenture Trustee is subject to this Section 8.1. 

 

	 	(g)	The Indenture Trustee will not be charged with knowledge of any Event of Default or potential Event of Default unless either (i) a Responsible Officer of the Indenture Trustee has actual knowledge of such Event of
Default or potential Event of Default or (ii) notice of such Event of Default or potential Event of Default has been given to the Indenture Trustee in accordance with this Indenture. 

 

	 	(h)	Upon direction by Issuer Order, the Indenture Trustee will execute any intercreditor agreement (including, without limitation, the Intercreditor Agreement and any supplement or amendment thereto) or related document to
which the Issuer is, or will be upon execution and delivery of such intercreditor agreement or related document, a party, including any amendment or supplement thereto. 

Section 8.2. Rights of Indenture Trustee. 
  

	 	(a)	The Indenture Trustee may rely and will be protected in acting or refraining from acting upon any certificate, instrument, opinion, report, notice, request, direction, consent or other document believed by it to be
genuine and appears on its face to be properly executed and signed or presented by the proper Person. The Indenture Trustee need not investigate any fact or matters stated in any such document. 

 

	 	(b)	Before the Indenture Trustee acts or refrains from acting, it may require an Officer’s Certificate or an Opinion of Counsel. The Indenture Trustee will not be liable for any action it takes or omits to take in good
faith in reliance on an Officer’s Certificate or Opinion of Counsel. 

  

	 	(c)	The Indenture Trustee may exercise any of its rights or powers under this Indenture or perform any duties under this Indenture either directly or by or through agents or attorneys or a custodian or nominee, and the
Indenture Trustee will not be responsible for any misconduct or negligence on the part of, or for the supervision of, any such agent, counsel, custodian or nominee appointed with due care by it under this Indenture. 

 

	 	(d)	The Indenture Trustee will not be liable for any action it takes or omits to take in good faith which it believes to be authorized or within its rights or powers if such action or omission by the Indenture Trustee does
not constitute negligence. 

  
 58 

	 	(e)	The Indenture Trustee may consult with counsel, and the advice or opinion of counsel with respect to legal matters relating to this Indenture and the Notes will be full and complete authorization and protection from
liability with respect to any action taken or not taken by the Indenture Trustee under this Indenture in good faith and in accordance with the advice or opinion of such counsel. 

 

	 	(f)	The Indenture Trustee is under no obligation to (i) exercise any of the rights or powers vested in it by this Indenture or to expend or risk its own funds or otherwise incur financial liability in the performance
of its duties under this Indenture (including its duties pursuant to Section 8.1(a)) if it has reasonable grounds to believe that repayment of funds advanced by it or adequate indemnity satisfactory to it against such risk or liability is not
reasonably assured to it or (ii) honor the request or direction of any of the Noteholders pursuant to this Indenture unless such Noteholders have offered to the Indenture Trustee reasonable security or indemnity satisfactory to it from and
against the reasonable costs, expenses, disbursements, advances and liabilities that might be incurred by the Indenture Trustee, or its agents, counsel, accountants and experts, in complying with such request or direction. 

 

	 	(g)	The Indenture Trustee will not be responsible or liable for any failure or delay in the performance of its obligations under this Indenture arising out of or caused by, directly or indirectly, forces beyond its control,
including strikes, work stoppages, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, but the Indenture Trustee will use reasonable efforts
which are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances. 

  

	 	(h)	The Indenture Trustee will not be responsible or liable for special, indirect, or consequential loss or damage of any kind whatsoever (including loss of profit) irrespective of whether the Indenture Trustee has been
advised of the likelihood of such loss or damage and regardless of the form of action. 

 Section 8.3. Individual
Rights of Indenture Trustee. The Indenture Trustee, in its individual or any other capacity, may become the owner or pledgee of Notes and may otherwise deal with the Issuer or any of its Affiliates with the same rights it would have if it were
not Indenture Trustee. Any Note Paying Agent, Note Registrar, co-registrar or co-paying agent under this Indenture may do the same with like rights. 

Section 8.4. Indenture Trustee’s Disclaimer. The Indenture Trustee (a) will not be responsible for, and makes no
representation or warranty as to, the validity or adequacy of this Indenture or the Notes and (b) will not be accountable for the Issuer’s use of the proceeds from the Notes, or responsible for any statement of the Issuer in this Indenture
or in any document issued in connection with the sale of the Notes or in the Notes other than the Indenture Trustee’s certificate of authentication. 

  
 59 

 Section 8.5. Notice of Defaults. Within 90 days of a Responsible Officer of the
Indenture Trustee obtaining actual knowledge of, or receiving notice of, any potential Event of Default under this Indenture, the Indenture Trustee will mail to each Noteholder, notice of such default, unless such potential Event of Default has been
cured or waived; provided, that (a) except in the case of a potential Event of Default in the payment of principal of or interest on any Note, the Indenture Trustee may withhold such notice if and so long as a committee of its
Responsible Officers in good faith determines that the withholding of such notice is in the interests of the Noteholders. 

Section 8.6. Reports by Indenture Trustee. 
  

	 	(a)	Upon delivery to the Indenture Trustee by the Servicer of the information prepared by the Servicer pursuant to Section 3.7 of the Sale and Servicing Agreement to enable each Noteholder to prepare its federal and
State income tax returns, the Indenture Trustee will make available the relevant portions of such information to each Noteholder of record as of the most recent Record Date (which delivery may be made by making such information available to the
Noteholders through the Indenture Trustee’s website, which initially is located at www.usbank.com/abs). 

  

	 	(b)	On each Payment Date, the Indenture Trustee will deliver the Servicer Report to each Noteholder of record as of the most recent Record Date through the Indenture Trustee’s website, which initially is located at
www.usbank.com/abs. 

  

	 	(c)	If requested in writing by the Depositor or the Servicer, the Indenture Trustee will deliver to the Depositor, the Owner Trustee, and the Servicer on or before April 1 of each year, beginning in the year after the
Closing Date, an Officer’s Certificate, dated as of December 31 of the preceding calendar year, signed by a Responsible Officer of the Indenture Trustee (i) to the effect that (A) a review of the Indenture Trustee’s
activities during the preceding calendar year (or, in the case of the first certificate, the portion of the preceding calendar year since the Closing Date) and of its performance under this Indenture has been made under such Responsible
Officer’s supervision and (B) to such Responsible Officer’s knowledge, based on such review, the Indenture Trustee has fulfilled in all material respects all of its obligations under this Indenture throughout such calendar year (or,
in the case of the first certificate, the portion of the preceding calendar year since the Closing Date), or, if there has been a failure to fulfill any such obligation in any material respect, specifically identifying each such failure known to
such Responsible Officer and the nature and status of such failure and (ii) certifying to matters related to the Indenture Trustee as required under Form 10-K under the Exchange Act. 

If the parties to this Indenture determine to further clarify or amend Section 8.6(c), this Indenture may be amended to reflect the new
agreement between the parties covering matters in Section 8.6(c) pursuant to Section 9.1(a), which amendment will not require the delivery of any Opinions of Counsel. 

  
 60 

 Section 8.7. Compensation and Indemnity. The Issuer will pay the Indenture Trustee as
compensation for the Indenture Trustee’s services under this Indenture such fees as have been separately agreed upon on the date of this Indenture between the Issuer and the Indenture Trustee. The Indenture Trustee’s compensation will not
be limited by any law on compensation of a trustee of an express trust. The Issuer will reimburse the Indenture Trustee for all reasonable out-of-pocket expenses incurred or made by the Indenture Trustee, including costs of collection, and the
reasonable compensation, expenses and disbursements of the Indenture Trustee’s agents, counsel, accountants and experts, but excluding any expenses incurred by the Indenture Trustee through the Indenture Trustee’s willful misconduct, bad
faith or negligence (except for errors in judgment). 
  

	 	(a)	The Issuer will, or will cause the Servicer to, indemnify, defend and hold harmless the Indenture Trustee, and its respective officers, directors, employees and agents, from and against any and all costs, expenses,
losses, damages, claims and liabilities (including the reasonable compensation, expenses and disbursements of the Indenture Trustee’s agents, counsel, accountants and experts) incurred by it in connection with the administration of and the
performance of its duties under this Indenture, including the costs and expenses of defending itself against any loss, damage, claim or liability incurred by it in connection with the exercise or performance of any of its powers or duties under this
Indenture, but excluding any cost, expense, loss, damage, claim or liability (i) incurred by the Indenture Trustee through the Indenture Trustee’s willful misconduct, bad faith or negligence (except for errors in judgment) or
(ii) arising from the Indenture Trustee’s breach of any of its representations or warranties set forth in this Indenture. 

  

	 	(b)	 Promptly upon receipt by the Indenture Trustee, or any of its officers, directors, employees and agents (each, an “Indemnified
Person”), of notice of the commencement of any Proceeding against any such Indemnified Person, such Indemnified Person will, if a claim in respect of such Proceeding is to be made under Section 8.7(b), notify the Issuer and the
Servicer of the commencement of such Proceeding. Failure by the Indenture Trustee to so notify the Issuer and the Servicer will not relieve the Issuer or the Servicer of its obligations under this Section 8.7; provided, that neither the
Issuer nor the Servicer has been materially prejudiced by such failure to so notify and notice is given within 180 days of a Responsible Officer of the Indenture Trustee learning of such Proceeding. The Issuer, or, if Issuer so causes, the Servicer,
may participate in and assume the defense and settlement of any such Proceeding at its expense, and no settlement of such Proceeding may be made without the approval of the Issuer or the Servicer, as applicable, and such Indemnified Person, which
approvals will not be unreasonably withheld, delayed or conditioned. After notice from the Issuer or the Servicer, as applicable, to the Indemnified Person of the intention of the Issuer or the Servicer, as applicable, to assume the defense of such
Proceeding with counsel reasonably satisfactory to the Indemnified Person, and so long as the Issuer or the Servicer, as applicable, so assumes the defense of such Proceeding in a manner reasonably satisfactory to the Indemnified Person, neither the
Issuer nor the Servicer will be liable for any legal expenses of counsel to the Indemnified 

  
 61 

	 	
Person unless there is a conflict between the interests of the Issuer or the Servicer, as applicable, on one hand, and an Indemnified Person, on the other hand, in which case the Issuer or the
Servicer, will pay for the separate counsel to the Indemnified Person. 

  

	 	(c)	The payment obligations of the Issuer and the Servicer, to the Indenture Trustee pursuant to this Section 8.7 will survive the resignation or removal of the Indenture Trustee and the discharge of this Indenture.
Notwithstanding anything else set forth in this Indenture or the Transaction Documents, the Indenture Trustee agrees that the obligations of the Issuer (but not the Servicer) to the Indenture Trustee hereunder and under the Transaction Documents
shall be recourse to the Owner Trust Estate only and specifically shall not be recourse to the assets of the Certificateholder or any Noteholder. In addition, the Indenture Trustee agrees that its recourse to the Issuer, the Owner Trust Estate and
the Certificateholder shall be limited to the right to receive the distributions referred to in Sections 4.5(a) and (b) of this Indenture. 

Section 8.8. Replacement of Indenture Trustee. 
  

	 	(a)	No resignation or removal of the Indenture Trustee, and no appointment of a successor Indenture Trustee, will become effective until the acceptance of appointment by the successor Indenture Trustee pursuant to this
Section 8.8. Subject to the preceding sentence, the Indenture Trustee may resign by notifying the Issuer. The Majority Holders may remove the Indenture Trustee without cause by notifying the Indenture Trustee and the Issuer and may appoint a
successor Indenture Trustee. 

  

	 	(b)	The Issuer must remove the Indenture Trustee if: 

  

	 	(i)	the Indenture Trustee fails to comply with Section 8.11; 

  

	 	(ii)	an Event of Bankruptcy occurs with respect to the Indenture Trustee; 

  

	 	(iii)	a receiver or other public officer takes charge of the Indenture Trustee or its property; or 

  

	 	(iv)	the Indenture Trustee becomes legally unable to act or otherwise incapable of acting as Indenture Trustee. 

  

	 	(c)	If the Indenture Trustee resigns or is removed or if a vacancy exists in the office of Indenture Trustee for any reason, the Issuer must appoint a successor Indenture Trustee promptly. 

 

	 	(d)	 Any successor Indenture Trustee will deliver a written acceptance of its appointment to the retiring Indenture Trustee, the Issuer and the Servicer.
Upon delivery of such acceptance, the resignation or removal of the retiring Indenture Trustee will become effective, and the successor Indenture Trustee will have all the rights, powers, duties and obligations of the Indenture Trustee under this

  
 62 

	 	
Indenture. The Issuer will continue to pay all amounts owed to the retiring Indenture Trustee in accordance with Sections 8.7 and 4.5(a) following the retiring Indenture Trustee’s
resignation or removal until all such amounts are paid. The successor Indenture Trustee will deliver a notice of its succession to the Noteholders. The retiring Indenture Trustee will promptly transfer all property held by it as Indenture Trustee to
the successor Indenture Trustee. 

  

	 	(e)	If a successor Indenture Trustee does not take office within 60 days after the retiring Indenture Trustee tenders its resignation or is removed, the retiring Indenture Trustee, the Issuer or the Majority Holders may
petition any court of competent jurisdiction for the appointment of a successor Indenture Trustee. 

  

	 	(f)	Notwithstanding the replacement of the retiring Indenture Trustee pursuant to this Section 8.8, any obligations of the Issuer and the Servicer owing to the retiring Indenture Trustee under Section 8.7 will
continue for the benefit of the retiring Indenture Trustee. 

 Section 8.9. Successor Indenture Trustee by Merger
If the Indenture Trustee consolidates with, merges or converts into, or transfers all or substantially all of its corporate trust business or assets to, another corporation or banking association, the resulting, surviving or transferee corporation
or banking association will be the successor Indenture Trustee so long as such corporation or banking association is otherwise qualified and eligible under Section 8.11. The Indenture Trustee will promptly notify the Servicer and the Issuer
(who will notify each Rating Agency) of any such transaction. 
  

	 	(b)	If, at the time any such successor by merger, conversion or consolidation to the Indenture Trustee succeeds to the trusts created by this Indenture, any of the Notes have been authenticated but not delivered, such
successor may adopt the certificate of authentication of any predecessor Indenture Trustee and deliver such Notes so authenticated. If at such time any of the Notes have not been authenticated, any successor to the Indenture Trustee may authenticate
such Notes either in the name of any predecessor Indenture Trustee or in the name of such successor Indenture Trustee. In all such cases, such certificates will have the same force and effect provided for anywhere in the Notes or in this Indenture
as the certificate of the predecessor Indenture Trustee. 

 Section 8.10. Appointment of Separate Indenture Trustee or
Co-Indenture Trustee. 
  

	 	(a)	 For the purpose of meeting any legal requirement of any jurisdiction in which any part of the Collateral may at the time be located, after delivering
written notice to the Issuer and the Servicer, the Indenture Trustee may appoint one or more Persons to act as a separate trustee or separate trustees, or co-trustee or co- trustees, of all or any part of the Issuer, and to vest in such Persons, in
such capacity and for the benefit of the Noteholders, such title to the Collateral, or any part of the Collateral, and, subject to this Section 8.10, such rights, powers, duties and obligations as the Indenture Trustee may consider necessary or
desirable. No 

  
 63 

	 	
separate trustee or co-trustee will be required to meet the terms of eligibility as a successor trustee under Section 8.11 and no notice to the Noteholders of the appointment of any
separate trustee or co-trustee will be required under Section 8.8. 

  

	 	(b)	Every separate trustee and co-trustee will, to the extent permitted by law, be appointed and act subject to the following: 

  

	 	(i)	all rights, powers, duties and obligations conferred or imposed upon the Indenture Trustee will be conferred or imposed upon and exercised or performed by the Indenture Trustee, or the Indenture Trustee and such
separate trustee or co-trustee jointly (it being understood that such separate trustee or co-trustee will not be authorized to act separately without the Indenture Trustee joining in such act), except to the extent that under any law of any
jurisdiction in which any particular act or acts are to be performed the Indenture Trustee will be incompetent or unqualified to perform such act or acts, in which event such rights, powers, duties and obligations (including the holding of title to
the Collateral or any portion of the Collateral in any such jurisdiction) will be exercised and performed singly by such separate trustee or co-trustee, but solely at the direction of the Indenture Trustee; 

 

	 	(ii)	no trustee will be personally liable by reason of any act or omission of any other trustee under this Indenture; and 

  

	 	(iii)	the Indenture Trustee may accept the resignation of or remove any separate trustee or co-trustee. 

  

	 	(c)	Any notice, request or other writing given to the Indenture Trustee will be deemed to have been given to each appointed separate trustee and co-trustee, as effectively as if given to each of them. Every instrument
appointing any separate trustee or co-trustee will refer to this Indenture and the conditions of this Section 8.10. Each separate trustee and co-trustee, upon its acceptance of the trusts conferred, will be vested with the estates or property
specified in its instrument of appointment, either jointly with the Indenture Trustee or separately, as may be provided in such instrument of appointment, subject to this Indenture. Every such instrument will be filed with the Indenture Trustee.

  

	 	(d)	Any separate trustee or co-trustee may appoint the Indenture Trustee as its agent or attorney-in-fact with power and authority, to the extent not prohibited by law, to do any lawful act under or in respect of this
Indenture on its behalf and in its name. If any separate trustee or co-trustee dies, becomes incapable of acting, resigns or is removed, all of its estates, properties, rights, remedies and trusts will vest in and be exercised by the Indenture
Trustee, to the extent permitted by law, without the appointment of a new or successor trustee. 

  
 64 

 Section 8.11. Eligibility; Disqualification. 

 

	 	(a)	The Indenture Trustee or its parent must have a combined capital and surplus of at least $50,000,000 as set forth in its most recent annual published report of condition. Within ten days after the Indenture Trustee
fails to satisfy any of the requirements set forth in this Section 8.11(a) or ceases to be a Qualified Institution, the Indenture Trustee will notify the Issuer and the Servicer of such failure. 

 

	 	(b)	Within 90 days after the occurrence of an Event of Default that has not been cured or waived, the Indenture Trustee will resign with respect to the Notes in accordance with Section 8.8, and the Issuer will appoint
a successor Indenture Trustee for the Notes. 

  

	 	(c)	If a successor Indenture Trustee is appointed with respect to the Notes, the retiring Indenture Trustee and the successor Indenture Trustee will execute an indenture supplemental to this Indenture. Such supplemental
indenture will contain: 

  

	 	(i)	provisions by which the successor Indenture Trustee accepts its appointment; 

  

	 	(ii)	provisions necessary or desirable to transfer and confirm to, and to vest in, the successor Indenture Trustee all the rights, powers, duties and obligations of the retiring Indenture Trustee with respect to the Notes to
which the appointment of such successor Indenture Trustee relates; 

  

	 	(iii)	if the retiring Indenture Trustee is not retiring with respect to all of the Notes, provisions necessary or desirable to confirm that all the rights, powers, duties and obligations of the retiring Indenture Trustee with
respect to the Notes as to which the retiring Indenture Trustee is not retiring continue to be vested in the Indenture Trustee; and 

  

	 	(iv)	provisions necessary to provide for or facilitate the administration of the trusts hereunder by more than one Indenture Trustee. 

Nothing in this Indenture or in such supplemental indenture will constitute such Indenture Trustees co-trustees of the same trust and each
such Indenture Trustee will be a trustee of a trust or trusts under this Indenture separate and apart from any trust or trusts under this Indenture administered by any other Indenture Trustee. The indenture supplement will become effective upon the
removal of the retiring Indenture Trustee. 
 Section 8.12. Audits of the Indenture Trustee. The Indenture Trustee agrees (at
the expense of the requesting party) that, with reasonable prior notice, it will permit any authorized representative of the Servicer or the Issuer, during the Indenture Trustee’s normal business hours, to examine and audit the books of
account, records, reports and other documents and materials of the Indenture Trustee relating to (a) the performance of the Indenture Trustee’s obligations under this Indenture, (b) any payments of fees and expenses of the Indenture
Trustee in connection with such performance and (c) any claim made by the Indenture Trustee under this Indenture. In addition, the Indenture Trustee will permit such representatives to discuss the same with the

  
 65 

 
Indenture Trustee’s officers and employees. Each of the Servicer and the Issuer will, and will cause its authorized representatives to, hold in confidence all such information except to the
extent disclosure may be required by law (and all reasonable applications for confidential treatment are unavailing) and except to the extent that the Servicer or the Issuer, as the case may be, may reasonably determine that such disclosure is
consistent with its obligations under this Indenture. The Indenture Trustee will maintain all such pertinent books, records, reports and other documents and materials for a period of two years after the termination of its obligations under this
Indenture. 
 Section 8.13. Representations and Warranties of the Indenture Trustee. The Indenture Trustee represents and
warrants to the Issuer as of the Closing Date: 
  

	 	(a)	Organization and Qualification. The Indenture Trustee is a national banking association duly organized, validly existing and in good standing under the laws of the United States of America. The Indenture Trustee
is qualified as a foreign banking corporation in good standing and has obtained all necessary licenses and approvals in all jurisdictions in which the ownership or lease of its properties or the conduct of its activities requires such qualification,
license or approval, unless the failure to obtain such qualifications, licenses or approvals would not reasonably be expected to have a material adverse effect on the Indenture Trustee’s ability to perform its obligations under this Indenture
or the other Transaction Documents to which it is a party. 

  

	 	(b)	Power, Authorization and Enforceability. The Indenture Trustee has the power and authority to execute deliver and perform the terms of this Indenture. The Indenture Trustee has authorized the execution, delivery
and performance of the terms of this Indenture. This Indenture is the legal, valid and binding obligation of the Indenture Trustee enforceable against the Indenture Trustee, except as may be limited by insolvency, bankruptcy, reorganization or other
laws relating to or affecting the enforcement of creditors’ rights or by general equitable principles. 

  

	 	(c)	No Conflicts and No Violation. The execution and delivery by the Indenture Trustee of this Indenture, the consummation by the Indenture Trustee of the transactions contemplated by this Indenture and the
compliance by the Indenture Trustee with this Indenture will not (i) violate any federal or New York State law, governmental rule or regulation governing the banking or trust powers of the Indenture Trustee or any judgment or order binding on
it or (ii) conflict with, result in a breach of, or constitute (with or without notice or lapse of time or both) a default under its charter documents or by-laws or any indenture, mortgage, deed of trust, loan agreement, guarantee or similar
agreement or instrument under which the Indenture Trustee is a debtor or guarantor or (iii) violate any law or, to the Indenture Trustee’s knowledge, any order, rule, or regulation applicable to the Indenture Trustee of any court or of any
federal or State regulatory body, administrative agency or other governmental instrumentality having jurisdiction over the Indenture Trustee or its properties, in each case which conflict, breach, default, Lien, or violation would reasonably be
expected to have a material adverse effect on the Indenture Trustee’s ability to perform its obligations under this Indenture. 

  
 66 

	 	(d)	No Proceedings. To the Indenture Trustee’s knowledge, there are no proceedings or investigations pending or overtly threatened in writing, before any court, regulatory body, administrative agency, or other
governmental instrumentality having jurisdiction over the Indenture Trustee or its properties: (i) asserting the invalidity of any of this Indenture or the Sale and Servicing Agreement, (ii) seeking to prevent the issuance of the Notes or
the consummation of any of the transactions contemplated by any of the Transaction Documents or (iii) seeking any determination or ruling that would reasonably be expected to have a material adverse effect on the Indenture Trustee’s
ability to perform its obligations under, or the validity or enforceability of, this Indenture. 

  

	 	(e)	Eligibility. The Indenture Trustee is a Qualified Institution. The Indenture Trustee or its parent has a combined capital and surplus of at least $50,000,000 as set forth in its most recent annual published
report of condition. 

  

	 	(f)	Information Provided by the Indenture Trustee. The information provided by the Indenture Trustee in any certificate delivered by a Responsible Officer of the Indenture Trustee is true and correct in all material
respects. 

 Section 8.14. Covenants for Reporting of Repurchase Demands due to Breaches of Representations and
Warranties. The Indenture Trustee will (a) notify the Depositor and the Servicer, as soon as practicable and in any event within five Business Days, of all demands or requests communicated to the Indenture Trustee for the repurchase of any
Pool Receivable pursuant to Section 5.4 of the Purchase Agreement or Section 5.5 of the Sale and Servicing Agreement, (b) promptly upon written request by the Depositor or the Servicer, provide to them any other information relating
to such demands or requests reasonably requested to facilitate compliance by them with Rule 15Ga-1 under the Exchange Act, and Items 1104(e) and 1121(c) of Regulation AB (the “Repurchase Rules and Regulations”) and (c) if
requested by the Depositor or the Servicer, provide a written certification no later than fifteen days following any calendar quarter or calendar year that the Indenture Trustee has not received any repurchase demands for such period, or if
repurchase demands have been received during such period, that the Indenture Trustee has provided all the information reasonably requested under clause (b) above. In no event will the Indenture Trustee or the Issuer have any responsibility or
liability in connection with any filing required to be made by a securitizer under the Exchange Act or Regulation AB. The Indenture Trustee acknowledges that interpretations of the requirements of the Repurchase Rules and Regulations may change over
time, whether due to interpretive guidance provided by the Securities and Exchange Commission or its staff, consensus among participants in the asset-backed securities markets, advice of counsel, or otherwise, and agrees to comply with reasonable
requests made by the Depositor in good faith for delivery of information under these provisions on the basis of evolving interpretations of the Repurchase Rules and Regulations. The Indenture Trustee shall cooperate fully with the Depositor to
deliver any and all records and any other information necessary in the good faith determination of the Depositor to permit them to comply with the provisions of Repurchase Rules and Regulations. The Indenture Trustee will not be responsible for
determining whether any alleged breach of a representation or warranty under Section 5.5 of Purchase Agreement or Section 5.5 of the Sale and Servicing Agreement is “material”. 

  
 67 

 Section 8.15. Indenture Trustee May Own Notes. The Indenture Trustee in its
individual or any other capacity may become the owner or pledgee of the Notes and may deal with the Depositor, the Servicer and the Issuer in banking transactions with the same rights as it would have if it were not Indenture Trustee. 

ARTICLE IX 
 SUPPLEMENTAL
INDENTURES 
 Section 9.1. Supplemental Indentures Without Consent of Noteholders. Without the consent of the Majority Holders
but with prior notice by the Issuer to each Rating Agency, the Issuer and the Indenture Trustee (when directed by Issuer Order) may enter into one or more indentures supplemental to this Indenture for any of the following purposes: 

 

	 	(a)	to correct or amplify the description of any property subject to the Lien of this Indenture, or better to assure, convey and confirm to the Indenture Trustee any property subject or required to be subjected to the Lien
of this Indenture, or to subject additional property to the Lien of this Indenture; 

  

	 	(b)	to add to the covenants of the Issuer, for the benefit of the Noteholders, or to surrender any right or power conferred upon the Issuer in this Indenture; 

 

	 	(c)	to convey, transfer, assign, mortgage or pledge any property to or with the Indenture Trustee; 

  

	 	(d)	to cure any ambiguity, to correct or supplement any provision in this Indenture or in any supplemental indenture that may be inconsistent with any other provision in this Indenture or in any supplemental indenture or in
the Offering Memorandum, or to add provisions that are not inconsistent with the provisions of this Indenture so long as such action does not materially adversely affect the interests of the Noteholders; or 

 

	 	(e)	to evidence the acceptance of the appointment under this Indenture of a successor or additional Trustee with respect to the Notes on any Class thereof and to add to or change any of the provisions of this Indenture as
will be necessary to facilitate the administration of the Issuer under this Indenture by more than one Trustee, pursuant to Article VIII. 

All supplemental indentures pursuant to this Section 9.1 will be in form reasonably satisfactory to the Indenture Trustee. The Indenture Trustee is
authorized to join in the execution of any such supplemental indenture and to make any further reasonably appropriate agreements and stipulations that may be contained in such supplemental indenture. 

Section 9.2. Supplemental Indentures Without Consent of Noteholders. The Issuer and the Indenture Trustee, when directed by Issuer
Order, may enter, with the consent of the Majority Holders, into an indenture or indentures supplemental to this Indenture for the purpose of adding 

  
 68 

 
any provisions to, or changing in any manner or eliminating any of the provisions of, this Indenture or modifying in any manner the rights of the Noteholders under this Indenture if the Issuer
delivers an Opinion of Counsel to the Indenture Trustee to the effect that such amendment will not (i) cause any Note to be deemed sold or exchanged for purposes of Section 1001 of the Code or (ii) cause the Issuer to be treated as an
association or publicly traded partnership taxable as a corporation for U.S. federal income tax purposes; provided, however, that no such supplemental indenture, without the consent of each Noteholder of each Outstanding Note adversely
affected by such supplemental indenture, will: 
  

	 	(a)	modify or alter Section 9.1 or this Section 9.2; 

  

	 	(b)	change (1) the Maturity Date for any Class or the date of payment of any installment of principal of or interest on any Note, (2) the principal amount of or interest rate on any Note, (3) the price at
which the Notes may be redeemed, (4) the provisions of this Indenture relating to the priority of payments on the Notes or relating to the application of collections on, or the proceeds of the sale of, the Collateral to payment of principal of
or interest on the Notes, or change any place of payment where, or the coin or currency in which, any Note or the interest on any Note is payable, or (5) the right of Noteholders to institute suits to enforce this Indenture; 

 

	 	(c)	modify the percentage of the Note Balance required for any action; 

  

	 	(d)	modify or alter the proviso to the definition of “Outstanding”; 

  

	 	(e)	modify the calculation of the amount of any payment of interest or principal due on any Note on any Payment Date; or 

  

	 	(f)	permit the creation of any Lien ranking prior or equal to the Lien of this Indenture with respect to any part of the Collateral other than Permitted Liens, or except as permitted by this Indenture or the other
Transaction Documents, release the Lien of this Indenture with respect to any part of the Collateral. 

 It will not be
necessary for any act of Noteholders under this Section 9.2 to approve the particular form of any proposed supplemental indenture, but it will be sufficient if such act of Noteholders approves the substance of such proposed supplemental
indenture. Promptly after the execution by the Issuer and the Indenture Trustee of any supplemental indenture pursuant to this Section 9.2, the Indenture Trustee shall mail to the Noteholders to which such amendment or supplemental indenture
relates a notice setting forth in general terms the substance of such supplemental indenture. Any failure of the Indenture Trustee to mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such
supplemental indenture. 
 Section 9.3. Execution of Supplemental Indentures. In executing, or permitting the additional trusts
created by, any supplemental indenture permitted by this Article IX or the modification of the trusts created by this Indenture, the Indenture Trustee will be entitled to receive, and subject to Sections 8.1 and 8.2, will be fully protected in
relying upon, an Opinion of Counsel to the effect that the execution of such supplemental indenture is authorized or 

  
 69 

 
permitted by this Indenture and that all conditions precedent to the execution and delivery of such supplemental indenture have been satisfied. The Indenture Trustee may, but is not obligated to,
enter into any such supplemental indenture that affects the Indenture Trustee’s own rights, powers, duties, obligations, liabilities or immunities under this Indenture or otherwise. 

Section 9.4. Effect of Supplemental Indenture. Upon the execution of any supplemental indenture pursuant to this Article IX, this
Indenture will be modified and amended in accordance with such supplemental indenture, and such supplemental indenture will be part of this Indenture for any and all purposes. Every Noteholder of Notes authenticated and delivered before or after
such supplemental indenture will be bound by such supplemental indenture. 
 Section 9.5. Reference in Notes to Supplemental
Indentures. Notes authenticated and delivered after the execution of any supplemental indenture pursuant to this Article IX may, and if required by the Indenture Trustee will, bear a notation as to any matter provided for in such supplemental
indenture. If the Issuer or the Indenture Trustee so determine, new Notes so modified as to conform, in the opinion of the Indenture Trustee and the Issuer, to any such supplemental indenture may be prepared and executed by the Issuer and
authenticated and delivered by the Indenture Trustee in exchange for Outstanding Notes. 
 Section 9.6. Indenture Trustee to
Consent. Neither the Issuer nor CCG, in its capacity as Servicer or Originator, will amend or modify any Transaction Document without the prior written consent of the Indenture Trustee to the extent the Indenture Trustee is a party to such
Transaction Document. 
 ARTICLE X 

SATISFACTION AND DISCHARGE 

Section 10.1. Satisfaction and Discharge of Indenture. 
  

	 	(a)	Subject to Section 10.1(b), this Indenture will cease to be of further effect with respect to the Notes, and the Indenture Trustee, upon Issuer Order and at the expense of the Issuer, will execute proper
instruments acknowledging satisfaction and discharge of this Indenture with respect to the Notes, if: 

  

	 	(i)	all Notes that have been authenticated and delivered (other than (x) Notes that have been destroyed, lost or stolen and that have been replaced or paid as provided in Section 3.7 and (y) Notes for whose
payment money has been deposited in trust or segregated and held in trust by the Issuer and thereafter repaid to the Issuer or discharged from such trust, as provided in Section 4.5(c)) have been delivered to the Indenture Trustee for
cancellation; 

  

	 	(ii)	the Issuer has paid or caused to be paid all other sums payable under the Transaction Documents by the Issuer; and 

  

	 	(iii)	the Issuer has delivered to the Indenture Trustee an Officer’s Certificate and an Opinion of Counsel, each to the effect that all conditions precedent relating to the satisfaction and discharge of this Indenture
pursuant to this Section 10.1(a) have been complied with. 

  
 70 

	 	(b)	After the satisfaction and discharge of this Indenture pursuant to Section 10.1(a), this Indenture will continue as to (i) rights of registration of transfer and exchange, (ii) replacement of mutilated,
destroyed, lost or stolen Notes, (iii) the rights of Noteholders to receive payments of principal of and interest on the Notes, (iv) the rights, obligations and immunities of the Indenture Trustee under this Indenture and (v) the
rights of the Noteholders as beneficiaries of this Indenture with respect to the property deposited with the Indenture Trustee payable to all or any of them for a period of two years following such satisfaction and discharge. 

 

	 	(c)	Upon the satisfaction and discharge of the Indenture pursuant to this Section 10.1, at the request of the Owner Trustee, the Indenture Trustee will deliver to the Owner Trustee a certificate of a Trustee Officer
stating that all Noteholders have been paid in full. 

 ARTICLE XI 

MISCELLANEOUS 
 Section 11.1.
Notices. Except as provided below, all communications and notices provided for hereunder shall be in writing (including facsimile or electronic transmission or similar writing) and shall be given to the other party at its address or facsimile
number set forth in Schedule II or at such other address or facsimile number as such party may hereafter specify for the purposes of notice to such party. Each such notice or other communication shall be effective (a) if given by facsimile,
when such facsimile is transmitted to the facsimile number specified in Schedule II and confirmation is received, (b) if given by mail, three (3) Business Days following such posting, if postage prepaid, and if sent via U.S. certified or
registered mail, (c) if given by overnight courier, one (1) Business Day after deposit thereof with a national overnight courier service, or (d) if given by any other means, when received at the address specified in Schedule II.
However, anything in this Section 11.1 to the contrary notwithstanding, the Issuer hereby authorizes the Indenture Trustee on behalf of the Noteholders to make investments in Eligible Investments based on telephonic notices made by any Person
which the Indenture Trustee or Noteholders in good faith believes to be acting on behalf of the Issuer subject to the policies of the Indenture Trustee. The Issuer agrees to deliver promptly to the Indenture Trustee a written confirmation of each
telephonic notice signed by an authorized officer of Issuer. However, the absence of such confirmation shall not affect the validity of such notice. If the written confirmation differs in any material respect from the action taken by Noteholders,
the records of such Noteholders shall govern. 
 Section 11.2. Governing Law; Submission to Jurisdiction. 

 

	 	(a)	 THIS INDENTURE SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK (WITHOUT REFERENCE TO THE CONFLICTS OF LAW
PRINCIPLES THEREOF OTHER THAN SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW). EACH OF THE ISSUER AND THE SERVICER HEREBY SUBMITS TO THE NONEXCLUSIVE JURISDICTION OF THE UNITED STATES DISTRICT COURT FOR THE

  
 71 

	 	
SOUTHERN DISTRICT OF NEW YORK AND OF ANY NEW YORK STATE COURT SITTING IN THE CITY OF NEW YORK FOR PURPOSES OF ALL LEGAL PROCEEDINGS ARISING OUT OF OR RELATING TO THIS INDENTURE, ANY OTHER
TRANSACTION DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH OF THE ISSUER AND THE SERVICER HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT IT MAY EFFECTIVELY DO SO, ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF
THE VENUE OF ANY SUCH PROCEEDING BROUGHT IN SUCH A COURT AND ANY CLAIM THAT ANY SUCH PROCEEDING BROUGHT IN SUCH A COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM. NOTHING IN THIS SECTION 11.2 SHALL AFFECT THE RIGHT OF THE NOTEHOLDERS TO BRING ANY
ACTION OR PROCEEDING AGAINST ANY OF THE ISSUER OR THE DEPOSITOR OR ANY OF THEIR RESPECTIVE PROPERTY IN THE COURTS OF OTHER JURISDICTIONS. 

  

	 	(b)	EACH OF THE PARTIES HERETO HEREBY WAIVES ANY RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE, WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE, AMONG ANY OF THEM ARISING OUT OF, CONNECTED WITH, RELATING TO OR
INCIDENTAL TO THE RELATIONSHIP BETWEEN THEM IN CONNECTION WITH THIS INDENTURE OR THE OTHER TRANSACTION DOCUMENTS. 

Section 11.3. Integration. This Indenture contains the final and complete integration of all prior expressions by the parties
hereto with respect to the subject matter hereof and shall constitute the entire agreement among the parties hereto with respect to the subject matter hereof superseding all prior oral or written understandings. 

Section 11.4. Severability of Provisions. If any one or more of the provisions of this Indenture shall for any reason whatsoever
be held invalid, then such provisions shall be deemed severable from the remaining provisions of this Indenture and shall in no way affect the validity or enforceability of such other provisions. 

Section 11.5. Counterparts; Facsimile Delivery. This Indenture may be executed in any number of counterparts and by different
parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same Indenture. Delivery by facsimile or other electronic transmission (i.e.,
“pdf” or “tif”) of an executed signature page of this Indenture shall be effective as delivery of an executed counterpart hereof. 

Section 11.6. Headings. The headings in this Indenture are included for convenience only and will not affect the meaning or
interpretation of this Indenture. 
 Section 11.7. Issuer Obligation. No recourse may be taken, directly or indirectly, with
respect to the obligations of the Issuer, the Owner Trustee or the Indenture Trustee on the Notes or under this Indenture or any certificate or other writing delivered in connection with this 

  
 72 

 
Indenture or the Notes, against (a) the Indenture Trustee or the Owner Trustee each in its individual capacities, (b) any holder of a beneficial interest in the Issuer, (c) any
partner, owner, beneficiary, agent, officer, director, employee or agent of the Indenture Trustee or the Owner Trustee, each in its individual capacity or (d) any holder of a beneficial interest in the Owner Trustee or the Indenture Trustee,
each in its individual capacity, except as any such Person may have agreed (it being understood that the Indenture Trustee and the Owner Trustee have no such obligations in their individual capacities). It is expressly understood and agreed by the
parties hereto that (a) this Indenture is executed and delivered by Wilmington Trust, National Association, not individually or personally, but solely as Owner Trustee of the Issuer under the Trust Agreement, in the exercise of the powers and
authority conferred and vested in it, (b) each of the representations, undertakings and agreements herein made on the part of the Issuer is made and intended not as a personal representation, undertaking and agreement by Wilmington Trust,
National Association but is made and intended for the purpose of binding only the Issuer, (c) nothing herein contained shall be construed as creating any liability on Wilmington Trust, National Association, individually or personally, to
perform any covenant either expressed or implied contained herein, all such liability, if any, being expressly waived by the parties hereto and by any Person claiming by, through or under the parties hereto, (d) Wilmington Trust, National
Association has made no investigation as to the accuracy or completeness of any representations and warranties made by the Issuer in this Indenture and (e) under no circumstances shall Wilmington Trust, National Association be personally liable
for the payment of any indebtedness or expenses of the Issuer or be liable for the breach or failure of any obligation, representation, warranty or covenant made or undertaken by the Issuer under this Indenture or the other Transaction Documents.

 Section 11.8. Subordination of Claims against the Depositor. 

 

	 	(a)	 The obligations of the Issuer under this Indenture are solely the obligations of the Issuer and do not represent any obligation or interest in any
assets of the Depositor. The Indenture Trustee, by entering into this Indenture, and each Noteholder and Note Owner, by accepting a Note or a beneficial interest in a Note, acknowledge and agree that they have no right, title or interest in or to
any Other Assets of the Depositor. Notwithstanding the preceding sentence, if such Indenture Trustee, Noteholder or Note Owner either (i) asserts an interest or claim to, or benefit from, the Other Assets, or (ii) is deemed to have any
such interest, claim to, or benefit in or from the Other Assets, whether by operation of law, legal process, pursuant to insolvency laws or otherwise (including by virtue of Section 1111(b) of the Bankruptcy Code), then such Indenture Trustee,
Noteholder or Note Owner further acknowledges and agrees that any such interest, claim or benefit in or from the Other Assets is expressly subordinated to the indefeasible payment in full of the other obligations and liabilities, which, under the
relevant documents relating to the securitization or conveyance of such Other Assets, are entitled to be paid from, entitled to the benefits of, or otherwise secured by such Other Assets (whether or not any such entitlement or security interest is
legally perfected or otherwise entitled to a priority of distributions or application under applicable law, including insolvency laws, and whether or not asserted against the Depositor), including the payment of post-petition interest on such other
obligations and liabilities. This subordination agreement is deemed a 

  
 73 

	 	
subordination agreement within the meaning of Section 510(a) of the Bankruptcy Code. The Indenture Trustee, each Noteholder and each Note Owner further acknowledges and agrees that no
adequate remedy at law exists for a breach of this Section 11.8 and this Section 11.8 may be enforced by an action for specific performance. 

  

	 	(b)	This Section 11.8 is for the third party benefit of those entitled to rely on this Section 11.8 and will survive the termination of this Indenture. 

Section 11.9. Non-Petition. The Indenture Trustee and each Noteholder or Note Owner, by accepting a Note or a beneficial interest
in a Note, each covenants and agrees that it will not institute against, or join any other Person in instituting against, the Depositor or the Issuer, respectively, any bankruptcy, reorganization, arrangement, insolvency or liquidation proceedings
or other proceedings under any federal or State bankruptcy or similar law in connection with any obligations relating to the Notes, this Indenture or any of the Transaction Documents. This Section 11.9 will survive the resignation or removal of
the Indenture Trustee under this Indenture and the termination of this Indenture. 
 [Remainder of Page Intentionally Left Blank] 

  
 74 

 IN WITNESS WHEREOF, the parties hereto have executed and delivered this Indenture as of the date
first written above. 
  

					
	CCG RECEIVABLES TRUST 2014-1,
			as Issuer
		
	By:		Wilmington Trust, National Association, not in its individual capacity but solely as Owner Trustee of CCG Receivables Trust 2014-1
		
	By:		/s/ Jennifer A. Luce
		 	  

			Name:		Jennifer A. Luce
			Title:		Vice President
	
	U.S. BANK NATIONAL ASSOCIATION,
			not in its individual capacity but solely as Indenture Trustee
		
	By:		/s/ Toby Robillard
		 	  

			Name:		Toby Robillard
			Title:		Vice President

 [Signature Page to Indenture] 

 SCHEDULE I 

Schedule of Pool Receivables 

[see attached] 

  
 SI-1 

											
	Customer #	 	Contract #	 	Customer #	 	Contract #	 	Customer #	 	Contract #
	1106	 	205281001	 	39	 	1C09091305	 	2184	 	1T05311301
	1932	 	209281206	 	1546	 	1C09101301	 	2224	 	1T06051302
	1075	 	303311006	 	2515	 	1C09101304	 	2044	 	1T06111302
	1454	 	305251202	 	2527	 	1C09181301	 	2273	 	1T06111303
	1786	 	305311205	 	2101	 	1C09241301	 	2283	 	1T06191302
	760	 	306151201	 	2545	 	1C09271301	 	2295	 	1T06251301
	65	 	307301004	 	1190	 	1C10071301	 	1457	 	1T06281302
	173	 	309281203	 	1307	 	1C10171301	 	1710	 	1T07021301
	1100	 	311051002	 	1307	 	1C10171302	 	2313	 	1T07101301
	300299	 	1C01071401	 	300048	 	1C10221301	 	2309	 	1T07111301
	300426	 	1C02191401	 	1857	 	1C10241301	 	2184	 	1T07121301
	1726	 	1C02261401	 	1857	 	1C10241302	 	1988	 	1T07151301
	1149	 	1C04091301	 	300035	 	1C10301301	 	1481	 	1T07181301
	2179	 	1C04111301	 	300098	 	1C10301305	 	1623	 	1T07181302
	1767	 	1C04121301	 	300098	 	1C10301307	 	2180	 	1T07231301
	2064	 	1C04151301	 	300092	 	1C10311302	 	2333	 	1T07301303
	2022	 	1C04151302	 	18	 	1C10311303	 	589	 	1T08021301
	2187	 	1C04161301	 	2128	 	1C11011302	 	1951	 	1T08201301
	39	 	1C04221301	 	1644	 	1C11041301	 	2303	 	1T08201303
	2089	 	1C04221302	 	300118	 	1C11071301	 	2474	 	1T08271302
	2211	 	1C05021301	 	2257	 	1C11141301	 	2173	 	1T09031301
	1857	 	1C05161304	 	1507	 	1C11151301	 	2173	 	1T09031302
	1738	 	1C06031301	 	300155	 	1C11151302	 	2275	 	1T09041301
	1397	 	1C06071301	 	1750	 	1C11271201	 	1892	 	1T09041302
	2043	 	1C06261302	 	300185	 	1C12041301	 	2226	 	1T09041303
	1546	 	1C06271301	 	300190	 	1C12051301	 	2508	 	1T09091301
	2307	 	1C06281301	 	300191	 	1C12051302	 	2534	 	1T09201301
	2257	 	1C06281302	 	615	 	1C12061301	 	14	 	1T09231301
	916	 	1C07021301	 	300214	 	1C12161302	 	2284	 	1T09251301
	2319	 	1C07161301	 	300227	 	1T01141401	 	2552	 	1T09271301
	2322	 	1C07191302	 	1759	 	1T01281401	 	2240	 	1T10041301
	2101	 	1C07241301	 	1257	 	1T01291401	 	792	 	1T10111301
	1441	 	1C07291302	 	470	 	1T02111301	 	300020	 	1T10151301
	1499	 	1C08051301	 	300462	 	1T02261402	 	2280	 	1T10221301
	2237	 	1C08051302	 	2123	 	1T03291301	 	300046	 	1T10241302
	2457	 	1C08121301	 	2062	 	1T04171301	 	2239	 	1T10251301
	2463	 	1C08161301	 	1257	 	1T04251301	 	1645	 	1T10291301
	2467	 	1C08201301	 	722	 	1T04251302	 	300084	 	1T10311301
	2468	 	1C08211301	 	2184	 	1T04261302	 	2240	 	1T11051303
	2470	 	1C08221301	 	2184	 	1T05061301	 	2184	 	1T11061301
	1371	 	1C08271301	 	1892	 	1T05061302	 	300137	 	1T11141301
	1371	 	1C08271302	 	2224	 	1T05101301	 	300129	 	1T11141302
	2496	 	1C08301302	 	2173	 	1T05161301	 	2	 	1T11151301
	39	 	1C09091304	 	1257	 	1T05171301	 	300136	 	1T11181301

  
 SI-2 

											
	Customer #	 	Contract #	 	Customer #	 	Contract #	 	Customer #	 	Contract #
	1751	 	1T11191301	 	1020	 	2W05211301	 	2504	 	2W09091303
	300156	 	1T11211301	 	1471	 	2W05231302	 	2511	 	2W09101301
	300166	 	1T11251301	 	1897	 	2W05281302	 	845	 	2W09111301
	300176	 	1T11251302	 	261	 	2W05291301	 	982	 	2W09111304
	2023	 	1T11261301	 	1849	 	2W05291304	 	2520	 	2W09161301
	300162	 	1T11261302	 	1616	 	2W05311301	 	883	 	2W09161302
	2117	 	1T12021301	 	2262	 	2W06031301	 	1762	 	2W09171301
	2226	 	1T12051301	 	2235	 	2W06041301	 	2136	 	2W09201303
	2284	 	1T12061301	 	896	 	2W06071303	 	783	 	2W09241302
	2184	 	1T12061302	 	294	 	2W06101301	 	1749	 	2W09271304
	300195	 	1T12091301	 	2277	 	2W06141301	 	2292	 	2W09301301
	300201	 	1T12101301	 	2287	 	2W06191301	 	896	 	2W09301302
	300200	 	1T12101302	 	2288	 	2W06201302	 	1591	 	2W09301306
	1988	 	1T12111301	 	2294	 	2W06241302	 	300029	 	2W10111301
	300205	 	1T12121301	 	1233	 	2W06261302	 	2516	 	2W10161301
	2024	 	1T12191301	 	1849	 	2W06271301	 	1301	 	2W10181301
	896	 	2W01131401	 	2298	 	2W06271302	 	646	 	2W10231303
	300375	 	2W01301403	 	2299	 	2W06271303	 	1931	 	2W10231304
	2096	 	2W02251302	 	1897	 	2W06271305	 	1931	 	2W10231305
	300497	 	2W02281402	 	2305	 	2W06281302	 	1931	 	2W10231306
	300506	 	2W03031401	 	1587	 	2W06281303	 	1682	 	2W10251301
	300502	 	2W03031402	 	1240	 	2W06281305	 	349	 	2W10251302
	300505	 	2W03031403	 	2308	 	2W06281308	 	1531	 	2W10251303
	598	 	2W03211301	 	2317	 	2W07121301	 	1427	 	2W10291302
	1346	 	2W03271302	 	2316	 	2W07121302	 	300091	 	2W10301302
	2158	 	2W03281301	 	1189	 	2W07221301	 	1085	 	2W10301304
	2152	 	2W03281302	 	1033	 	2W07261301	 	955	 	2W10301307
	1189	 	2W03291301	 	2516	 	2W07301301	 	1737	 	2W11011301
	1533	 	2W03291302	 	1136	 	2W07301302	 	300106	 	2W11041301
	1732	 	2W04021301	 	1395	 	2W07301304	 	300016	 	2W11081303
	267	 	2W04031301	 	2334	 	2W07301305	 	1448	 	2W11121301
	2172	 	2W04041301	 	2321	 	2W08021301	 	300138	 	2W11151301
	2175	 	2W04051303	 	2444	 	2W08051302	 	300140	 	2W11191303
	300293	 	2W04101403	 	2445	 	2W08051303	 	300143	 	2W11191304
	1442	 	2W04181301	 	719	 	2W08121301	 	300029	 	2W11201303
	89	 	2W04231301	 	1897	 	2W08291301	 	1305	 	2W11201305
	1395	 	2W04241301	 	89	 	2W08291302	 	300145	 	2W11211301
	409	 	2W04261301	 	51	 	2W08301303	 	300178	 	2W11271302
	2201	 	2W04261303	 	2080	 	2W08301304	 	300169	 	2W11271304
	1921	 	2W04291302	 	1851	 	2W08301305	 	1799	 	2W11271306
	2119	 	2W05011303	 	521	 	2W08301306	 	445	 	2W11291302
	521	 	2W05021302	 	2497	 	2W09031301	 	300187	 	2W12041301
	2080	 	2W05061302	 	2164	 	2W09061301	 	300039	 	2W12041302
	2223	 	2W05101302	 	187	 	2W09061302	 	1199	 	2W12051301
	1897	 	2W05171302	 	2509	 	2W09091301	 	300189	 	2W12051302

  
 SI-2 

											
	Customer #	 	Contract #	 	Customer #	 	Contract #	 	Customer #	 	Contract #
	300202	 	2W12121301	 	1398	 	3C12161301	 	2255	 	3T06201302
	2031	 	2W12121302	 	308	 	3C12171301	 	1321	 	3T06211301
	1897	 	2W12141202	 	2594	 	3C12191301	 	1875	 	3T06241301
	1392	 	2W12141204	 	2603	 	3C12311301	 	2291	 	3T06241302
	300123	 	2W12161302	 	744	 	3T01241402	 	1553	 	3T06241304
	300240	 	2W12231301	 	1832	 	3T01301401	 	2026	 	3T06261301
	13	 	2W12241301	 	2289	 	3T02241402	 	1320	 	3T06261304
	51	 	2W12281207	 	300467	 	3T02271402	 	2300	 	3T06271301
	1392	 	2W12301302	 	182	 	3T02281403	 	2274	 	3T06281302
	1667	 	3C01311407	 	1009	 	3T03181301	 	1841	 	3T06281304
	2093	 	3C02251301	 	2165	 	3T04011302	 	1388	 	3T06281305
	999	 	3C02271302	 	2168	 	3T04031301	 	1654	 	3T07111302
	300498	 	3C02281403	 	2178	 	3T04101301	 	1832	 	3T07161302
	2121	 	3C03211301	 	1819	 	3T04121301	 	1850	 	3T07231301
	1382	 	3C04041301	 	2182	 	3T04151301	 	2242	 	3T07291301
	308	 	3C04191301	 	1813	 	3T04151302	 	1571	 	3T07301302
	2204	 	3C04291301	 	2183	 	3T04151303	 	2242	 	3T08061301
	473	 	3C04291302	 	1278	 	3T04161302	 	1875	 	3T08151301
	684	 	3C04301301	 	736	 	3T04251301	 	2462	 	3T08151302
	2110	 	3C05141301	 	1638	 	3T04251302	 	2469	 	3T08221301
	993	 	3C05201301	 	1927	 	3T04251304	 	2478	 	3T08271301
	993	 	3C05201302	 	2203	 	3T04291302	 	2479	 	3T08271304
	2195	 	3C05221301	 	2206	 	3T04301302	 	2490	 	3T08291301
	2260	 	3C06051301	 	2206	 	3T04301306	 	1069	 	3T08291303
	2264	 	3C06071301	 	2053	 	3T05021301	 	961	 	3T08291306
	2266	 	3C06171301	 	2026	 	3T05021303	 	2489	 	3T08291310
	1990	 	3C06271301	 	2218	 	3T05091301	 	2501	 	3T08301303
	2451	 	3C08091301	 	1781	 	3T05101302	 	1969	 	3T08301305
	2477	 	3C08271301	 	2138	 	3T05171303	 	2254	 	3T08301306
	2487	 	3C08291301	 	2084	 	3T05221303	 	1832	 	3T09051301
	2499	 	3C08301301	 	2241	 	3T05231302	 	1819	 	3T09091302
	2502	 	3C08301303	 	2241	 	3T05231303	 	2480	 	3T09101301
	1748	 	3C09111302	 	1553	 	3T05311301	 	2145	 	3T09181303
	2256	 	3C09301302	 	2102	 	3T05311302	 	2488	 	3T09231301
	2487	 	3C11051301	 	2259	 	3T06051302	 	2255	 	3T09271303
	2110	 	3C11061301	 	2259	 	3T06051304	 	1813	 	3T09271304
	1425	 	3C11081301	 	2218	 	3T06061301	 	2199	 	3T09301302
	1171	 	3C11191301	 	2267	 	3T06101301	 	2247	 	3T09301305
	1928	 	3C11201301	 	1363	 	3T06121303	 	2558	 	3T10151301
	2578	 	3C11221301	 	2274	 	3T06141301	 	1553	 	3T10221302
	2581	 	3C11261301	 	2183	 	3T06141304	 	2488	 	3T10251302
	2578	 	3C11261302	 	960	 	3T06171301	 	701	 	3T10281301
	993	 	3C11301202	 	1278	 	3T06171302	 	1956	 	3T10281303
	2589	 	3C12051301	 	2281	 	3T06181301	 	1956	 	3T10281304
	2006	 	3C12101301	 	1786	 	3T06191301	 	2248	 	3T10311303

  
 SI-3 

											
	Customer #	 	Contract #	 	Customer #	 	Contract #	 	Customer #	 	Contract #
	2011	 	3T10311304	 	2054	 	4C08281302	 	300317	 	5T01171401
	1983	 	3T10311309	 	2495	 	4C08301301	 	300326	 	5T01221401
	2567	 	3T11051301	 	2533	 	4C09161301	 	300474	 	5T02271403
	1746	 	3T11071202	 	2525	 	4C09171301	 	300519	 	5T03101402
	2571	 	3T11081301	 	2532	 	4C09181302	 	300548	 	5T03171403
	2255	 	3T11131301	 	2013	 	4C09191303	 	300474	 	5T03211401
	2573	 	3T11141301	 	2555	 	4C10031301	 	2126	 	5T03261402
	2574	 	3T11181301	 	2135	 	4C10151301	 	300521	 	5T03311402
	2577	 	3T11181302	 	1674	 	4C10231301	 	1989	 	5T04291302
	2576	 	3T11191301	 	2054	 	4C10311301	 	2181	 	5T05231301
	1008	 	3T11261301	 	2048	 	4C10311304	 	2453	 	5T08091301
	2580	 	3T11261303	 	1155	 	4C11211303	 	2481	 	5T08271301
	1009	 	3T11261305	 	300183	 	4C11291301	 	2155	 	5T08301301
	2582	 	3T11271303	 	300192	 	4C12061301	 	1989	 	5T08301303
	2587	 	3T12031301	 	300078	 	4C12231301	 	1943	 	5T09201301
	2588	 	3T12041301	 	2039	 	4C12261303	 	2536	 	5T09241301
	2026	 	3T12041302	 	300292	 	4C12311302	 	2537	 	5T09241302
	2562	 	3T12091301	 	300292	 	4C12311304	 	2514	 	5T10081301
	958	 	3T12111301	 	2258	 	4T06041301	 	2181	 	5T10311303
	2591	 	3T12121301	 	2318	 	4T07161301	 	2568	 	5T11051301
	2182	 	3T12121302	 	2338	 	4T07311302	 	2575	 	5T11191302
	2595	 	3T12191302	 	2483	 	4T08281301	 	2551	 	5T11201301
	1889	 	4C01301401	 	2454	 	4T08291301	 	1943	 	5T12121301
	1889	 	4C01301402	 	2338	 	4T08301302	 	2592	 	5T12131302
	1889	 	4C01301404	 	2144	 	4T10281301	 	2605	 	5T12311304
	1885	 	4C03291301	 	2337	 	4T10311302	 	18	 	105041201
	2019	 	4C04011301	 	300107	 	4T11041301	 	1315	 	105161104
	2169	 	4C04031301	 	300133	 	4T11131301	 	375	 	107061201
	2170	 	4C04041301	 	300132	 	4T11141302	 	1505	 	108101101
	1878	 	4C04111403	 	300107	 	4T11191301	 	1479	 	108151101
	1795	 	4C04151301	 	2529	 	4T11211302	 	39	 	108231101
	1816	 	4C04231301	 	2337	 	4T11211303	 	1	 	108301201
	2194	 	4C04251301	 	300107	 	4T12041301	 	1140	 	111021101
	2209	 	4C04301301	 	300198	 	4T12091301	 	1608	 	111231103
	1878	 	4C05151301	 	300198	 	4T12091302	 	845	 	206081101
	1776	 	4C06071301	 	300102	 	4T12101301	 	1802	 	206131201
	2276	 	4C06131301	 	300102	 	4T12131301	 	1395	 	206131203
	1677	 	4C06181301	 	300212	 	4T12161301	 	217	 	307141001
	2301	 	4C06261301	 	300531	 	5C03141401	 	1189	 	206291103
	2048	 	4C06281305	 	2290	 	5C06201301	 	1482	 	207211101
	2306	 	4C06281306	 	1943	 	5C06251301	 	1199	 	209141203
	1478	 	4C07221301	 	2452	 	5C08091302	 	783	 	212011103
	2336	 	4C07311303	 	2517	 	5C09121301	 	1395	 	212221104
	2464	 	4C08201302	 	2565	 	5C10311301	 	1649	 	212291102
	2054	 	4C08231301	 	2590	 	5C12101301	 	827	 	302251001

  
 SI-4 

											
	Customer #	 	Contract #	 	Customer #	 	Contract #	 	Customer #	 	Contract #
	723	 	305111001	 	2278	 	1C06141301	 	300034	 	1T01081401
	1772	 	305161203	 	1782	 	1C06191301	 	2280	 	1T01161401
	1446	 	306201101	 	2307	 	1C07181301	 	300200	 	1T01231401
	1446	 	306281103	 	1275	 	1C07221301	 	1828	 	1T01231402
	1204	 	306301107	 	1370	 	1C07231301	 	300136	 	1T01241402
	1470	 	307121101	 	2331	 	1C08011302	 	1759	 	1T01281402
	1156	 	307181104	 	2465	 	1C08191301	 	2303	 	1T01281403
	402	 	308271006	 	2485	 	1C08281301	 	300462	 	1T02261401
	1523	 	308301102	 	2496	 	1C08301303	 	300499	 	1T03031401
	1529	 	308311106	 	1307	 	1C09061301	 	2123	 	1T03111301
	1579	 	310241104	 	2510	 	1C09091301	 	2139	 	1T03181301
	778	 	311221101	 	39	 	1C09091302	 	300583	 	1T03241401
	1570	 	311291105	 	1149	 	1C09101302	 	2184	 	1T03261401
	1582	 	312061101	 	2021	 	1C09101303	 	2173	 	1T04051301
	1368	 	312091101	 	2514	 	1C09111301	 	1869	 	1T04101302
	1274	 	312151102	 	2101	 	1C09241302	 	1	 	1T04111301
	1171	 	312191102	 	2307	 	1C09271302	 	2180	 	1T04111302
	1574	 	312211103	 	2546	 	1C09271303	 	2184	 	1T04161301
	1835	 	407131201	 	2179	 	1C10011301	 	2072	 	1T04301301
	1874	 	408241201	 	300008	 	1C10031301	 	2212	 	1T05021301
	1358	 	412211101	 	1371	 	1C10101301	 	2216	 	1T05071301
	1560	 	1C01071402	 	300015	 	1C10111301	 	2226	 	1T05131301
	1595	 	1C01081401	 	300018	 	1C10111302	 	2224	 	1T05231301
	444	 	1C01101401	 	300026	 	1C10151301	 	1879	 	1T05241301
	300256	 	1C01141401	 	1441	 	1C10151302	 	722	 	1T05281301
	300008	 	1C01151401	 	1307	 	1C10171303	 	2280	 	1T06181301
	1149	 	1C01171301	 	300037	 	1C10171304	 	2273	 	1T06281301
	300324	 	1C01221401	 	300035	 	1C10181301	 	2303	 	1T06281304
	300035	 	1C01271401	 	300056	 	1C10251301	 	2309	 	1T06281305
	300352	 	1C01291402	 	324	 	1C10281302	 	1257	 	1T06281306
	2063	 	1C02051301	 	300098	 	1C10301303	 	1481	 	1T07011301
	2074	 	1C02061301	 	300098	 	1C10301306	 	2184	 	1T07091301
	1995	 	1C02211301	 	2124	 	1C11111301	 	1583	 	1T07261301
	39	 	1C02221303	 	1371	 	1C11211301	 	1892	 	1T07261302
	2022	 	1C02261301	 	1981	 	1C11261202	 	2330	 	1T07291301
	1549	 	1C03051301	 	2101	 	1C12131203	 	2442	 	1T08021302
	1316	 	1C03251401	 	2278	 	1C12181302	 	2461	 	1T08141301
	2151	 	1C03271301	 	300008	 	1C12181303	 	14	 	1T08291301
	2197	 	1C04251301	 	300225	 	1C12181304	 	1481	 	1T08291302
	1316	 	1C05161301	 	300253	 	1C12201301	 	1787	 	1T09031303
	1144	 	1C05201304	 	300242	 	1C12241301	 	2482	 	1T09051301
	1397	 	1C05201305	 	300270	 	1C12301304	 	2521	 	1T09161302
	2237	 	1C05211301	 	2486	 	1C12301305	 	2530	 	1T09191301
	1546	 	1C05211302	 	589	 	1T01031402	 	1710	 	1T09301301
	1584	 	1C06101301	 	1710	 	1T01071301	 	300011	 	1T10081301

  
 SI-5 

											
	Customer #	 	Contract #	 	Customer #	 	Contract #	 	Customer #	 	Contract #
	300012	 	1T10081303	 	1818	 	2W04241302	 	2296	 	2W09271305
	1257	 	1T10151302	 	1897	 	2W04241303	 	300039	 	2W10111302
	2224	 	1T10231301	 	1085	 	2W05011301	 	1849	 	2W10221301
	2173	 	1T10231302	 	2210	 	2W05021301	 	1931	 	2W10231307
	300105	 	1T11041301	 	2222	 	2W05101301	 	1931	 	2W10231308
	2062	 	1T11051301	 	2223	 	2W05101303	 	1931	 	2W10231309
	1257	 	1T11071201	 	2229	 	2W05151301	 	1736	 	2W10241301
	1892	 	1T11131301	 	1199	 	2W05171304	 	300051	 	2W10241302
	14	 	1T11141303	 	89	 	2W05281303	 	508	 	2W10281301
	300160	 	1T11191302	 	261	 	2W05291302	 	300089	 	2W10301306
	2295	 	1T11201301	 	409	 	2W05301301	 	300085	 	2W10311302
	300238	 	1T12231301	 	1189	 	2W05311302	 	366	 	2W10311304
	300138	 	2W01061401	 	1189	 	2W06071301	 	51	 	2W10311305
	2320	 	2W01081401	 	51	 	2W06111301	 	1855	 	2W11051301
	300303	 	2W01091401	 	294	 	2W06141302	 	51	 	2W11071302
	2320	 	2W01101401	 	1390	 	2W06141303	 	1297	 	2W11211302
	347	 	2W01101403	 	1732	 	2W06201301	 	1516	 	2W11221301
	300202	 	2W01141402	 	1799	 	2W06211301	 	300172	 	2W11271301
	51	 	2W01211401	 	2292	 	2W06241303	 	1511	 	2W12171202
	1448	 	2W01241401	 	1794	 	2W06261301	 	1233	 	2W12191203
	1897	 	2W01251303	 	1897	 	2W06271306	 	300231	 	2W12191301
	300169	 	2W01271401	 	89	 	2W06281306	 	725	 	2W12201301
	300351	 	2W01281403	 	1749	 	2W06281311	 	521	 	2W12281208
	2061	 	2W01291302	 	2310	 	2W07021301	 	300262	 	2W12301301
	300360	 	2W01301401	 	1640	 	2W07181301	 	1531	 	2W12301311
	1975	 	2W01301404	 	2235	 	2W07191301	 	300283	 	2W12311301
	1255	 	2W01311301	 	1762	 	2W07191302	 	2563	 	3C01021401
	1395	 	2W02061301	 	1240	 	2W07191303	 	2020	 	3C01131401
	1033	 	2W02111401	 	2332	 	2W07301306	 	2578	 	3C01211401
	2080	 	2W02131302	 	21	 	2W08021302	 	1372	 	3C03051401
	1033	 	2W02191301	 	2288	 	2W08061301	 	2121	 	3C03111301
	2119	 	2W03071301	 	2455	 	2W08091301	 	365	 	3C03171401
	1063	 	2W03071403	 	693	 	2W08121303	 	473	 	3C03191301
	1063	 	2W03071404	 	2494	 	2W08221301	 	626	 	3C03241401
	2129	 	2W03121301	 	2148	 	2W08231301	 	1383	 	3C03261402
	2085	 	2W03211302	 	1471	 	2W08261303	 	2006	 	3C04031301
	300584	 	2W03211401	 	409	 	2W08281301	 	2174	 	3C04051302
	1066	 	2W03241402	 	349	 	2W08281302	 	1748	 	3C04251301
	1199	 	2W03251402	 	896	 	2W08301301	 	2207	 	3C04301303
	2149	 	2W03271301	 	2445	 	2W09041301	 	2208	 	3C04301304
	1849	 	2W04011302	 	2518	 	2W09121301	 	907	 	3C05031301
	2012	 	2W04021302	 	2535	 	2W09201301	 	2236	 	3C05211301
	2167	 	2W04021303	 	896	 	2W09241301	 	993	 	3C05211302
	646	 	2W04151301	 	524	 	2W09241303	 	2238	 	3C05221302
	1572	 	2W04221301	 	2544	 	2W09271303	 	2256	 	3C05311301

  
 SI-6 

											
	Customer #	 	Contract #	 	Customer #	 	Contract #	 	Customer #	 	Contract #
	2270	 	3C06111302	 	2232	 	3T05171301	 	1666	 	3T10151303
	2304	 	3C06281301	 	1363	 	3T05201301	 	1908	 	3T10221301
	2329	 	3C07261301	 	1713	 	3T05221302	 	1009	 	3T10281302
	1118	 	3C07291301	 	2241	 	3T05231304	 	2469	 	3T10311301
	2335	 	3C07301301	 	2218	 	3T05231305	 	2469	 	3T10311302
	684	 	3C08131301	 	2242	 	3T05231306	 	1777	 	3T10311305
	2477	 	3C08271302	 	1571	 	3T05241302	 	2255	 	3T10311308
	2502	 	3C08301302	 	2247	 	3T05281301	 	2083	 	3T11011301
	2505	 	3C09041301	 	2248	 	3T05281302	 	1746	 	3T11071203
	2459	 	3C09091301	 	2254	 	3T05301301	 	2026	 	3T11121302
	2556	 	3C10091301	 	2102	 	3T05311303	 	2145	 	3T11151301
	2556	 	3C10091302	 	2259	 	3T06051303	 	2577	 	3T11181303
	2561	 	3C10211301	 	1904	 	3T06071301	 	2267	 	3T11211301
	1990	 	3C10241301	 	2274	 	3T06121301	 	1008	 	3T11261302
	173	 	3C10311301	 	2183	 	3T06141303	 	827	 	3T11261304
	1118	 	3C11151301	 	1321	 	3T06241305	 	2583	 	3T11271301
	2093	 	3C11201302	 	2289	 	3T06261302	 	1321	 	3T11271302
	2578	 	3C11211302	 	1320	 	3T06261303	 	1998	 	3T12071201
	2598	 	3C12271301	 	2274	 	3T06281301	 	2577	 	3T12191301
	300325	 	3T01221401	 	1654	 	3T07111301	 	2599	 	3T12271302
	2051	 	3T01251301	 	2146	 	3T07161301	 	2577	 	3T12271303
	2138	 	3T01281401	 	1553	 	3T07181301	 	1015	 	3T12311302
	958	 	3T01281402	 	1781	 	3T07221301	 	2078	 	4C02121302
	300353	 	3T01291401	 	2274	 	3T07291302	 	1353	 	4C03241402
	300359	 	3T01291403	 	1813	 	3T07311301	 	2161	 	4C03291303
	1937	 	3T02261301	 	736	 	3T07311304	 	2114	 	4C04181301
	2102	 	3T02271304	 	2274	 	3T08051301	 	1878	 	4C04241301
	2034	 	3T03191301	 	2472	 	3T08231301	 	2054	 	4C04261301
	1786	 	3T03261401	 	2053	 	3T08271302	 	2215	 	4C05061301
	2165	 	3T04011303	 	1786	 	3T08271303	 	2209	 	4C05071301
	2185	 	3T04161301	 	2491	 	3T08291305	 	2144	 	4C05161301
	2186	 	3T04161304	 	1278	 	3T08291307	 	2234	 	4C05171301
	1927	 	3T04191302	 	2267	 	3T08291308	 	1776	 	4C05221301
	1850	 	3T04191303	 	1819	 	3T08301301	 	2250	 	4C05231303
	2034	 	3T04241301	 	2500	 	3T08301302	 	1669	 	4C05301301
	1952	 	3T04251303	 	2507	 	3T09091301	 	2048	 	4C06281303
	2198	 	3T04261301	 	736	 	3T09091303	 	2324	 	4C07191301
	2202	 	3T04291301	 	1815	 	3T09171301	 	2328	 	4C07251302
	1875	 	3T04301301	 	2523	 	3T09181302	 	1885	 	4C08081301
	2206	 	3T04301303	 	2488	 	3T09231302	 	2464	 	4C08201301
	1819	 	3T05021302	 	2102	 	3T09251301	 	2471	 	4C08221301
	1786	 	3T05061301	 	1253	 	3T09271302	 	1203	 	4C09271301
	2220	 	3T05091303	 	2199	 	3T09301303	 	300076	 	4C10241301
	1781	 	3T05101301	 	1777	 	3T10101303	 	300070	 	4C10291302
	960	 	3T05151301	 	701	 	3T10111301	 	1816	 	4C11121301

  
 SI-7 

											
	Customer #	 	Contract #	 	Customer #	 	Contract #	 	Customer #	 	Contract #
	300174	 	4C11271301	 	2181	 	5T09171301	 	669	 	106071201
	1968	 	4C11301201	 	2540	 	5T09251301	 	1801	 	106131201
	2039	 	4C12261305	 	2559	 	5T10171301	 	1622	 	106211203
	1878	 	4C12311301	 	2566	 	5T10311301	 	1787	 	107021201
	300198	 	4T01101401	 	2452	 	5T10311302	 	1826	 	107021202
	2245	 	4T01171401	 	2575	 	5T11191301	 	537	 	107271202
	300320	 	4T01211402	 	2575	 	5T11191304	 	39	 	107280901
	300320	 	4T01211403	 	2593	 	5T12181301	 	282	 	107301201
	300320	 	4T01211405	 	2604	 	5T12311301	 	1210	 	107311201
	300198	 	4T01211406	 	2579	 	5T12311302	 	1502	 	108041102
	300361	 	4T01301402	 	1678	 	101301202	 	1858	 	108091201
	300580	 	4T03211401	 	282	 	102091201	 	1861	 	108141201
	300577	 	4T03211404	 	1691	 	102161201	 	1879	 	108301202
	2483	 	4T03211405	 	1696	 	102211201	 	1881	 	108311202
	2318	 	4T03261401	 	1693	 	102211202	 	18	 	109101201
	1806	 	4T05141301	 	1	 	102211203	 	1149	 	109181202
	2244	 	4T05231301	 	1694	 	102221201	 	1549	 	109271101
	2245	 	4T05241301	 	572	 	102241202	 	615	 	110211101
	2337	 	4T07311301	 	1660	 	102271201	 	1186	 	110241103
	2454	 	4T08091301	 	1441	 	102281201	 	1481	 	112271101
	2528	 	4T09161302	 	1	 	102281202	 	1403	 	201101201
	2529	 	4T09181301	 	1247	 	102281204	 	160	 	201171201
	2553	 	4T10021301	 	1520	 	102291201	 	415	 	201171203
	2553	 	4T10031301	 	1704	 	102291202	 	1448	 	202031201
	300080	 	4T10301302	 	1718	 	103021201	 	397	 	202061201
	300061	 	4T11211304	 	1316	 	103121201	 	1682	 	202061202
	2483	 	4T12301301	 	1507	 	103151201	 	1367	 	202061203
	300198	 	4T12311304	 	1307	 	103161201	 	1473	 	202101201
	2608	 	5C01131401	 	212	 	103231201	 	725	 	202131202
	300496	 	5C03061401	 	470	 	103291201	 	646	 	202171201
	2290	 	5C06201302	 	1307	 	103291202	 	1240	 	202171202
	894	 	5C07011301	 	1077	 	104021201	 	392	 	202271201
	2522	 	5C09171301	 	270	 	104041201	 	1427	 	202291204
	2569	 	5C11061301	 	1179	 	104091201	 	1700	 	203011201
	2584	 	5C11271301	 	1738	 	104091202	 	1327	 	203081201
	2559	 	5T01241401	 	1481	 	104101201	 	1725	 	203281202
	300326	 	5T03101401	 	1607	 	104251202	 	1734	 	203291203
	2514	 	5T03241401	 	1750	 	104261201	 	860	 	203291204
	300548	 	5T03261401	 	1759	 	104301202	 	1335	 	203291206
	2181	 	5T04121301	 	1618	 	105111202	 	1533	 	203301201
	2196	 	5T04251301	 	2	 	105161201	 	1616	 	203301202
	1989	 	5T04291301	 	1782	 	105241201	 	1735	 	203301204
	1989	 	5T06281301	 	1315	 	105241203	 	1732	 	203301207
	1989	 	5T08081301	 	1787	 	105311204	 	1493	 	204051201
	1989	 	5T08301302	 	1503	 	106051201	 	1686	 	204111201

  
 SI-8 

											
	Customer #	 	Contract #	 	Customer #	 	Contract #	 	Customer #	 	Contract #
	1385	 	204121101	 	1207	 	301051201	 	1582	 	304231201
	1743	 	204181201	 	1265	 	301261201	 	1748	 	304241206
	1496	 	204201201	 	1672	 	301301203	 	1748	 	304241207
	1744	 	204231202	 	1685	 	302071201	 	1758	 	304301201
	1736	 	204241201	 	1684	 	302071202	 	1494	 	304301202
	1749	 	204241204	 	1383	 	302101202	 	1368	 	305011201
	1124	 	204301203	 	1571	 	302141203	 	1138	 	305091201
	1763	 	205041202	 	1278	 	302161201	 	736	 	305101201
	1766	 	205111201	 	1278	 	302161202	 	1373	 	305111201
	609	 	205151201	 	1278	 	302161203	 	700	 	305141201
	1775	 	205161201	 	1009	 	302171201	 	1774	 	305171202
	1756	 	205171201	 	1259	 	302171202	 	1138	 	305181202
	445	 	205231201	 	1171	 	302221201	 	1638	 	305251201
	1783	 	205251201	 	1659	 	302221202	 	1786	 	305311203
	1789	 	205311204	 	954	 	302221203	 	1570	 	306131207
	1810	 	206191202	 	1697	 	302231201	 	1807	 	306181201
	1775	 	206191203	 	1313	 	302271201	 	1321	 	306201201
	725	 	206261203	 	1699	 	302271203	 	1814	 	306251203
	967	 	206281204	 	1322	 	302271204	 	1069	 	306251205
	1390	 	207031201	 	1702	 	302281205	 	886	 	306271201
	499	 	207161201	 	953	 	302291208	 	1807	 	307181202
	1395	 	207231201	 	1553	 	302291209	 	1838	 	307231203
	1854	 	208011201	 	1553	 	302291210	 	1839	 	307231204
	1107	 	208061201	 	1313	 	303061201	 	1617	 	307241201
	1849	 	208071202	 	1571	 	303081201	 	167	 	307251203
	646	 	208081201	 	1714	 	303161203	 	1841	 	307261201
	1395	 	208081202	 	1171	 	303221201	 	1847	 	307301202
	1859	 	208101201	 	827	 	303231201	 	1850	 	307311202
	1471	 	208161201	 	1641	 	303261201	 	1848	 	308131201
	1346	 	208171102	 	1363	 	303261202	 	1863	 	308151201
	263	 	208221201	 	1363	 	303261203	 	736	 	308161201
	1392	 	208291202	 	717	 	303261204	 	1171	 	308181102
	1525	 	208301106	 	1570	 	303271201	 	1425	 	308281202
	1492	 	208301202	 	1570	 	303271203	 	778	 	308291201
	1882	 	208311202	 	1570	 	303271205	 	1877	 	308291202
	1395	 	209051201	 	1009	 	303271207	 	1865	 	308311201
	1893	 	209121202	 	1671	 	303291202	 	1321	 	309041202
	1897	 	209171201	 	1617	 	303291203	 	701	 	309111201
	1542	 	209191101	 	173	 	303301202	 	1894	 	309131201
	1299	 	209201201	 	1731	 	303301203	 	1629	 	309131203
	1346	 	209241202	 	1739	 	304101203	 	1905	 	309181208
	1547	 	209261101	 	700	 	304111201	 	1907	 	309191201
	1921	 	209261202	 	627	 	304121201	 	1204	 	309211002
	1547	 	210111102	 	1582	 	304161201	 	1699	 	309211201
	1586	 	210261101	 	1740	 	304161202	 	1919	 	309261201

  
 SI-9 

											
	Customer #	 	Contract #	 	Customer #	 	Contract #	 	Customer #	 	Contract #
	1924	 	309281204	 	300372	 	2W01311409	 	1425	 	3C12311302
	1540	 	309291106	 	300374	 	2W01311412	 	760	 	3C12311303
	1663	 	401251201	 	1424	 	2W02071403	 	760	 	3C12311304
	1661	 	402081201	 	89	 	2W02181401	 	1553	 	3T01311401
	1661	 	402141201	 	300482	 	2W02211402	 	1553	 	3T01311402
	1707	 	403071201	 	300486	 	2W02241401	 	960	 	3T02181402
	1727	 	403291201	 	1897	 	2W02261401	 	736	 	3T02271403
	1657	 	403301201	 	1599	 	2W02271401	 	2595	 	3T02271405
	1677	 	404091201	 	300485	 	2W02271403	 	300488	 	3T02281401
	1776	 	405171201	 	1736	 	2W02271404	 	182	 	3T02281402
	1795	 	406071201	 	1063	 	2W03071402	 	300467	 	3T03061403
	1795	 	406291201	 	788	 	2W03151401	 	300523	 	3T03131402
	1816	 	407111201	 	300372	 	2W03261401	 	2165	 	3T03181404
	1161	 	408041002	 	1757	 	2W03281403	 	1553	 	3T03271401
	1870	 	408211201	 	1757	 	2W03281404	 	300607	 	3T03281401
	1871	 	408221201	 	274	 	2W03311402	 	1553	 	3T03311401
	1532	 	408291102	 	1784	 	2W03311406	 	1553	 	3T03311404
	1880	 	408301201	 	1784	 	2W03311407	 	300616	 	3T03311406
	1885	 	409041201	 	1124	 	2W05131301	 	2199	 	3T03311407
	1890	 	409101201	 	857	 	2W10011201	 	2206	 	3T04301304
	1915	 	409191201	 	1395	 	2W10031202	 	1069	 	3T08291304
	1726	 	1C02261402	 	1935	 	2W10101201	 	1937	 	3T10051202
	916	 	1C02261403	 	1930	 	2W10121204	 	1944	 	3T10111203
	300408	 	1C03111401	 	1947	 	2W10151203	 	1946	 	3T10151202
	300216	 	1C12181301	 	300123	 	2W11081302	 	995	 	3T10161201
	1307	 	1C12241302	 	445	 	2W12031301	 	1952	 	3T10191201
	300270	 	1C12301303	 	1011	 	2W12131302	 	1956	 	3T10241202
	1767	 	1C12301306	 	2148	 	2W12201302	 	1866	 	3T10261201
	1595	 	1C12311301	 	896	 	2W12301303	 	1381	 	3T10261202
	1914	 	1T02261404	 	300258	 	2W12301305	 	2131	 	3T12201301
	300462	 	1T03181402	 	300259	 	2W12301306	 	2588	 	3T12311303
	300136	 	1T03281401	 	2509	 	2W12301307	 	1889	 	4C01301403
	300628	 	1T03311401	 	300269	 	2W12301310	 	300380	 	4C01311402
	300628	 	1T03311402	 	1876	 	2W12311303	 	300484	 	4C02241401
	1949	 	1T10171201	 	1118	 	3C01311401	 	300495	 	4C02281401
	1951	 	1T10191201	 	1118	 	3C01311402	 	300620	 	4C03311401
	1949	 	1T10311203	 	1284	 	3C01311405	 	300621	 	4C03311402
	2240	 	1T12181304	 	1554	 	3C02211401	 	2048	 	4C06281302
	1760	 	1T12201301	 	2174	 	3C02281401	 	1878	 	4C07251301
	1140	 	1T12261301	 	907	 	3C02281402	 	2464	 	4C08201303
	2173	 	1T12301301	 	626	 	3C03241402	 	1561	 	4C12261301
	1984	 	2W01301405	 	1310	 	3C03311406	 	2039	 	4C12261304
	369	 	2W01311401	 	1856	 	3C10301201	 	300292	 	4C12311303
	369	 	2W01311402	 	767	 	3C12271302	 	300292	 	4C12311305
	1599	 	2W01311408	 	2578	 	3C12301301	 	300473	 	4T02271401

  
 SI-10 

											
	Customer #	 	Contract #	 	Customer #	 	Contract #	 	Customer #	 	Contract #
	300491	 	4T02281402	 	300568	 	1T03201402	 	300395	 	3C02061401
	300577	 	4T03211403	 	2240	 	1T03271401	 	300395	 	3C02071401
	2245	 	4T12181302	 	1808	 	1T04081401	 	1425	 	3C02141401
	300381	 	5C01311401	 	2184	 	1T04301403	 	1425	 	3C02141402
	300436	 	5C02201401	 	300243	 	1T12261304	 	2502	 	3C02211402
	300440	 	5C02201403	 	300305	 	2W01141401	 	2020	 	3C02241401
	1943	 	5C10011201	 	300202	 	2W01241402	 	173	 	3C02261401
	1943	 	5C10181201	 	851	 	2W01271402	 	1383	 	3C03261401
	1592	 	5T01311401	 	1923	 	2W01271403	 	684	 	3C03281401
	300469	 	5T02271401	 	2287	 	2W01301402	 	1494	 	3C03311401
	300472	 	5T02271402	 	1101	 	2W01311403	 	607	 	3C03311402
	300475	 	5T02271404	 	1107	 	2W01311404	 	300629	 	3C03311407
	300483	 	5T02281401	 	716	 	2W01311405	 	2166	 	3T01161401
	2481	 	5T02281402	 	725	 	2W01311406	 	2469	 	3T01291402
	300521	 	5T03111401	 	1531	 	2W01311407	 	701	 	3T01291404
	300521	 	5T03171402	 	1931	 	2W01311410	 	2448	 	3T01311403
	300519	 	5T03311401	 	1931	 	2W01311411	 	1015	 	3T01311404
	2601	 	5T12271302	 	300396	 	2W02071402	 	960	 	3T01311405
	300274	 	1C01161401	 	719	 	2W02211403	 	778	 	3T01311406
	300319	 	1C01171401	 	300446	 	2W02211404	 	300392	 	3T02051401
	300350	 	1C01291401	 	300202	 	2W02251401	 	1832	 	3T02071402
	300256	 	1C02041401	 	300464	 	2W02261402	 	2183	 	3T02101401
	300408	 	1C02121401	 	1736	 	2W03031404	 	300411	 	3T02121402
	300417	 	1C02121402	 	300512	 	2W03051401	 	1777	 	3T02131401
	1441	 	1C02181402	 	300509	 	2W03051402	 	1819	 	3T02141401
	1499	 	1C02181403	 	1438	 	2W03061401	 	2199	 	3T02181401
	1307	 	1C02271401	 	300520	 	2W03061402	 	2202	 	3T02241401
	300408	 	1C03111402	 	725	 	2W03141401	 	1321	 	3T02251401
	300525	 	1C03141401	 	300520	 	2W03171401	 	300455	 	3T02251402
	300008	 	1C03181401	 	300584	 	2W03241401	 	300458	 	3T02261401
	300554	 	1C03281401	 	1572	 	2W03271401	 	1216	 	3T02261403
	2237	 	1C03311401	 	300039	 	2W03281401	 	1363	 	3T02271401
	1404	 	1C04231402	 	89	 	2W03281402	 	182	 	3T02281404
	2496	 	1C04301401	 	1606	 	2W03281405	 	1647	 	3T03041401
	1808	 	1T02181401	 	2164	 	2W03311401	 	2225	 	3T03061401
	2180	 	1T03071401	 	300300	 	2W03311404	 	300467	 	3T03061404
	2044	 	1T03111401	 	2148	 	2W04071401	 	1363	 	3T03071401
	2212	 	1T03111402	 	300677	 	2W04091401	 	300523	 	3T03131401
	300536	 	1T03141401	 	1897	 	2W04101401	 	300523	 	3T03131403
	300537	 	1T03141402	 	300726	 	2W04211401	 	2488	 	3T03141401
	2303	 	1T03141403	 	1852	 	2W04241401	 	2095	 	3T03141402
	300535	 	1T03141404	 	1721	 	2W04251403	 	2138	 	3T03171401
	300549	 	1T03181401	 	1382	 	3C01151401	 	300455	 	3T03181401
	300046	 	1T03181403	 	300349	 	3C01281401	 	1321	 	3T03181402
	1025	 	1T03191401	 	2256	 	3C01311406	 	2255	 	3T03201401

  
 SI-11 

											
	Customer #	 	Contract #	 	 	 	 	 	 	 	 
	2289	 	3T03211402	 		 		 		 	
	300575	 	3T03211403	 		 		 		 	
	1571	 	3T03211404	 		 		 		 	
	1553	 	3T03311402	 		 		 		 	
	1553	 	3T03311403	 		 		 		 	
	1638	 	3T03311405	 		 		 		 	
	300707	 	3T04281403	 		 		 		 	
	1561	 	4C01171401	 		 		 		 	
	300369	 	4C01301405	 		 		 		 	
	1677	 	4C01311401	 		 		 		 	
	300078	 	4C02241402	 		 		 		 	
	300448	 	4C02241403	 		 		 		 	
	300530	 	4C03131401	 		 		 		 	
	2495	 	4C03141401	 		 		 		 	
	300539	 	4C03141402	 		 		 		 	
	300556	 	4C03171401	 		 		 		 	
	300558	 	4C03191402	 		 		 		 	
	1545	 	4C03281401	 		 		 		 	
	1834	 	4C03311403	 		 		 		 	
	300623	 	4C03311404	 		 		 		 	
	2337	 	4T01291401	 		 		 		 	
	2337	 	4T03171402	 		 		 		 	
	300555	 	4T03191401	 		 		 		 	
	2454	 	4T03241401	 		 		 		 	
	300605	 	4T03271401	 		 		 		 	
	300107	 	4T03311401	 		 		 		 	
	300740	 	4T04241401	 		 		 		 	
	894	 	5C01291401	 		 		 		 	
	300404	 	5C02101401	 		 		 		 	
	2450	 	5C02121401	 		 		 		 	
	2590	 	5C02201402	 		 		 		 	
	300440	 	5C02201404	 		 		 		 	
	300314	 	5T01161401	 		 		 		 	
	300345	 	5T01241402	 		 		 		 	
	1592	 	5T01311402	 		 		 		 	
	300453	 	5T02251401	 		 		 		 	
	1989	 	5T03041401	 		 		 		 	
	300546	 	5T03171401	 		 		 		 	
	2551	 	5T03171404	 		 		 		 	
	300469	 	5T03191401	 		 		 		 	
	300546	 	5T03191402	 		 		 		 	
	300611	 	5T03281401	 		 		 		 	

  
 SI-12 

 SCHEDULE II 

Addresses for Notice 
  

			
	Commercial Credit Group Inc.,		Portfolio Financial Servicing Company,
	 as Originator and Servicer
		 as Back-Up Servicer

	227 West Trade Street, Suite 1450		7303 SE Lake Road
	Charlotte, NC 28202		Portland, Oregon 97267
			Attention: President
	CCG Receivables IV, LLC,		
	 as Depositor
		U.S. Bank National Association,
	227 West Trade Street, Suite 1450A		 as Indenture Trustee

	Charlotte, NC 28202		60 Livingston Avenue
			EP-MN-WS3D
	CCG Receivables Trust 2014-1,		St. Paul, MN 55107
	 as Issuer
		Attn: Global Structured Finance/CCG
	c/o Wilmington Trust, National Association,		Receivables Trust 2014-1
	as Owner Trustee		
	Rodney Square North		
	1100 North Market Street		
	Wilmington, Delaware 19890		
	Attention: Corporate Trust Administration		
		
	With a copy to:		
		
	Commercial Credit Group Inc.,		
	227 West Trade Street, Suite 1450		
	Charlotte, NC 28202		
		
	Standard & Poor’s Ratings Services,		
	 a Standard & Poor’s Financial

Services LLC business
		
	55 Water Street, 41st Floor		
	New York, New York 10004		
		
	DBRS, Inc.		
	 Attn: Surveillance
 e-mail address:
abs_surveillance@dbrs.com
		
	140 Broadway		
	New York, New York 10005		
	Main Line: 212-806-3223		

  
 SII-1 

 SCHEDULE III 

Schedule of Lock-Box Accounts 

Account number 2000026298881 of CCG maintained with Wells Fargo Bank, National Association, having offices located at 1 South Broad Street,
Mail Code: PA1227, Philadelphia, Pennsylvania and 401 S. Tryon Street, 10th Floor, TS Legal Risk Mgmt., Mail Code NC0817, Charlotte, North Carolina 28288 

  
 SIII-1 

 SCHEDULE IV 

List of Equipment Types 
  

			
	equip_type	 	Description
	1	 	Asphalt Plant
	2	 	Asphalt Paving
	3	 	Concrete Batching EQ
	4	 	Concrete Pump Equip
	5	 	Compaction Equipment
	6	 	Rock Crushing/Screening
	7	 	Excavation
	8	 	Front-End Loaders
	9	 	Crawler Tractor
	10	 	Off-Road Hauling Equipment
	11	 	Crawler Crane
	12	 	Hydraulic Truck Crane
	13	 	Rough Terrain Crane
	14	 	Motor Grader/Scraper
	15	 	Trencher
	16	 	Multiple Constr & Engin.
	17	 	Other-Constr & Engin.
	18	 	Packaging/Weighing
	19	 	Other-Food Process
	20	 	Tub Grinders
	21	 	Forklift-Rough Terrain
	22	 	Platerm-Scissor Lift
	23	 	Forklift
	24	 	Lathes
	25	 	Milling Machines
	26	 	Sheet Metal
	27	 	Plastic Injection
	28	 	Multiple Machine Tools
	29	 	Other-Machine Tools
	30	 	FL/RL Roll-Off Con
	31	 	Recycling
	32	 	Baling
	33	 	Portable Toilets
	34	 	Landfill Compact
	35	 	Truck - Rear Load
	36	 	Truck - Front Load

  
 SIV-1 

			
	37		Null
	38		Truck - Side Load
	39		Truck - Roll-Off
	40		Truck - Septic
	41		Truck - Vacuum
	42		Waterblaster
	43		Multiple Refuse Equip
	44		Other-Refuse Equip
	45		Null
	46		Tractor - Over Road
	47		Tractor - Day Cab
	48		Trailer - Dry Van
	49		Trailer - Dump
	50		Trailer - Refr
	51		Trailer - Tank
	52		Trailer - Walkg Floor
	53		Trailer - Flatbed
	54		Trailer Lowboy
	55		Dump Truck - General
	56		Truck - Light
	57		Truck Crane
	58		Roller
	59		Other - Constr & Engine
	60		Truck Heavy Equipment
	61		Sweeper
	62		Trailer Vacuum
	63		All Terrain Crane
	64		Dozer
	65		Skid Steer
	66		Multiple Vehicles
	67		Trailer - Roll off
	68		Vehicle - Other
	69		Backhoe Loaders
	70		Compaction Equipment
	71		Trailer Plate Van

  
 SIV-2 

 EXHIBIT A 

Form of Class [A-[    ] / B] Note 

CCG RECEIVABLES TRUST 2014-1 

[For Book-Entry Notes only] [UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY
(“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC, ANY
TRANSFER, PLEDGE OR OTHER USE OF THIS NOTE FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER OF THIS NOTE, CEDE & CO., HAS AN INTEREST IN THIS NOTE.] 

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), ANY UNITED STATES STATE
SECURITIES OR “BLUE SKY” LAWS OR ANY SECURITIES LAWS OF ANY OTHER JURISDICTION, AND, AS A MATTER OF UNITED STATES LAW, MAY NOT BE OFFERED OR SOLD IN VIOLATION OF THE ACT OR SUCH OTHER LAWS. THIS NOTE MAY BE TRANSFERRED ONLY IN MINIMUM
DENOMINATIONS OF $100,000 AND $1,000 INCREMENTS IN EXCESS THEREOF. THE HOLDER HEREOF, BY PURCHASING OR ACCEPTING THIS NOTE IS HEREBY DEEMED TO HAVE AGREED FOR THE BENEFIT OF THE ISSUER AND THE INITIAL PURCHASERS THAT IT WILL RESELL, PLEDGE OR
OTHERWISE TRANSFER THIS NOTE, AS A MATTER OF UNITED STATES LAW, ONLY (1) SO LONG AS THIS NOTE IS ELIGIBLE FOR RESALE, PURSUANT TO RULE 144A PROMULGATED UNDER THE ACT (“RULE 144A”), TO A PERSON WHOM THE SELLER REASONABLY BELIEVES IS A
QUALIFIED INSTITUTIONAL BUYER, AS DEFINED IN RULE 144A (A “QUALIFIED INSTITUTIONAL BUYER”), THAT IS ACQUIRING THIS NOTE FOR ITS OWN ACCOUNT OR AS A FIDUCIARY OR AGENT FOR OTHERS (WHICH OTHERS MUST ALSO BE QUALIFIED INSTITUTIONAL BUYERS) TO
WHOM NOTICE IS GIVEN THAT THE RESALE OR OTHER TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A OR (2) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE ACT OTHER THAN RULE 144A, IN EACH CASE IN ACCORDANCE WITH ANY UNITED STATES STATE
SECURITIES OR “BLUE SKY” LAWS OR ANY SECURITIES LAWS OF ANY OTHER JURISDICTION. 
 EACH NOTEHOLDER OR NOTE OWNER, BY ACCEPTANCE OF
A NOTE, OR, IN THE CASE OF A NOTE OWNER, A BENEFICIAL INTEREST IN THE NOTE, SHALL BE DEEMED TO REPRESENT THAT (I) IT IS NOT, AND IS NOT ACTING ON BEHALF OF OR INVESTING THE ASSETS OF, (A) AN “EMPLOYEE BENEFIT PLAN” (WITHIN THE
MEANING OF SECTION 3(3) OF THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED (“ERISA”)) THAT IS SUBJECT TO TITLE I OF ERISA, (B) A “PLAN” (WITHIN THE MEANING OF SECTION 4975(e)(1) OF THE INTERNAL REVENUE CODE
OF 1986, AS AMENDED (THE “CODE”)) THAT IS SUBJECT TO 

  
 EA-1 

 
SECTION 4975 OF THE CODE, (C) AN ENTITY WHOSE UNDERLYING ASSETS ARE DEEMED TO BE ASSETS OF AN EMPLOYEE BENEFIT PLAN OR PLAN DESCRIBED IN (A) OR (B) ABOVE BY REASON OF SUCH EMPLOYEE
BENEFIT PLAN’S OR PLAN’S INVESTMENT IN THE ENTITY (COLLECTIVELY, A “BENEFIT PLAN INVESTOR”) OR (D) ANY GOVERNMENTAL, CHURCH, NON-U.S. OR OTHER PLAN THAT IS SUBJECT TO ANY FEDERAL, STATE, LOCAL OR NON-U.S. LAW OR REGULATION
THAT IS SUBSTANTIALLY SIMILAR TO ERISA OR SECTION 4975 OF THE CODE, OR (II) ITS ACQUISITION, HOLDING AND DISPOSITION OF THE NOTE (OR ANY BENEFICIAL INTEREST THEREIN) WILL NOT CONSTITUTE OR RESULT IN A NON-EXEMPT PROHIBITED TRANSACTION UNDER ERISA OR
SECTION 4975 OF THE CODE OR RESULT IN A NON-EXEMPT VIOLATION OF ANY OTHER SUBSTANTIALLY SIMILAR APPLICABLE LAW. 
 THIS NOTE AND RELATED
DOCUMENTATION MAY BE AMENDED OR SUPPLEMENTED FROM TIME TO TIME TO MODIFY THE RESTRICTIONS ON AND PROCEDURES UNDERTAKEN OR REPRESENTED BY THE HOLDER, FOR RESALES AND OTHER TRANSFERS OF THIS NOTE, TO REFLECT ANY CHANGE IN APPLICABLE LAWS OR
REGULATIONS (OR THE INTERPRETATION THEREOF) OR IN PRACTICES RELATING TO RESALES OR OTHER TRANSFERS OF RESTRICTED SECURITIES GENERALLY. THE HOLDER OF THIS NOTE AND ANY BENEFICIAL OWNER OF ANY INTEREST THEREIN SHALL BE DEEMED, BY ITS ACCEPTANCE OR
PURCHASE HEREOF OR THEREOF, TO HAVE AGREED TO ANY SUCH AMENDMENT OR SUPPLEMENT (EACH OF WHICH SHALL BE CONCLUSIVE AND BINDING ON THE HOLDER HEREOF AND ALL FUTURE HOLDERS OF THIS NOTE AND ANY NOTES ISSUED IN EXCHANGE OR SUBSTITUTION HEREFOR, WHETHER
OR NOT ANY NOTATION THEREOF IS MADE HEREON) AND AGREES TO TRANSFER THIS NOTE ONLY IN ACCORDANCE WITH ANY SUCH AMENDMENT OR SUPPLEMENT IN ACCORDANCE WITH APPLICABLE LAW IN EFFECT AT THE DATE OF SUCH TRANSFER. 

  
 EA-2 

			
	REGISTERED		$[            ]
		
	No. R-[    ]		[CUSIP Number]

 CCG RECEIVABLES TRUST 2014-1 

CLASS [A-[    ] / B] [    ]% ASSET BACKED NOTES 

CCG Receivables Trust 2014-1, a statutory trust organized under the laws of the State of Delaware (the “Issuer”), for value
received, promises to pay to [                    ], or registered assigns, the principal sum of
[             DOLLARS [$            ]] payable on the fourteenth day of each calendar month, or, if any such day is not a
Business Day, the next succeeding Business Day, commencing in June 2014 (each, a “Payment Date”) in an amount equal to the aggregate amount payable to Noteholders of Class [A-[    ] / B] Notes on such Payment
Date from the Collection Account in respect of principal on the Class [A-[    ] / B] Notes pursuant to Sections 4.5(a) and (b) of the Indenture, dated as of May 14, 2014, (the “Indenture”), between the
Issuer and U.S. Bank National Association, as Indenture Trustee (the “Indenture Trustee”). However, the entire unpaid principal amount of this Note and accrued interest thereon will be due and payable on the earlier of the
[                    ] Payment Date (the “Class [A-[    ] / B] Maturity Date”) or the redemption date pursuant
to Section 3.13 of the Indenture. Notwithstanding the foregoing, the entire unpaid principal amount of the Notes will be due and payable on the date on which the Notes are declared to be immediately due and payable in the manner provided in
Section 7.2(a) of the Indenture. All principal payments on the Notes will be made ratably to the Noteholders entitled to such principal payments. Capitalized terms used but not otherwise defined in this Note are defined in the Indenture. 

The Issuer will pay interest on this Note at the rate per annum shown above on each Payment Date until the principal of this Note is paid or
made available for payment, on the principal amount of this Note outstanding on the preceding Payment Date (after giving effect to all payments of principal made on the preceding Payment Date), subject to certain limitations contained in the
Indenture. Interest on this Note will accrue for each Payment Date [Class A-1:][from and including the previous Payment Date on which interest has been paid (or, in the case of the initial Payment Date, from and including the Closing Date) to
but excluding such Payment Date][other than Class A-1][from and including the fourteenth day of the calendar month preceding such Payment Date (or, in the case of the first Payment Date, from and including the Closing Date) to but
excluding the fourteenth day of the calendar month of such Payment Date]. [Class A-1:][Interest will be computed on the basis of actual days elapsed in the related Interest Period and a 360-day year.][other than
Class A-1:][Interest will be computed on the basis of a 360-day year of twelve 30 day months.] 
 The principal of and interest on
this Note are payable in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts. All payments made by the Issuer with respect to this Note will be applied first to
interest due and payable on this Note as provided above and then to the unpaid principal of this Note. 

  
 EA-3 

 The Notes are and will be equally and ratably secured by the collateral pledged as security
therefor as provided in the Indenture. Interest on and principal of the Notes will be payable in accordance with the priority of payments set forth in Sections 4.5(a) and (b) of the Indenture. [for Class A-2 and Class B only:] [The
Class [A-2][B] Notes are subordinated in right of payment to the Class [A-1][A] Notes.] 
 Payments of interest on this Note on each Payment
Date, together with any installment of principal to the extent not in full payment of this Note, will be made to the Registered Noteholder of this Note either by wire transfer in immediately available funds, to the account of such Noteholder at a
bank or other entity having appropriate facilities for such wire transfer, if such Noteholder has provided to the Note Registrar appropriate written instructions at least five Business Days before such Payment Date and such Noteholder’s Notes
in the aggregate evidence a denomination of not less than $1,000,000, or, if not, by check mailed first class mail, postage prepaid, to such Registered Noteholder’s address as it appears on the Note Register on each Record Date. However, unless
Definitive Notes have been issued to [Note Owner]s, payment will be made by wire transfer in immediately available funds to the account designated by Cede & Co., as nominee of the Clearing Agency or any successor nominee. Such payments will
be made without requiring that this Note be submitted for notation of payment. Any reduction in the principal amount of this Note effected by any payments made on any Payment Date will be binding upon all future Noteholders of this Note and of any
Note issued upon the registration of transfer of this Note or in exchange of this Note or in lieu of this Note, whether or not noted on this Note. If funds are expected to be available for payment in full of the then remaining unpaid principal
amount of this Note on a Payment Date, then the Indenture Trustee, in the name of and on behalf of the Issuer, will notify the Registered Noteholder of this Note as of the preceding Record Date by notice mailed or transmitted by facsimile before
such Payment Date, and the amount then due and payable will be payable only upon presentation and surrender of this Note at the Indenture Trustee’s Corporate Trust Office or at the office of the Indenture Trustee’s agent appointed for such
purposes located in The City of St. Paul, Minnesota. 
 The Issuer will pay interest on overdue installments of interest at the Note Rate
set forth herein to the extent lawful. 
 The Notes may be redeemed, in whole but not in part, in the manner and to the extent described in
the Indenture and the Sale and Servicing Agreement. 
 The transfer of this Note is subject to the restrictions on transfer specified on the
face of this Note and to the other limitations set forth in the Indenture. Subject to the satisfaction of such restrictions and limitations, the transfer of this Note may be registered on the Note Register upon surrender of this Note for
registration of transfer at the office or agency designated by the Issuer pursuant to the Indenture, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Indenture Trustee duly executed by, the Noteholder
of this Note or such Noteholder’s attorney duly authorized in writing, with such signature guaranteed by an “eligible guarantor institution” meeting the requirements of the Note Registrar, and thereupon one or more new Notes in
authorized denominations and in the same aggregate principal amount will be issued to the designated transferee or transferees. No service charge will be charged for any registration of transfer or exchange of this Note, but the transferor may be
required to pay an amount sufficient to cover any tax or other governmental charge that may be imposed in connection with any such registration of transfer or exchange. 

  
 EA-4 

 Each Noteholder or [Note Owner], by its acceptance of a Note [or, in the case of a Note Owner, a
beneficial interest in a Note], covenants and agrees that no recourse may be taken, directly or indirectly, with respect to the obligations of the Issuer, the Owner Trustee or the Indenture Trustee on the Notes or under the Indenture or any
certificate or other writing delivered in connection with the Notes and the Indenture, against (i) the Indenture Trustee or the Owner Trustee, each in its individual capacity, (ii) any holder of a beneficial interest in the Issuer,
(iii) any partner, owner, beneficiary, agent, officer, director, employee or agent of the Indenture Trustee or the Owner Trustee, each in its individual capacity, or (iv) any holder of a beneficial interest in the Owner Trustee or the
Indenture Trustee, each in its individual capacity, except as any such Person may have agreed. 
 The obligations of the Issuer under the
Indenture are solely the obligations of the Issuer and do not represent any obligation or interest in any assets of the Depositor. Each Noteholder and [Note Owner], by its acceptance of a Note or a beneficial interest in a Note, acknowledges and
agrees that it has no right, title or interest in or to any Other Assets of the Depositor. Notwithstanding the preceding sentence, if such Noteholder or [Note Owner] either (i) asserts an interest or claim to, or benefit from, Other Assets, or
(ii) is deemed to have any such interest, claim to, or benefit in or from Other Assets, whether by operation of law, legal process, pursuant to insolvency laws or otherwise (including by virtue of Section 1111(b) of the Bankruptcy Code),
then such Noteholder or [Note Owner] further acknowledges and agrees that any such interest, claim or benefit in or from Other Assets is and will be expressly subordinated to the indefeasible payment in full of the other obligations and liabilities,
which, under the relevant documents relating to the securitization or conveyance of such Other Assets, are entitled to be paid from, entitled to the benefits of, or otherwise secured by such Other Assets (whether or not any such entitlement or
security interest is legally perfected or otherwise entitled to a priority of distributions or application under applicable law, including insolvency laws, and whether or not asserted against the Depositor), including the payment of post-petition
interest on such other obligations and liabilities. 
 The Issuer has entered into the Indenture and this Note is issued with the intention
that, for federal, state, and local income and franchise tax purposes, Notes that are beneficially owned by a Person other than Commercial Credit Group Inc. or its Affiliates will qualify as indebtedness of the Issuer secured by the Collateral. Each
Noteholder or [Note Owner], by its acceptance of a Note or a beneficial interest in a Note, will be deemed to agree to treat the Notes for federal, state and local income, single business and franchise tax purposes as indebtedness of the Issuer.

 With respect to any date of determination, the Issuer, the Indenture Trustee and any agent of the Issuer or the Indenture Trustee may
treat the Person in whose name this Note is registered as of such date as the owner of such Note for the purpose of receiving payments of principal of and any interest on such Note and for all other purposes, and none of the Issuer, the Indenture
Trustee or any agent of the Issuer or the Indenture Trustee will recognize notice to the contrary. 

  
 EA-5 

 The Indenture permits, with certain exceptions requiring the consent of all adversely affected
Noteholders as provided in the Indenture, the amendment of the Indenture and the modification of the rights and obligations of the Issuer and the rights of the Noteholders under the Indenture by the Issuer with the consent of the Majority Holders.

 The term “Issuer”, as used in this Note, includes any successor to the Issuer under the Indenture. 

The Issuer is permitted by the Indenture, under certain circumstances, to merge or consolidate, subject to the rights of the Indenture Trustee
and the Noteholders under the Indenture. 
 The Notes are issuable only in registered form in denominations as provided in the Indenture,
subject to certain limitations set forth in the Indenture. 
 THIS NOTE AND THE INDENTURE WILL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE
WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REFERENCE TO THE CONFLICTS OF LAW PRINCIPLES THEREOF OTHER THAN SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW. 

No reference in this Note to the Indenture, and no provision of this Note or of the Indenture, will alter or impair the obligation of the
Issuer, which is absolute and unconditional, to pay the principal of and interest on this Note at the time, place and rate, and in the coin or currency prescribed in this Note. 

Anything in this Note to the contrary notwithstanding, except as provided in the Transaction Documents, none of U.S. Bank National
Association, in its individual capacity, Wilmington Trust, National Association, in its individual capacity, any owner of a beneficial interest in the Issuer, or any of their respective partners, beneficiaries, agents, officers, directors, employees
or successors or assigns will be personally liable for, nor will recourse be had to any of them for, the payment of principal or of interest on this Note or performance of, or omission to perform, any of the covenants, obligations or
indemnifications contained in the Indenture. The Noteholder of this Note, by its acceptance of this Note, agrees that, except as provided in the Transaction Documents, in the case of an Event of Default under the Indenture, the Noteholder has no
claim against any of the foregoing for any deficiency, loss or claim therefrom; provided, however, that nothing contained in this Note will be taken to prevent recourse to, and enforcement against, the assets of the Issuer for any and all
liabilities, obligations and undertakings contained in the Indenture or in this Note. 
 Unless the certificate of authentication on this
Note has been executed by the Indenture Trustee whose name appears below by manual signature, this Note will not be entitled to any benefit under the Indenture, or be valid or obligatory for any purpose. 

[Remainder of This Page Intentionally Left Blank] 

  
 EA-6 

 The Issuer has caused this instrument to be signed, manually or in facsimile, by its Responsible
Officer, as of the date set forth below. 
 Date:
[                    ] 
  

			
	CCG RECEIVABLES TRUST 2014-1
		
	By:		 WILMINGTON TRUST, NATIONAL ASSOCIATION,
 not in
its individual capacity but solely as Owner Trustee of CCG Receivables Trust 2014-1

		
	By:		  

			Responsible Officer

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

This is one of the Class [A-[    ]][B] Notes designated above and referred to in the Indenture. 

Date: [                    ] 

 

			
	U.S. BANK NATIONAL ASSOCIATION,
			not in its individual capacity but solely as Indenture Trustee
		
	By:		  

			Responsible Officer

  
 EA-7 

 ASSIGNMENT 

Social Security or taxpayer I.D. or other identifying number of assignee: 

                          
              . 
 FOR VALUE RECEIVED, the undersigned hereby sells, assigns and
transfers unto: 
  

	
	  

	(name and address of assignee)

 the within Note and all rights under said Note, and hereby irrevocably constitutes and appoints
                    , attorney, to transfer said Note on the books kept for registration of said Note, with full power of substitution in the
premises. 
  

									
	Dated:		  
				  
		*/
					
							Signature Guaranteed*/		

  

	*/	NOTICE: The signature to this assignment must correspond with the name of the registered owner as it appears on the face of the within Note in every particular, without alteration, enlargement or any change whatever.
Such signature must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Note Registrar, which requirements include membership or participation in the Securities Transfer Agents Medallion Program or such
other “signature guarantee program” as may be determined by the Note Registrar in addition to, or in substitution for, the Securities Transfer Agents Medallion Program, all in accordance with the Exchange Act. 

  
 EA-8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}]]